Term,Overlap,P.value,Adjusted.P.value,Old.P.value,Old.Adjusted.P.value,Odds.Ratio,Combined.Score,Genes
SRP-dependent cotranslational protein targeting to membrane (GO:0006614),58/90,1.00539071332528e-99,1.4266494222085724e-96,0,0,296.4261363636364,67570.50021700923,RPL4;RPL5;RPL30;RPL3;RPL32;RPL31;RPL34;RPLP1;RPLP0;RPL10A;RPL9;RPL6;RPL7;RPS4X;RPL7A;RPS14;RPS16;RPS19;RPS18;RPL38;RPL37;RPS11;RPL39;RPS13;RPS12;RPL21;RPS7;RPS8;RPL23;RPS5;RPS6;RPL13A;RPS3A;RPSA;RPL37A;RPL24;RPL27;RPL29;UBA52;RPL10;RPL12;RPL11;RPL14;RPS3;RPL13;RPS2;RPS27A;RPL19;RPL35A;RPL23A;RPS26;RPS25;RPS27;RPS29;RPL27A;RPS20;RPS24;RPS23
cytoplasmic translation (GO:0002181),58/93,1.9591043572635493e-98,1.3899845414784882e-95,0,0,270.9770956316411,60964.65776780592,RPL4;RPL5;RPL30;RPL3;RPL32;RPL31;RPL34;RPLP1;RPLP0;RPL10A;RPL9;RPL6;RPL7;RPS4X;RPL7A;RPS14;RPS16;RPS19;RPS18;RPL38;RPL37;RPS11;RPL39;RPS13;RPS12;RPL21;RPS7;RPS8;RPL23;RPS5;RPS6;RPL13A;RPS3A;RPSA;RPL37A;RPL24;RPL27;RPL29;UBA52;RPL10;RPL12;RPL11;RPL14;RPS3;RPL13;RPS2;RPS27A;RPL19;RPL35A;RPL23A;RPS26;RPS25;RPS27;RPS29;RPL27A;RPS20;RPS24;RPS23
cotranslational protein targeting to membrane (GO:0006613),58/94,5.0859139845018926e-98,2.4056373146693953e-95,0,0,263.4366391184573,59016.88421892067,RPL4;RPL5;RPL30;RPL3;RPL32;RPL31;RPL34;RPLP1;RPLP0;RPL10A;RPL9;RPL6;RPL7;RPS4X;RPL7A;RPS14;RPS16;RPS19;RPS18;RPL38;RPL37;RPS11;RPL39;RPS13;RPS12;RPL21;RPS7;RPS8;RPL23;RPS5;RPS6;RPL13A;RPS3A;RPSA;RPL37A;RPL24;RPL27;RPL29;UBA52;RPL10;RPL12;RPL11;RPL14;RPS3;RPL13;RPS2;RPS27A;RPL19;RPL35A;RPL23A;RPS26;RPS25;RPS27;RPS29;RPL27A;RPS20;RPS24;RPS23
protein targeting to ER (GO:0045047),58/103,1.3670032858481324e-94,4.849444156546249e-92,0,0,210.6534435261708,45528.608329970986,RPL4;RPL5;RPL30;RPL3;RPL32;RPL31;RPL34;RPLP1;RPLP0;RPL10A;RPL9;RPL6;RPL7;RPS4X;RPS14;RPL7A;RPS16;RPS19;RPS18;RPL38;RPL37;RPS11;RPL39;RPS13;RPS12;RPL21;RPS7;RPS8;RPL23;RPS5;RPS6;RPL13A;RPSA;RPS3A;RPL37A;RPL24;RPL27;RPL29;UBA52;RPL10;RPL12;RPL11;RPL14;RPS3;RPL13;RPS2;RPS27A;RPL19;RPL35A;RPL23A;RPS26;RPS25;RPS27;RPS29;RPL27A;RPS20;RPS24;RPS23
"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",58/113,2.73715743937177e-91,7.768052812937083e-89,0,0,172.2656649135988,35922.27030301768,RPL4;RPL5;RPL30;RPL3;RPL32;RPL31;RPL34;RPLP1;RPLP0;RPL10A;RPL9;RPL6;RPL7;RPS4X;RPS14;RPL7A;RPS16;RPS19;RPS18;RPL38;RPL37;RPS11;RPL39;RPS13;RPS12;RPL21;RPS7;RPS8;RPL23;RPS5;RPS6;RPL13A;RPSA;RPS3A;RPL37A;RPL24;RPL27;RPL29;UBA52;RPL10;RPL12;RPL11;RPL14;RPS3;RPL13;RPS2;RPS27A;RPL19;RPL35A;RPL23A;RPS26;RPS25;RPS27;RPS29;RPL27A;RPS20;RPS24;RPS23
nuclear-transcribed mRNA catabolic process (GO:0000956),59/171,7.222469987693335e-80,1.7081141520894737e-77,0,0,86.5201636904762,15766.53572465586,RPL4;RPL5;RPL30;RPL3;RPL32;RPL31;RPL34;RPLP1;RPLP0;RPL10A;RPL9;RPL6;RPL7;RPS4X;RPS14;RPL7A;RPS16;RPS19;RPS18;RPL38;RPL37;RPS11;RPL39;RPS13;RPS12;RPL21;RPS7;RPS8;RPL23;RPS5;RPS6;RPL13A;RPSA;RPS3A;RPL37A;RPL24;RPL27;RPL29;UBA52;DDX5;RPL10;RPL12;RPL11;RPL14;RPS3;RPL13;RPS2;RPS27A;RPL19;RPL35A;RPL23A;RPS26;RPS25;RPS27;RPS29;RPL27A;RPS20;RPS24;RPS23
peptide biosynthetic process (GO:0043043),57/162,1.2446536222687858e-77,2.523090699999153e-75,0,0,87.72927400468384,15535.116937814499,RPL4;RPL5;RPL30;RPL3;RPL32;RPL31;RPL34;RPLP1;RPLP0;RPL10A;RPL9;RPL6;RPL7;RPS4X;RPS14;RPL7A;RPS16;RPS19;RPS18;RPL38;RPL37;RPS11;RPL39;RPS13;RPS12;RPL21;RPS7;RPS8;RPL23;RPS5;RPS6;RPL13A;RPSA;RPS3A;RPL37A;RPL24;RPL27;RPL29;RPL10;RPL12;RPL11;RPL14;RPS3;RPL13;RPS2;RPS27A;RPL19;RPL35A;RPL23A;RPS26;RPS25;RPS27;RPS29;RPL27A;RPS20;RPS24;RPS23
translation (GO:0006412),60/214,6.321192128944811e-75,1.1212214538715858e-72,0,0,64.39048346611372,11001.112436089792,RPL4;RPL5;RPL30;RPL3;RPL32;RPL31;RPL34;RPLP1;RPLP0;RPL10A;RPL9;RPL6;RPL7;EEF1B2;RPS4X;RPS14;RPL7A;RPS16;RPS19;RPS18;RPL38;RPL37;RPS11;RPL39;RPS13;RPS12;RPL21;RPS7;RPS8;RPL23;RPS5;RPS6;RPL13A;RPSA;RPS3A;RPL37A;RPL24;RPL27;RPL29;UBA52;RPL10;RPL12;RPL11;RPS3;RPL14;RPL13;RPS2;RPS27A;RPL19;RPL35A;RPL23A;EEF2;RPS26;RPS25;RPS27;RPS29;RPL27A;RPS20;RPS24;RPS23
gene expression (GO:0010467),64/356,1.571906713827058e-66,2.4783729188006614e-64,0,0,37.22025014889815,5639.550025181064,RPL4;RPL5;RPL30;RPL3;RPL32;RPL31;RPL34;RPLP1;RPLP0;RPL10A;RPL9;RPL6;RPL7;RPS4X;RPS14;RPL7A;RPS16;RPS19;RPS18;RPL38;RPL37;RPS11;RPL39;RPS13;RPS12;DDX17;RPL21;RPS7;RPS8;RPL23;RPS5;RPS6;RPL13A;RPSA;RPS3A;HNRNPH1;RPL37A;SRSF3;RPL24;RPL27;RPL29;RPL10;RPL12;RPL11;BAZ2A;HSPD1;RPS3;RPL14;RPL13;RPS2;RPS27A;RPL19;RBM39;RPL35A;RPL23A;RPS26;RPS25;RPS27;RPS29;RPL27A;HNRNPA2B1;RPS20;RPS24;RPS23
cellular macromolecule biosynthetic process (GO:0034645),61/314,1.99370758621277e-65,2.8290710648359205e-63,0,0,39.98284986936424,5956.566408463811,RPL4;RPL5;RPL30;RPL3;RPL32;RPL31;RPL34;RPLP1;RPLP0;RPL10A;RPL9;RPL6;RPL7;EEF1B2;RPS4X;RPS14;RPL7A;RPS16;RPS19;RPS18;RPL38;RPL37;RPS11;RPL39;RPS13;RPS12;RPL21;RPS7;RPS8;RPL23;RPS5;RPS6;RPL13A;RPSA;RPS3A;RPL37A;RPL24;RPL27;RPL29;RPL10;RPL12;RPL11;BAZ2A;RPS3;RPL14;RPL13;RPS2;RPS27A;RPL19;RPL35A;RPL23A;EEF2;RPS26;RPS25;RPS27;RPS29;RPL27A;RPS20;RPS24;EIF4G2;RPS23
cellular protein metabolic process (GO:0044267),59/417,1.377647150523661e-54,1.777164824175523e-52,0,0,26.729911545623835,3315.022725520435,RPL4;RPL5;RPL30;RPL3;RPL32;RPL31;RPL34;RPLP1;RPLP0;RPL10A;RPL9;RPL6;RPL7;RPS4X;RPS14;RPL7A;RPS16;RPS19;RPS18;RPL38;RPL37;RPS11;RPL39;RPS13;RPS12;RPL21;RPS7;RPS8;RPL23;RPS5;RPS6;RPL13A;RPSA;RPS3A;RPL37A;RPL24;RPL27;RPL29;UBA52;RPL10;PRKDC;RPL12;RPL11;RPS3;RPL14;RPL13;RPS2;RPS27A;RPL19;RPL35A;RPL23A;RPS26;RPS25;RPS27;RPS29;RPL27A;RPS20;RPS24;RPS23
rRNA processing (GO:0006364),44/173,2.9059676695366897e-52,3.4363067692271357e-50,0,0,49.75297157622739,5904.068635194729,RPL4;RPL5;RPL30;RPL3;RPL32;RPL10;RPL31;PRKDC;RPL34;RPLP1;RPL12;RPLP0;RPL11;RPL10A;RPL9;RPL6;RPL7;RPS14;RPL7A;RPS16;RPS19;RPL14;RPL13;RPL38;RPL37;RPS2;RPL39;RPL19;RPL21;RPS7;RPL23;RPS6;RPL13A;RPL35A;RPL23A;RPS25;RPS27;RPL27A;RPL37A;RPL24;RPL27;RPL29;UBA52;RPS24
rRNA metabolic process (GO:0016072),43/162,5.9285406135172636e-52,6.471230100446921e-50,0,0,52.347132970835396,6174.5875782245985,RPL4;RPL5;RPL30;RPL3;RPL32;RPL10;RPL31;RPL34;RPLP1;RPL12;RPLP0;RPL11;RPL10A;RPL9;RPL6;RPL7;RPS14;RPL7A;RPS16;RPS19;RPL14;RPL13;RPL38;RPL37;RPS2;RPL39;RPL19;RPL21;RPS7;RPL23;RPS6;RPL13A;RPL35A;RPL23A;RPS25;RPS27;RPL27A;RPL37A;RPL24;RPL27;RPL29;UBA52;RPS24
ribosome biogenesis (GO:0042254),44/192,4.791058504555154e-50,4.85608001283126e-48,0,0,43.32392392392392,4919.973252736068,RPL4;RPL5;RPL30;RPL3;RPL32;RPL10;RPL31;RPL34;RPLP1;RPL12;RPLP0;RPL11;RPL10A;RPL9;RPL6;RPL7;RPS14;RPL7A;RPS16;RPS19;RPL14;RPL13;RPL38;RPL37;RPS2;RPL39;RPL19;NPM1;RPL21;RPS7;RPL23;RPS6;RPL13A;RPL35A;RPL23A;RPS25;RPS27;RPL27A;RPL37A;RPL24;RPL27;RPL29;UBA52;RPS24
ncRNA processing (GO:0034470),44/201,4.391440322153244e-49,4.154302544756969e-47,0,0,40.82170323189431,4545.374691534959,RPL4;RPL5;RPL30;RPL3;RPL32;RPL10;RPL31;RPL34;RPLP1;RPL12;RPLP0;RPL11;RPL10A;RPL9;RPL6;RPL7;RPS14;RPL7A;RPS16;RPS19;RPL14;RPL13;RPL38;RPL37;RPS2;RPL39;RPL19;RPL21;RPS7;RPL23;RPS6;RPL13A;RPL35A;RPL23A;RPS25;RPS27;RPL27A;RPL37A;HNRNPA2B1;RPL24;RPL27;RPL29;UBA52;RPS24
ribosome assembly (GO:0042255),15/50,1.787438138248426e-19,1.585234198859073e-17,0,0,51.70557491289198,2232.043495437699,RPL5;NPM1;DDX3X;RPL3;RPL10;RPS5;RPLP0;RPL11;RPSA;RPL23A;RPL6;RPS14;RPS27;RPS19;RPL24
ribosomal large subunit biogenesis (GO:0042273),14/57,6.955916722262924e-17,5.8061446052300524e-15,0,0,39.026356589147284,1451.9503841772125,RPL5;NPM1;RPL3;RPL10;RPLP0;RPL11;RPL35A;RPL23A;RPL10A;RPL6;RPL7;RPL7A;RPL14;RPL24
ribonucleoprotein complex assembly (GO:0022618),17/136,5.145784258334077e-15,4.056593256986697e-13,0,0,17.37389770723104,571.611634688668,RPL5;HSP90AA1;RPL3;HSP90AB1;RPL10;PRKDC;RPS5;RPLP0;RPL11;RPSA;RPL23A;RPL6;RPS14;RPS27;RPS19;RPL24;RPL38
ribonucleoprotein complex biogenesis (GO:0022613),13/60,5.451703260474412e-15,4.0715615403227325e-13,0,0,32.94821840553704,1082.11333918451,RPL5;NPM1;RPS7;RPS6;RPL11;RPL35A;RPL7;RPS25;RPS16;RPS19;RPL14;RPL38;RPS24
ribosomal small subunit biogenesis (GO:0042274),11/40,3.9946073375293895e-14,2.834173905977102e-12,0,0,44.6863711001642,1378.6302283737637,RPS14;RPS25;NPM1;RPS16;RPS27;RPS19;RPS7;RPS5;RPS6;RPSA;RPS24
ribosomal large subunit assembly (GO:0000027),8/25,3.341178580261204e-11,2.2576820978050703e-9,0,0,54.50017199862401,1314.6592753068373,RPL5;RPL3;RPL10;RPL11;RPLP0;RPL24;RPL23A;RPL6
ribosomal small subunit assembly (GO:0000028),6/17,5.388331105410302e-9,3.4754735629896446e-7,0,0,62.45927482921702,1189.164015240802,RPS14;RPS27;RPS19;PRKDC;RPS5;RPSA
regulation of translation (GO:0006417),11/178,6.183754973978906e-7,3.815107960033073e-5,0,0,7.705802680353578,110.16346481995306,RPS4X;RPL5;NPM1;DDX3X;RPL10;PRKDC;RACK1;RPS3;RPL13A;EEF2;EIF4G2
negative regulation of ubiquitin protein ligase activity (GO:1904667),4/9,7.548301755239691e-7,4.462933412785467e-5,0,0,90.58742857142857,1276.9904213993627,RPL5;RPS7;RPL23;RPL11
positive regulation of signal transduction by p53 class mediator (GO:1901798),5/22,1.2638023783008579e-6,7.173342299235669e-5,0,0,33.475321162947935,454.641245492246,DDX5;RPS7;RPL23;RPS20;RPL37
negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),5/26,3.066599277268182e-6,1.6736555286321348e-4,0,0,27.0935960591133,343.9516125956887,RPL5;HSP90AB1;RPS7;RPL23;RPL11
protein stabilization (GO:0050821),10/179,5.017226275225519e-6,2.636831142424078e-4,0,0,6.880711459682784,83.96279886667072,RPL5;HSP90AA1;HSP90AB1;RPS7;USP9X;RPL23;RPL11;HPS4;MDM4;HSPD1
regulation of RNA splicing (GO:0043484),7/76,5.314771435906962e-6,2.6934502384114216e-4,0,0,11.65015166835187,141.49133143075784,RPS26;RBM39;SON;HNRNPH1;TRA2B;SRSF3;RPS13
negative regulation of ubiquitin-protein transferase activity (GO:0051444),4/15,7.840621602909468e-6,3.836497260182253e-4,0,0,41.163636363636364,483.92763064824004,RPL5;RPS7;RPL23;RPL11
positive regulation of cellular amide metabolic process (GO:0034250),7/81,8.141778687442232e-6,3.851061319160175e-4,0,0,10.860229415461973,127.26561892928807,RPS4X;RPL5;NPM1;DDX3X;PRKDC;RACK1;EEF2
negative regulation of programmed cell death (GO:0043069),14/381,8.992895104378008e-6,4.116425210681417e-4,0,0,4.497663281314508,52.25869025222982,KANK2;NPM1;DDX3X;RPL10;PRKDC;RPS3A;YWHAZ;HSPD1;SON;MYO18A;RPS27A;UBA52;CD44;TPT1
regulation of apoptotic process (GO:0042981),20/742,1.155762232884015e-5,5.125083151445054e-4,0,0,3.3274098851896374,37.826545917688065,HSP90AA1;NPM1;DDX3X;RPL10;PRKDC;RPS6;RPS3A;YWHAZ;HSPD1;PREX1;AKAP13;SON;TP53INP1;RACK1;MYO18A;RPS3;RPS27A;UBA52;CD44;TPT1
negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),5/38,2.1451969211677395e-5,9.22434676102128e-4,0,0,17.230929989550678,185.22722665405718,RPL5;HSP90AB1;RPS7;RPL23;RPL11
regulation of ubiquitin protein ligase activity (GO:1904666),4/21,3.296427963395873e-5,0.001336466080016784,0,0,26.6272268907563,274.79527193576683,RPL5;RPS7;RPL23;RPL11
stress granule assembly (GO:0034063),4/21,3.296427963395873e-5,0.001336466080016784,0,0,26.6272268907563,274.79527193576683,DYNC1H1;DDX3X;PRRC2C;RPS23
positive regulation of cellular biosynthetic process (GO:0031328),9/180,3.623743324304984e-5,0.0014165911908471315,0,0,6.08359133126935,62.207263731088545,RPS4X;RPL5;HSP90AA1;NPM1;HSP90AB1;DDX3X;PRKDC;INSR;EEF2
positive regulation of cellular protein metabolic process (GO:0032270),7/102,3.693719102279342e-5,0.0014165911908471315,0,0,8.450550795593635,86.2487858345048,RPS4X;RPL5;HSP90AA1;NPM1;DDX3X;PRKDC;EEF2
regulation of cellular localization (GO:0060341),5/49,7.526653396591046e-5,0.0028106108341480777,0,0,12.916013584117032,122.63076753149764,DYNC1H1;HSP90AA1;HSP90AB1;GSN;NUMA1
modulation by symbiont of host process (GO:0044003),3/10,8.077454161610682e-5,0.002938950629570656,0,0,48.24837662337662,454.68540233705124,PGK1;RPS27A;UBA52
regulation of protein-containing complex assembly (GO:0043254),7/116,8.397940464753864e-5,0.002979169379871433,0,0,7.359931726050779,69.07251008670936,CDC42;HSPA8;HSP90AA1;DDX3X;GSN;RACK1;RPS3
negative regulation of apoptotic process (GO:0043066),14/485,1.2422283378910065e-4,0.0042993219791886295,0,0,3.485813549507817,31.34943255457183,NPM1;DDX3X;RPL10;PRKDC;RPS3A;YWHAZ;HSPD1;RNF213;SON;MYO18A;RPS27A;UBA52;CD44;TPT1
"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",4/30,1.4174297331786713e-4,0.004788887598525082,0,0,17.4021978021978,154.20949207670594,RPS14;RPS16;RPS19;RPS8
"regulation of mRNA splicing, via spliceosome (GO:0048024)",6/90,1.5793245210928618e-4,0.005211770919606444,0,0,8.149050371593724,71.33143412406592,DDX17;RBM39;DDX5;SON;TRA2B;SRSF3
positive regulation of macromolecule biosynthetic process (GO:0010557),7/129,1.6333564735168655e-4,0.005267574627091891,0,0,6.571340068623713,57.300135604053345,RPS4X;RPL5;NPM1;DDX3X;PRKDC;INSR;EEF2
maturation of SSU-rRNA (GO:0030490),4/35,2.6153373249825865e-4,0.008247030364778423,0,0,14.591705069124425,120.36620593695766,RPS14;RPS16;RPS19;RPS8
positive regulation of translation (GO:0045727),6/100,0.00028091435779162733,0.008665597254485199,0,0,7.278440536219407,59.51916152684456,RPS4X;RPL5;NPM1;DDX3X;PRKDC;EEF2
regulation of signal transduction by p53 class mediator (GO:1901796),7/156,5.199016239655147e-4,0.0156966043490865,0,0,5.373185578273763,40.63133592776318,RPL5;RPL23;RPL11;TP53INP1;MDM4;RPS20;RPL37
regulation of ubiquitin-dependent protein catabolic process (GO:2000058),4/42,5.32484784922706e-4,0.015741581454277495,0,0,11.899548872180452,89.6982785993182,RPL5;RPS7;RPL23;RPL11
regulation of metaphase plate congression (GO:0090235),2/5,7.825622025090394e-4,0.022209115307206536,0,0,74.64406779661017,533.9243253220434,DYNC1H1;NUMA1
regulation of plasma membrane organization (GO:1903729),2/5,7.825622025090394e-4,0.022209115307206536,0,0,74.64406779661017,533.9243253220434,GSN;MYH9
regulation of interleukin-2 production (GO:0032663),4/48,8.878658506546296e-4,0.024703561609390575,0,0,10.273766233766233,72.19056938319332,IRF4;PDE4B;RPS3;TNFAIP3
chaperone-mediated protein complex assembly (GO:0051131),3/22,9.578185836806674e-4,0.02570524536168513,0,0,17.76495215311005,123.48155618394075,HSP90AA1;HSP90AB1;HSPD1
response to unfolded protein (GO:0006986),4/49,9.60097254523828e-4,0.02570524536168513,0,0,10.044952380952381,69.79711025730377,HSPA8;HSP90AA1;HSP90AB1;HSPD1
protein-DNA complex subunit organization (GO:0071824),2/6,0.001166934587194574,0.028549658262570696,0,0,55.98022598870057,378.0554575306027,RPL23;TCF4
negative regulation of relaxation of muscle (GO:1901078),2/6,0.001166934587194574,0.028549658262570696,0,0,55.98022598870057,378.0554575306027,GRK2;PDE4B
macromolecule biosynthetic process (GO:0009059),2/6,0.001166934587194574,0.028549658262570696,0,0,55.98022598870057,378.0554575306027,EIF4G2;RPS23
positive regulation of tau-protein kinase activity (GO:1902949),2/6,0.001166934587194574,0.028549658262570696,0,0,55.98022598870057,378.0554575306027,HSP90AA1;HSP90AB1
protein deubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0071947),2/6,0.001166934587194574,0.028549658262570696,0,0,55.98022598870057,378.0554575306027,USP9X;TNFAIP3
negative regulation of protein-containing complex assembly (GO:0031333),4/52,0.0012014889054010008,0.02889682638583085,0,0,9.415714285714285,63.31308702737686,CDC42;DDX3X;RPL13A;LDLRAD4
axon extension (GO:0048675),3/24,0.0012424168519632242,0.0289014674251773,0,0,16.071428571428573,107.52905446363681,HSP90AA1;HSP90AB1;USP9X
"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",3/24,0.0012424168519632242,0.0289014674251773,0,0,16.071428571428573,107.52905446363681,TNFAIP3;RPS27A;UBA52
neutrophil degranulation (GO:0043312),12/481,0.0013536282918481433,0.030980621711814763,0,0,2.9649528235639595,19.583414572255517,HSPA8;DYNC1H1;HSP90AA1;HSP90AB1;DDX3X;GSN;GDI2;HLA-B;PECAM1;HUWE1;EEF2;CD44
positive regulation of gene expression (GO:0010628),12/482,0.0013775595782944208,0.03102788954920291,0,0,2.958491527583132,19.488890655649524,RPS4X;RPL5;DDX5;NPM1;DDX3X;GSN;RPS7;PRKDC;RPL23;RPL11;RPS3;EEF2
regulation of cell cycle (GO:0051726),9/296,0.0014299595001676377,0.03150272349037037,0,0,3.6033203525312563,23.60214163553928,NR4A1;CENPF;SON;HSP90AB1;RPL23;TP53INP1;RACK1;PTPRK;EIF4G2
neutrophil activation involved in immune response (GO:0002283),12/485,0.0014514652419282592,0.03150272349037037,0,0,2.939271562583079,19.20867378913674,HSPA8;DYNC1H1;HSP90AA1;HSP90AB1;DDX3X;GSN;GDI2;HLA-B;PECAM1;HUWE1;EEF2;CD44
negative regulation of protein modification by small protein conjugation or removal (GO:1903321),4/55,0.0014824543291079941,0.03150272349037037,0,0,8.860504201680673,57.71782263346279,RPL5;RPL11;RPS3;TNFAIP3
neutrophil mediated immunity (GO:0002446),12/488,0.0015286213261845039,0.03150272349037037,0,0,2.920293866049414,18.93340125583308,HSPA8;DYNC1H1;HSP90AA1;HSP90AB1;DDX3X;GSN;GDI2;HLA-B;PECAM1;HUWE1;EEF2;CD44
positive regulation of cellular process (GO:0048522),14/625,0.0015289616524169654,0.03150272349037037,0,0,2.6676585825521997,17.294874575830985,DYNC1H1;NPM1;HSP90AB1;DDX3X;NUMA1;RPL23;INSR;RPS6;RPS4X;CDC42;RPS19;IL7R;SLC25A5;EIF4G2
positive regulation of interleukin-2 production (GO:0032743),3/26,0.0015751764026870785,0.03150272349037037,0,0,14.672430830039525,94.68688921476807,IRF4;PDE4B;RPS3
maturation of LSU-rRNA (GO:0000470),3/26,0.0015751764026870785,0.03150272349037037,0,0,14.672430830039525,94.68688921476807,RPL7A;RPL10A;RPL7
response to host defenses (GO:0052200),2/7,0.001624099055397294,0.03150272349037037,0,0,44.781920903954806,287.62541313407934,RPS27A;UBA52
positive regulation of respiratory burst (GO:0060267),2/7,0.001624099055397294,0.03150272349037037,0,0,44.781920903954806,287.62541313407934,RPS19;INSR
modulation by symbiont of host defense response (GO:0052031),2/7,0.001624099055397294,0.03150272349037037,0,0,44.781920903954806,287.62541313407934,RPS27A;UBA52
mRNA metabolic process (GO:0016071),5/95,0.0016428481594696316,0.03150272349037037,0,0,6.299808429118774,40.39011210028048,DDX5;SON;HNRNPA2B1;PRPF8;ZFP36L2
cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),3/27,0.0017604877931649211,0.03287016024343452,0,0,14.060369318181818,89.17317308154722,TNFAIP3;RPS27A;UBA52
positive regulation of nitric oxide biosynthetic process (GO:0045429),3/27,0.0017604877931649211,0.03287016024343452,0,0,14.060369318181818,89.17317308154722,HSP90AA1;HSP90AB1;INSR
nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),3/28,0.0019588606200114374,0.03521439479078634,0,0,13.497272727272728,84.16079031437903,TNFAIP3;RPS27A;UBA52
positive regulation of nitric oxide metabolic process (GO:1904407),3/28,0.0019588606200114374,0.03521439479078634,0,0,13.497272727272728,84.16079031437903,HSP90AA1;HSP90AB1;INSR
positive regulation of apoptotic process (GO:0043065),9/310,0.0019604913237999443,0.03521439479078634,0,0,3.433261676763729,21.404876474798378,PREX1;AKAP13;DDX3X;RPS6;RACK1;RPS3;RPS27A;UBA52;HSPD1
regulation of mRNA stability (GO:0043488),6/146,0.0020388130433868362,0.035609460871723744,0,0,4.875557390586292,30.205967225111017,HSPA8;NPM1;RPS27A;UBA52;YWHAZ;ZFP36L2
negative regulation of keratinocyte proliferation (GO:0010839),2/8,0.0021527365166767467,0.035609460871723744,0,0,37.31638418079096,229.16049170690178,KLF9;PTPRK
regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051342),2/8,0.0021527365166767467,0.035609460871723744,0,0,37.31638418079096,229.16049170690178,RACK1;CALM1
regulation of endodeoxyribonuclease activity (GO:0032071),2/8,0.0021527365166767467,0.035609460871723744,0,0,37.31638418079096,229.16049170690178,NPM1;RPS3
establishment of Golgi localization (GO:0051683),2/8,0.0021527365166767467,0.035609460871723744,0,0,37.31638418079096,229.16049170690178,CDC42;YWHAZ
aggrephagy (GO:0035973),3/29,0.002170610401299741,0.035609460871723744,0,0,12.977491258741258,79.58766876854182,DYNC1H1;RPS27A;UBA52
MyD88-dependent toll-like receptor signaling pathway (GO:0002755),3/29,0.002170610401299741,0.035609460871723744,0,0,12.977491258741258,79.58766876854182,RPS27A;UBA52;HSPD1
positive regulation of transferase activity (GO:0051347),6/148,0.0021832439012261914,0.035609460871723744,0,0,4.806399088170642,29.44853555608563,HSP90AA1;HSP90AB1;INSR;HNRNPA2B1;RPS2;SERINC5
plasma membrane invagination (GO:0099024),3/30,0.0023960411238384944,0.038636163121895724,0,0,12.496212121212121,75.40136211810157,CDC42;GSN;MYH9
amyloid fibril formation (GO:1990000),4/63,0.002449651618883304,0.03905680502466751,0,0,7.655980629539951,46.026296781216004,GSN;USP9X;RPS27A;UBA52
negative regulation of response to DNA damage stimulus (GO:2001021),3/31,0.0026354454644766366,0.04141700255211359,0,0,12.049310064935066,71.55727448784889,RPS3;CD44;TPT1
regulation of cell cycle process (GO:0010564),5/106,0.0026560586555619005,0.04141700255211359,0,0,5.6105610561056105,33.275743689263955,CDC42;DYNC1H1;NUMA1;MKI67;CALM1
regulation of skeletal muscle cell differentiation (GO:2001014),2/9,0.002751545414793024,0.042439597212948925,0,0,31.983857949959646,188.56379484621226,DDX17;DDX5
regulation of protein ubiquitination (GO:0031396),5/109,0.0029970739558552372,0.045729547778049266,0,0,5.447889036251105,31.65288258787036,HSP90AA1;HSP90AB1;RPS3;HUWE1;TNFAIP3
neuron projection extension (GO:1990138),3/33,0.003157290461851909,0.04766165069540275,0,0,11.244886363636363,64.74851748662961,HSP90AA1;HSP90AB1;USP9X
"mRNA splicing, via spliceosome (GO:0000398)",8/274,0.003340520165575112,0.049009128563908815,0,0,3.4393000043969573,19.609611770923895,DDX17;HSPA8;DDX5;HNRNPH1;TRA2B;HNRNPA2B1;SRSF3;PRPF8
regulation of high voltage-gated calcium channel activity (GO:1901841),2/10,0.003419241527714568,0.049009128563908815,0,0,27.98446327683616,158.90520004204714,PDE4B;CALM1
regulation of protein neddylation (GO:2000434),2/10,0.003419241527714568,0.049009128563908815,0,0,27.98446327683616,158.90520004204714,RPL5;RPL11
regulation of tau-protein kinase activity (GO:1902947),2/10,0.003419241527714568,0.049009128563908815,0,0,27.98446327683616,158.90520004204714,HSP90AA1;HSP90AB1
modification-dependent macromolecule catabolic process (GO:0043632),2/10,0.003419241527714568,0.049009128563908815,0,0,27.98446327683616,158.90520004204714,RPS27A;UBA52
cellular response to transforming growth factor beta stimulus (GO:0071560),5/114,0.0036340622707771468,0.05156734362232771,0,0,5.196667721185279,29.191782945554937,USP9X;PTPRK;RPS27A;UBA52;ZFP36L2
regulation of cell population proliferation (GO:0042127),15/764,0.003701590169659711,0.05200550941333792,0,0,2.328958937119411,13.039824264707653,KANK2;CD164;NPM1;H2AC6;PRKDC;RPL23;INSR;RPS6;PTPRK;SMARCA2;RPS4X;TP53INP1;MDM4;IL7R;SLC25A5
Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),4/71,0.003780992235143354,0.05260027433008254,0,0,6.73910447761194,37.589166747237485,CDC42;HSP90AA1;HSP90AB1;WASF2
Fc-gamma receptor signaling pathway (GO:0038094),4/72,0.0039758806079191345,0.054586272906754794,0,0,6.639663865546218,36.700801898793216,CDC42;HSP90AA1;HSP90AB1;WASF2
regulation of mRNA processing (GO:0050684),3/36,0.0040515505959769806,0.054586272906754794,0,0,10.22107438016529,56.30437870339693,RBM39;SON;SRSF3
cellular protein-containing complex assembly (GO:0034622),6/168,0.004086903403465356,0.054586272906754794,0,0,4.208734746307001,23.147905203592117,HSP90AA1;CENPF;HSP90AB1;RPL38;TCF4;HSPD1
nucleus localization (GO:0051647),2/11,0.004154557768801633,0.054586272906754794,0,0,24.87382297551789,136.39683431302154,DYNC1H1;SYNE2
positive regulation of actin nucleation (GO:0051127),2/11,0.004154557768801633,0.054586272906754794,0,0,24.87382297551789,136.39683431302154,GSN;WASF2
tetrahydrobiopterin metabolic process (GO:0046146),2/11,0.004154557768801633,0.054586272906754794,0,0,24.87382297551789,136.39683431302154,HSP90AA1;CALM1
positive regulation of programmed cell death (GO:0043068),8/286,0.0043215632605516224,0.0550751002232969,0,0,3.288821574319492,17.904798758960137,PREX1;AKAP13;DDX3X;RPS6;RACK1;RPS27A;UBA52;HSPD1
positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),5/119,0.00436284203163782,0.0550751002232969,0,0,4.967483363581367,26.996442019754426,DDX3X;GSN;RACK1;RPS3;HSPD1
"phagocytosis, engulfment (GO:0006911)",3/37,0.004380336525286229,0.0550751002232969,0,0,9.91995320855615,53.871592767852086,CDC42;GSN;MYH9
proteolysis involved in cellular protein catabolic process (GO:0051603),4/74,0.004385825458232945,0.0550751002232969,0,0,6.44930612244898,35.01571706802796,USP9X;TNFAIP3;RPS27A;UBA52
Fc receptor mediated stimulatory signaling pathway (GO:0002431),4/74,0.004385825458232945,0.0550751002232969,0,0,6.44930612244898,35.01571706802796,CDC42;HSP90AA1;HSP90AB1;WASF2
positive regulation of growth (GO:0045927),4/76,0.004823357292987982,0.05980820532166675,0,0,6.269523809523809,33.44342718777245,CDC42;DDX3X;INSR;EIF4G2
regulation of mRNA catabolic process (GO:0061013),5/122,0.004847035667365523,0.05980820532166675,0,0,4.839375184202771,25.790907857542365,HSPA8;RPS27A;UBA52;YWHAZ;ZFP36L2
Golgi localization (GO:0051645),2/12,0.004956243986150177,0.060503244359205816,0,0,22.38531073446328,118.80124122048696,CDC42;YWHAZ
positive regulation of type I interferon production (GO:0032481),4/77,0.00505272500099873,0.060503244359205816,0,0,6.183326810176125,32.69636602488978,HSP90AA1;DDX3X;PRKDC;HSPD1
organelle assembly (GO:0070925),10/425,0.005064117515886545,0.060503244359205816,0,0,2.7669494546232265,14.624919937945801,DYNC1H1;NPM1;CENPF;DDX3X;GSN;TP53INP1;HPS4;RPS3;PRRC2C;RPS23
negative regulation of cellular process (GO:0048523),12/566,0.005073915488897457,0.060503244359205816,0,0,2.499016407617977,13.203909233662745,KANK2;CD164;NR4A1;NPM1;DDX3X;H2AC6;TP53INP1;RACK1;MYH9;MDM4;PTPRK;SMARCA2
bone development (GO:0060348),3/40,0.005461865243558454,0.06352776049679874,0,0,9.114250614250615,47.48492604401497,AKAP13;GNAS;RPL13
regulation of nitric oxide biosynthetic process (GO:0045428),3/40,0.005461865243558454,0.06352776049679874,0,0,9.114250614250615,47.48492604401497,HSP90AA1;HSP90AB1;INSR
positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),3/40,0.005461865243558454,0.06352776049679874,0,0,9.114250614250615,47.48492604401497,RPS7;RACK1;RPS3
RNA processing (GO:0006396),6/179,0.0055504768580830425,0.06403355009447022,0,0,3.938922115673761,20.458255059473505,DDX17;RBM39;SON;HNRNPH1;HNRNPA2B1;PRPF8
mRNA processing (GO:0006397),8/300,0.005731505328844907,0.06506245466324802,0,0,3.1288952976047426,16.15066000993813,HSPA8;DDX5;SON;HNRNPH1;TRA2B;HNRNPA2B1;SRSF3;PRPF8
pteridine-containing compound metabolic process (GO:0042558),2/13,0.005823066766900985,0.06506245466324802,0,0,20.3492552645095,104.71580692420976,HSP90AA1;CALM1
regulation of actomyosin structure organization (GO:0110020),2/13,0.005823066766900985,0.06506245466324802,0,0,20.3492552645095,104.71580692420976,CDC42;AKAP13
central nervous system neuron axonogenesis (GO:0021955),2/13,0.005823066766900985,0.06506245466324802,0,0,20.3492552645095,104.71580692420976,HSP90AA1;HSP90AB1
regulation of lamellipodium organization (GO:1902743),2/14,0.006753809240721558,0.07429190164793713,0,0,18.652542372881356,93.21885230078709,CDC42;CD44
nuclear migration (GO:0007097),2/14,0.006753809240721558,0.07429190164793713,0,0,18.652542372881356,93.21885230078709,DYNC1H1;SYNE2
RNA metabolic process (GO:0016070),5/133,0.00694996551391307,0.07528245087208127,0,0,4.42102191091954,21.968140024333103,DDX17;RBM39;DDX3X;HNRNPH1;HNRNPA2B1
transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),5/133,0.00694996551391307,0.07528245087208127,0,0,4.42102191091954,21.968140024333103,DDX5;USP9X;PTPRK;RPS27A;UBA52
regulation of mitotic cell cycle phase transition (GO:1901990),6/188,0.007007173823858231,0.07532711860647598,0,0,3.7424252048529505,18.56550088373983,DYNC1H1;HSP90AA1;CENPF;RPS27A;UBA52;ZFP36L2
regulation of cell cycle G2/M phase transition (GO:1902749),4/85,0.007155128227402877,0.07633930041116303,0,0,5.57037037037037,27.517217114538557,DYNC1H1;HSP90AA1;NPM1;CENPF
negative regulation of cell population proliferation (GO:0008285),9/379,0.007262895427496472,0.07691081053445892,0,0,2.7831319554848966,13.70686006283968,KANK2;CD164;NPM1;H2AC6;TP53INP1;TNFAIP3;MDM4;PTPRK;SMARCA2
negative regulation of cellular amide metabolic process (GO:0034249),4/86,0.007452781837148835,0.0783370179771422,0,0,5.502160278745644,26.95600710262218,DDX3X;RACK1;RPS3;RPL13A
"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",7/251,0.007560522124955596,0.07888515364199994,0,0,3.2653211971025544,15.950490051679447,HSPA8;DDX5;HNRNPH1;TRA2B;HNRNPA2B1;SRSF3;PRPF8
androgen receptor signaling pathway (GO:0030521),2/15,0.0077472708863843154,0.07908904595524707,0,0,17.216862233811387,83.68108927891602,DDX17;DDX5
central nervous system neuron development (GO:0021954),2/15,0.0077472708863843154,0.07908904595524707,0,0,17.216862233811387,83.68108927891602,HSP90AA1;HSP90AB1
myoblast differentiation (GO:0045445),2/15,0.0077472708863843154,0.07908904595524707,0,0,17.216862233811387,83.68108927891602,DDX17;DDX5
erythrocyte differentiation (GO:0030218),3/46,0.00807020096447049,0.08121712885520302,0,0,7.840116279069767,37.78604326762049,RPS14;RPS19;SLC25A5
interleukin-12-mediated signaling pathway (GO:0035722),3/46,0.00807020096447049,0.08121712885520302,0,0,7.840116279069767,37.78604326762049,CDC42;RPLP0;HNRNPA2B1
transforming growth factor beta receptor signaling pathway (GO:0007179),4/89,0.008394379699230646,0.08388468164231189,0,0,5.307159663865546,25.369246840855016,USP9X;PTPRK;RPS27A;UBA52
epithelial to mesenchymal transition (GO:0001837),3/47,0.008564565028712343,0.0849868375926071,0,0,7.661544421487603,36.46988564317298,DDX17;DDX5;AKNA
negative regulation of translation (GO:0017148),4/90,0.00872474349472797,0.08555080380136083,0,0,5.2451827242524915,24.87051754644813,DDX3X;RACK1;RPS3;RPL13A
regulation of establishment of cell polarity (GO:2000114),2/16,0.008802267339674898,0.08555080380136083,0,0,15.986279257465698,75.65899822667954,GSN;RACK1
regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),2/16,0.008802267339674898,0.08555080380136083,0,0,15.986279257465698,75.65899822667954,RPS3;TPT1
cellular response to interleukin-12 (GO:0071349),3/48,0.00907634647386554,0.08761452820690613,0,0,7.490909090909091,35.22288032147819,CDC42;RPLP0;HNRNPA2B1
cellular response to fibroblast growth factor stimulus (GO:0044344),4/92,0.009410716394683254,0.09022842273010499,0,0,5.125454545454545,23.914890126452256,NR4A1;HNRNPH1;CD44;ZFP36L2
negative regulation of cellular protein metabolic process (GO:0032269),4/94,0.010130883864957637,0.09648137049916032,0,0,5.011047619047619,23.01156606999504,DDX3X;RACK1;RPS3;RPL13A
cytokine-mediated signaling pathway (GO:0019221),12/621,0.010243179502316515,0.09690047809191424,0,0,2.266835786554969,10.384699370157046,CDC42;HSPA8;HSP90AA1;IRF4;RPLP0;HNRNPA2B1;HLA-B;IL7R;RPS27A;UBA52;YWHAZ;CD44
mesenchymal cell differentiation (GO:0048762),3/51,0.010717389713271996,0.10025376771918977,0,0,7.021661931818182,31.849469638208287,DDX17;DDX5;AKNA
"alternative mRNA splicing, via spliceosome (GO:0000380)",2/18,0.011092206858289495,0.10025376771918977,0,0,13.986581920903955,62.960773378309824,DDX17;DDX5
regulation of chromosome segregation (GO:0051983),2/18,0.011092206858289495,0.10025376771918977,0,0,13.986581920903955,62.960773378309824,NUMA1;MKI67
cellular response to glucocorticoid stimulus (GO:0071385),2/18,0.011092206858289495,0.10025376771918977,0,0,13.986581920903955,62.960773378309824,KLF9;ZFP36L2
regulation of spindle organization (GO:0090224),2/18,0.011092206858289495,0.10025376771918977,0,0,13.986581920903955,62.960773378309824,DYNC1H1;NUMA1
intracellular estrogen receptor signaling pathway (GO:0030520),2/18,0.011092206858289495,0.10025376771918977,0,0,13.986581920903955,62.960773378309824,DDX17;DDX5
positive regulation of phosphoprotein phosphatase activity (GO:0032516),2/18,0.011092206858289495,0.10025376771918977,0,0,13.986581920903955,62.960773378309824,HSP90AB1;CALM1
myeloid cell differentiation (GO:0030099),3/52,0.011299997456111065,0.10148542019127596,0,0,6.878014842300557,30.8338157470768,RPS14;RPS19;SLC25A5
regulation of peptidyl-serine phosphorylation (GO:0033135),4/98,0.01167625781293575,0.10420509331167188,0,0,4.7968389057750755,21.346881684711466,HSP90AA1;HSP90AB1;RACK1;CD44
negative regulation of RNA metabolic process (GO:0051253),2/19,0.012324860283012329,0.10729433583800303,0,0,13.163177135260884,57.86712866213049,RPS26;RPS13
negative regulation of RNA splicing (GO:0033119),2/19,0.012324860283012329,0.10729433583800303,0,0,13.163177135260884,57.86712866213049,RPS26;RPS13
diol metabolic process (GO:0034311),2/19,0.012324860283012329,0.10729433583800303,0,0,13.163177135260884,57.86712866213049,HSP90AA1;CALM1
endoplasmic reticulum mannose trimming (GO:1904380),2/19,0.012324860283012329,0.10729433583800303,0,0,13.163177135260884,57.86712866213049,RPS27A;UBA52
regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),4/100,0.01250263079178256,0.10766490326494488,0,0,4.696428571428571,20.578886765787093,HSP90AB1;LDLRAD4;RPS27A;UBA52
"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",3/54,0.012519174798249405,0.10766490326494488,0,0,6.607620320855615,28.944640021152686,DDX17;DDX5;TRA2B
positive regulation of protein kinase activity (GO:0045860),5/154,0.01259672879345494,0.10767926601152146,0,0,3.7938748746432154,16.59561560271028,HSP90AA1;DDX3X;HSP90AB1;INSR;CALM1
positive regulation of protein modification process (GO:0031401),6/214,0.01275213752228169,0.10835498888693244,0,0,3.2702867941307248,14.26517535064207,HSP90AA1;DDX3X;INSR;RACK1;PECAM1;CALM1
positive regulation of cell cycle process (GO:0090068),4/101,0.012929481788136089,0.10920794438907803,0,0,4.647776141384389,20.20967013597892,CDC42;DYNC1H1;NUMA1;INSR
positive regulation of cell growth (GO:0030307),4/102,0.013365530879222336,0.11039389321766237,0,0,4.600116618075802,19.84985377533982,CDC42;MACF1;DDX3X;EIF4G2
intrinsic apoptotic signaling pathway (GO:0097193),4/102,0.013365530879222336,0.11039389321766237,0,0,4.600116618075802,19.84985377533982,DDX5;DDX3X;PRKDC;ITPR1
regulation of lymphocyte differentiation (GO:0045619),2/20,0.013614468860529185,0.11039389321766237,0,0,12.431261770244822,53.412434860491224,PRKDC;ZFP36L2
regulation of protein modification by small protein conjugation or removal (GO:1903320),2/20,0.013614468860529185,0.11039389321766237,0,0,12.431261770244822,53.412434860491224,HSP90AA1;HSP90AB1
establishment of epithelial cell polarity (GO:0090162),2/20,0.013614468860529185,0.11039389321766237,0,0,12.431261770244822,53.412434860491224,CDC42;MYO18A
positive regulation of interferon-alpha production (GO:0032727),2/20,0.013614468860529185,0.11039389321766237,0,0,12.431261770244822,53.412434860491224,DDX3X;HSPD1
positive regulation of protein processing (GO:0010954),2/20,0.013614468860529185,0.11039389321766237,0,0,12.431261770244822,53.412434860491224,GSN;MYH9
positive regulation of establishment of protein localization to mitochondrion (GO:1903749),3/56,0.013810842880000066,0.11134992072000054,0,0,6.3576329331046315,27.225299643326743,HPS4;HUWE1;YWHAZ
supramolecular fiber organization (GO:0097435),8/351,0.013957330802099847,0.11189521134564794,0,0,2.6567098017151722,11.348801166708848,CDC42;DYNC1H1;HSP90AB1;GSN;USP9X;FAT1;RPS27A;UBA52
error-prone translesion synthesis (GO:0042276),2/21,0.014959926202755396,0.11728251536856302,0,0,11.776390127862028,49.48886916501484,RPS27A;UBA52
positive regulation of glycolytic process (GO:0045821),2/21,0.014959926202755396,0.11728251536856302,0,0,11.776390127862028,49.48886916501484,PFKFB2;INSR
positive regulation of phosphatase activity (GO:0010922),2/21,0.014959926202755396,0.11728251536856302,0,0,11.776390127862028,49.48886916501484,HSP90AB1;CALM1
positive regulation of purine nucleotide metabolic process (GO:1900544),2/21,0.014959926202755396,0.11728251536856302,0,0,11.776390127862028,49.48886916501484,PFKFB2;INSR
selective autophagy (GO:0061912),3/59,0.0158854521495647,0.12385415714413356,0,0,6.016132305194805,24.920934965792853,DYNC1H1;RPS27A;UBA52
negative regulation of lymphocyte activation (GO:0051250),2/22,0.016360140971545267,0.1248120432184018,0,0,11.187005649717515,46.01111754868441,TNFAIP3;PAG1
cell projection assembly (GO:0030031),2/22,0.016360140971545267,0.1248120432184018,0,0,11.187005649717515,46.01111754868441,CDC42;GSN
"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",2/22,0.016360140971545267,0.1248120432184018,0,0,11.187005649717515,46.01111754868441,RPS27A;UBA52
error-free translesion synthesis (GO:0070987),2/22,0.016360140971545267,0.1248120432184018,0,0,11.187005649717515,46.01111754868441,RPS27A;UBA52
regulation of gene expression (GO:0010468),17/1079,0.016931813261926176,0.12848258298755744,0,0,1.8536130292250819,7.560073782455031,RPL5;DDX3X;GSN;RPS7;RPL23;INSR;RPL11;JMJD1C;BAZ2A;SMARCA2;RPL6;AFF1;SON;HNRNPH1;TRA2B;RACK1;RPS3
blood vessel endothelial cell migration (GO:0043534),2/23,0.017814036689101743,0.13234616786301243,0,0,10.653753026634382,42.91085142711737,NR4A1;MYH9
"nucleotide-excision repair, DNA damage recognition (GO:0000715)",2/23,0.017814036689101743,0.13234616786301243,0,0,10.653753026634382,42.91085142711737,RPS27A;UBA52
regulation of supramolecular fiber organization (GO:1902903),2/23,0.017814036689101743,0.13234616786301243,0,0,10.653753026634382,42.91085142711737,HSPA8;AKAP13
positive regulation of protein autophosphorylation (GO:0031954),2/23,0.017814036689101743,0.13234616786301243,0,0,10.653753026634382,42.91085142711737,DDX3X;CALM1
positive regulation of metabolic process (GO:0009893),4/113,0.018786427301205857,0.13707931348018582,0,0,4.133577981651376,16.429404288279603,DYNC1H1;IRF4;INSR;GNAS
positive regulation of protein phosphorylation (GO:0001934),8/371,0.018828191323652405,0.13707931348018582,0,0,2.5077569957952734,9.96181387464743,HSP90AA1;HSP90AB1;DDX3X;INSR;RACK1;PECAM1;CALM1;CD44
cellular response to reactive oxygen species (GO:0034614),3/63,0.018909645520071013,0.13707931348018582,0,0,5.613920454545455,22.276503116889778,RPS3;TNFAIP3;PTPRK
regulation of keratinocyte proliferation (GO:0010837),2/24,0.019320551582830983,0.13707931348018582,0,0,10.168977914740626,40.13274486355007,KLF9;PTPRK
"nucleotide-excision repair, DNA gap filling (GO:0006297)",2/24,0.019320551582830983,0.13707931348018582,0,0,10.168977914740626,40.13274486355007,RPS27A;UBA52
regulation of monooxygenase activity (GO:0032768),2/24,0.019320551582830983,0.13707931348018582,0,0,10.168977914740626,40.13274486355007,HSP90AA1;CALM1
positive regulation of carbohydrate metabolic process (GO:0045913),2/24,0.019320551582830983,0.13707931348018582,0,0,10.168977914740626,40.13274486355007,PFKFB2;INSR
positive regulation of lamellipodium assembly (GO:0010592),2/24,0.019320551582830983,0.13707931348018582,0,0,10.168977914740626,40.13274486355007,CDC42;WASF2
"protein alpha-1,2-demannosylation (GO:0036508)",2/24,0.019320551582830983,0.13707931348018582,0,0,10.168977914740626,40.13274486355007,RPS27A;UBA52
antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),3/64,0.019712008985830577,0.13916089925817707,0,0,5.521609538002981,21.680750236285256,RPL30;RPS19;RPL39
regulation of RNA metabolic process (GO:0051252),3/65,0.020532943274140292,0.14381935861277764,0,0,5.432276392961877,21.10833052302948,SON;HNRNPH1;TRA2B
cellular response to hexose stimulus (GO:0071331),2/25,0.020878638389169975,0.14381935861277764,0,0,9.72635716040285,37.6315552854272,TRA2B;RACK1
regulation of interferon-alpha production (GO:0032647),2/25,0.020878638389169975,0.14381935861277764,0,0,9.72635716040285,37.6315552854272,DDX3X;HSPD1
regulation of spindle assembly (GO:0090169),2/25,0.020878638389169975,0.14381935861277764,0,0,9.72635716040285,37.6315552854272,DYNC1H1;NUMA1
"RNA splicing, via transesterification reactions (GO:0000375)",2/25,0.020878638389169975,0.14381935861277764,0,0,9.72635716040285,37.6315552854272,TRA2B;PRPF8
regulation of protein localization (GO:0032880),3/66,0.021372461190642036,0.14650977019092296,0,0,5.345779220779221,20.558006797428334,HSP90AA1;HSP90AB1;RACK1
regulation of cellular response to stress (GO:0080135),4/118,0.021640958235317417,0.14693071643978667,0,0,3.951278195488722,15.145911341159557,HSPA8;HSP90AA1;NPM1;HSP90AB1
positive regulation of protein-containing complex assembly (GO:0031334),4/118,0.021640958235317417,0.14693071643978667,0,0,3.951278195488722,15.145911341159557,HSP90AA1;DDX3X;RACK1;RPS3
vascular endothelial growth factor receptor signaling pathway (GO:0048010),3/67,0.022230570284182818,0.14975060632007134,0,0,5.2619850852272725,20.028624884876177,CDC42;HSP90AA1;WASF2
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),2/26,0.022487264197140474,0.14975060632007134,0,0,9.320621468926554,35.36995181856022,CD44;TPT1
global genome nucleotide-excision repair (GO:0070911),2/26,0.022487264197140474,0.14975060632007134,0,0,9.320621468926554,35.36995181856022,RPS27A;UBA52
positive regulation of microtubule polymerization or depolymerization (GO:0031112),2/26,0.022487264197140474,0.14975060632007134,0,0,9.320621468926554,35.36995181856022,NUMA1;RPS3
positive regulation of macromolecule metabolic process (GO:0010604),8/384,0.022583953313950154,0.14975060632007134,0,0,2.4194351126042055,9.170906671190258,RPL5;DDX3X;GSN;RPS7;RPL23;INSR;RPL11;RPS3
negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),3/68,0.02310727294948565,0.15110239776645226,0,0,5.180769230769231,19.519106899093753,LDLRAD4;RPS27A;UBA52
regulation of translational initiation (GO:0006446),3/68,0.02310727294948565,0.15110239776645226,0,0,5.180769230769231,19.519106899093753,NPM1;DDX3X;EIF4G2
interferon-gamma-mediated signaling pathway (GO:0060333),3/68,0.02310727294948565,0.15110239776645226,0,0,5.180769230769231,19.519106899093753,IRF4;HLA-B;CD44
cellular response to interferon-gamma (GO:0071346),4/121,0.023474278606319347,0.15279817129526216,0,0,3.8493772893772893,14.442286124082377,IRF4;HLA-B;RPL13A;CD44
positive regulation of protein polymerization (GO:0032273),3/69,0.024002566562535146,0.15433485211640283,0,0,5.102014462809917,19.028445152100872,HSP90AA1;NUMA1;RPS3
cellular response to unfolded protein (GO:0034620),2/27,0.024145410267682473,0.15433485211640283,0,0,8.947344632768361,33.316877976043884,HSPA8;HSPD1
dendritic spine organization (GO:0097061),2/27,0.024145410267682473,0.15433485211640283,0,0,8.947344632768361,33.316877976043884,CDC42;INSR
stress-activated protein kinase signaling cascade (GO:0031098),2/27,0.024145410267682473,0.15433485211640283,0,0,8.947344632768361,33.316877976043884,RPS27A;UBA52
positive regulation of intracellular signal transduction (GO:1902533),10/546,0.025462290151744872,0.16202237544989226,0,0,2.1289631723041595,7.81448011902697,AKAP13;HSP90AA1;HSP90AB1;DDX3X;RPL23;INSR;RACK1;RPS3;RPS20;RPL37
regulation of B cell activation (GO:0050864),2/28,0.025852071865354247,0.16231898219883928,0,0,8.602781399391569,31.446302001384918,TNFAIP3;ZFP36L2
"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",2/28,0.025852071865354247,0.16231898219883928,0,0,8.602781399391569,31.446302001384918,DDX5;CD44
positive regulation of microtubule polymerization (GO:0031116),2/28,0.025852071865354247,0.16231898219883928,0,0,8.602781399391569,31.446302001384918,NUMA1;RPS3
negative regulation of gene expression (GO:0010629),7/322,0.02617274395841935,0.16360847434800466,0,0,2.52015503875969,9.181017337828063,RPS26;DDX3X;RACK1;RPS3;RPL13A;RPS13;ZFP36L2
actin filament polymerization (GO:0030041),2/29,0.027606258107739257,0.169581299804684,0,0,8.283741368487131,29.73625233062454,PREX1;GSN
"nucleotide-excision repair, preincision complex assembly (GO:0006294)",2/29,0.027606258107739257,0.169581299804684,0,0,8.283741368487131,29.73625233062454,RPS27A;UBA52
glycolytic process (GO:0006096),2/29,0.027606258107739257,0.169581299804684,0,0,8.283741368487131,29.73625233062454,PFKFB2;PGK1
telomere maintenance via telomerase (GO:0007004),2/29,0.027606258107739257,0.169581299804684,0,0,8.283741368487131,29.73625233062454,HSP90AA1;HSP90AB1
transcription-coupled nucleotide-excision repair (GO:0006283),3/73,0.027769428707809858,0.1698483592085439,0,0,4.809496753246753,17.236368490688502,RPS27A;UBA52;HMGN1
regulation of cytokine-mediated signaling pathway (GO:0001959),3/74,0.028757470022751305,0.17513669511709914,0,0,4.74151728553137,16.82697021667898,HSP90AB1;RACK1;TNFAIP3
cell projection organization (GO:0030030),2/30,0.02940699177614776,0.17531198388211525,0,0,7.9874899112187245,28.16806542563237,CDC42;GSN
regulation of macrophage activation (GO:0043030),2/30,0.02940699177614776,0.17531198388211525,0,0,7.9874899112187245,28.16806542563237,MYO18A;HSPD1
regulation of striated muscle contraction (GO:0006942),2/30,0.02940699177614776,0.17531198388211525,0,0,7.9874899112187245,28.16806542563237,GRK2;CALM1
RNA-dependent DNA biosynthetic process (GO:0006278),2/30,0.02940699177614776,0.17531198388211525,0,0,7.9874899112187245,28.16806542563237,HSP90AA1;HSP90AB1
TRIF-dependent toll-like receptor signaling pathway (GO:0035666),2/30,0.02940699177614776,0.17531198388211525,0,0,7.9874899112187245,28.16806542563237,RPS27A;UBA52
Golgi organization (GO:0007030),4/130,0.02952752935012371,0.17531198388211525,0,0,3.5727891156462586,12.584907612283033,CDC42;MYO18A;HUWE1;YWHAZ
cellular response to cytokine stimulus (GO:0071345),9/482,0.029838475731027988,0.17641998775970297,0,0,2.165551548314886,7.6053230231873785,HSPA8;HSP90AA1;IRF4;RPS3;RPL13A;RPS27A;UBA52;YWHAZ;ZFP36L2
cellular response to hypoxia (GO:0071456),4/131,0.03025194371210583,0.17812244036297997,0,0,3.5444769403824523,12.399270949100758,PGK1;MDM4;RPS27A;UBA52
regulation of programmed cell death (GO:0043067),5/194,0.030575181246020443,0.17882437786084826,0,0,2.984856777960226,10.4098870120776,KANK2;HSP90AA1;TP53INP1;RPS3;TPT1
actomyosin structure organization (GO:0031032),3/76,0.030788946694637238,0.17882437786084826,0,0,4.611145703611457,16.04955155475152,PDLIM1;MYO18A;MYH9
regulation of cell migration (GO:0030334),8/408,0.03085615227178006,0.17882437786084826,0,0,2.2714619883040936,7.901096817675252,MACF1;INSR;TP53INP1;RACK1;PECAM1;LDLRAD4;PTPRK;SYNE2
negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),2/31,0.03125330916806932,0.17882437786084826,0,0,7.711669588934346,26.725793593388094,HSP90AB1;RPL11
positive regulation of leukocyte cell-cell adhesion (GO:1903039),2/31,0.03125330916806932,0.17882437786084826,0,0,7.711669588934346,26.725793593388094,CD44;HSPD1
positive regulation of protein targeting to mitochondrion (GO:1903955),2/31,0.03125330916806932,0.17882437786084826,0,0,7.711669588934346,26.725793593388094,HPS4;HUWE1
MyD88-independent toll-like receptor signaling pathway (GO:0002756),2/31,0.03125330916806932,0.17882437786084826,0,0,7.711669588934346,26.725793593388094,RPS27A;UBA52
regulation of protein phosphorylation (GO:0001932),6/266,0.03281065721517254,0.18516419230230263,0,0,2.6092930191196086,8.915959207299094,HSP90AA1;NPM1;PRKDC;INSR;RACK1;PECAM1
regulation of cell morphogenesis (GO:0022604),2/32,0.033144259932899836,0.18516419230230263,0,0,7.454237288135594,25.395734657694085,MACF1;CD44
cellular response to glucose stimulus (GO:0071333),2/32,0.033144259932899836,0.18516419230230263,0,0,7.454237288135594,25.395734657694085,TRA2B;RACK1
positive regulation of immune effector process (GO:0002699),2/32,0.033144259932899836,0.18516419230230263,0,0,7.454237288135594,25.395734657694085,RPS19;MYO18A
positive regulation of interleukin-10 production (GO:0032733),2/32,0.033144259932899836,0.18516419230230263,0,0,7.454237288135594,25.395734657694085,IRF4;HSPD1
positive regulation of lamellipodium organization (GO:1902745),2/32,0.033144259932899836,0.18516419230230263,0,0,7.454237288135594,25.395734657694085,CDC42;WASF2
regulation of cellular response to heat (GO:1900034),3/79,0.03397406692449045,0.18905569006216447,0,0,4.428453947368421,14.977729984364867,HSPA8;HSP90AA1;HSP90AB1
negative regulation of cellular component organization (GO:0051129),3/80,0.035072365891547774,0.1929339880022633,0,0,4.370720188902007,14.64340634885976,CDC42;HSPA8;DDX3X
positive regulation of ATP metabolic process (GO:1903580),2/33,0.03507890690950242,0.1929339880022633,0,0,7.213413522872243,24.166055342030788,PFKFB2;INSR
signal transduction by p53 class mediator (GO:0072331),2/33,0.03507890690950242,0.1929339880022633,0,0,7.213413522872243,24.166055342030788,DDX5;MDM4
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),2/34,0.037056325973216946,0.19917775210604108,0,0,6.987641242937853,23.026487389719286,DDX3X;TNFAIP3
negative regulation of mitochondrion organization (GO:0010823),2/34,0.037056325973216946,0.19917775210604108,0,0,6.987641242937853,23.026487389719286,HUWE1;SLC25A5
cardiac muscle contraction (GO:0060048),2/34,0.037056325973216946,0.19917775210604108,0,0,6.987641242937853,23.026487389719286,GRK2;GSN
regulation of lamellipodium assembly (GO:0010591),2/34,0.037056325973216946,0.19917775210604108,0,0,6.987641242937853,23.026487389719286,CDC42;WASF2
positive regulation of protein dephosphorylation (GO:0035307),2/34,0.037056325973216946,0.19917775210604108,0,0,6.987641242937853,23.026487389719286,HSP90AB1;CALM1
positive regulation of telomerase activity (GO:0051973),2/34,0.037056325973216946,0.19917775210604108,0,0,6.987641242937853,23.026487389719286,HSP90AA1;HSP90AB1
positive regulation of cytoskeleton organization (GO:0051495),3/82,0.03732353279517086,0.19985695485414134,0,0,4.25963751438435,14.00624720441449,CDC42;DYNC1H1;NUMA1
positive regulation of cellular catabolic process (GO:0031331),4/141,0.03807325710742709,0.20187551357456393,0,0,3.284087591240876,10.733196795408952,PFKFB2;HSP90AA1;INSR;TP53INP1
chromatin organization (GO:0006325),4/142,0.03891336043342399,0.20187551357456393,0,0,3.2601242236024843,10.583724760230522,NPM1;BAZ2A;SMARCA2;HMGN1
cellular response to hydrogen peroxide (GO:0070301),2/35,0.03907560587771475,0.20187551357456393,0,0,6.775552131484335,21.968080631233196,RPS3;TNFAIP3
cellular response to virus (GO:0098586),2/35,0.03907560587771475,0.20187551357456393,0,0,6.775552131484335,21.968080631233196,HSP90AA1;DDX3X
regulation of mitotic spindle organization (GO:0060236),2/35,0.03907560587771475,0.20187551357456393,0,0,6.775552131484335,21.968080631233196,DYNC1H1;NUMA1
positive regulation of lymphocyte activation (GO:0051251),2/35,0.03907560587771475,0.20187551357456393,0,0,6.775552131484335,21.968080631233196,PRKDC;HSPD1
protein-DNA complex assembly (GO:0065004),4/143,0.03976403227464379,0.20187551357456393,0,0,3.2365056526207607,10.437059112632317,NPM1;TCF4;RPS27A;UBA52
positive regulation of protein catabolic process (GO:0045732),3/85,0.040835786202569384,0.20187551357456393,0,0,4.103173503325943,13.122755010862717,HSP90AA1;HUWE1;TNFAIP3
regulation of cardiac muscle contraction (GO:0055117),2/36,0.04113584808749641,0.20187551357456393,0,0,6.575938850116318,20.983000991863147,PDE4B;CALM1
regulation of defense response to virus by host (GO:0050691),2/36,0.04113584808749641,0.20187551357456393,0,0,6.575938850116318,20.983000991863147,HSP90AA1;TNFAIP3
cellular response to heat (GO:0034605),2/36,0.04113584808749641,0.20187551357456393,0,0,6.575938850116318,20.983000991863147,HSP90AA1;HSP90AB1
platelet aggregation (GO:0070527),2/36,0.04113584808749641,0.20187551357456393,0,0,6.575938850116318,20.983000991863147,GNAS;MYH9
positive regulation of interferon-beta production (GO:0032728),2/36,0.04113584808749641,0.20187551357456393,0,0,6.575938850116318,20.983000991863147,HSP90AA1;DDX3X
telomere maintenance via telomere lengthening (GO:0010833),2/36,0.04113584808749641,0.20187551357456393,0,0,6.575938850116318,20.983000991863147,HSP90AA1;HSP90AB1
positive regulation of T cell mediated immunity (GO:0002711),2/36,0.04113584808749641,0.20187551357456393,0,0,6.575938850116318,20.983000991863147,HLA-B;HSPD1
centromere complex assembly (GO:0034508),2/37,0.043236166661996527,0.20187551357456393,0,0,6.38773204196933,20.064364221107684,NPM1;CENPF
"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",2/37,0.043236166661996527,0.20187551357456393,0,0,6.38773204196933,20.064364221107684,RPS27A;UBA52
regulation of protein autophosphorylation (GO:0031952),2/37,0.043236166661996527,0.20187551357456393,0,0,6.38773204196933,20.064364221107684,DDX3X;CALM1
ADP transport (GO:0015866),1/5,0.043960206972896584,0.20187551357456393,0,0,27.832865168539325,86.9629645143461,SLC25A5
negative regulation of hydrogen peroxide-induced neuron death (GO:1903208),1/5,0.043960206972896584,0.20187551357456393,0,0,27.832865168539325,86.9629645143461,RACK1
regulation of chromosome separation (GO:1905818),1/5,0.043960206972896584,0.20187551357456393,0,0,27.832865168539325,86.9629645143461,NUMA1
regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:2001270),1/5,0.043960206972896584,0.20187551357456393,0,0,27.832865168539325,86.9629645143461,RPS3
cellular response to antibiotic (GO:0071236),1/5,0.043960206972896584,0.20187551357456393,0,0,27.832865168539325,86.9629645143461,RPL23
regulation of germinal center formation (GO:0002634),1/5,0.043960206972896584,0.20187551357456393,0,0,27.832865168539325,86.9629645143461,TNFAIP3
regulation of mitophagy (GO:1901524),1/5,0.043960206972896584,0.20187551357456393,0,0,27.832865168539325,86.9629645143461,SLC25A5
regulation of protein import (GO:1904589),1/5,0.043960206972896584,0.20187551357456393,0,0,27.832865168539325,86.9629645143461,HSPA8
positive regulation of amine transport (GO:0051954),1/5,0.043960206972896584,0.20187551357456393,0,0,27.832865168539325,86.9629645143461,GRK2
regulation of respiratory burst involved in inflammatory response (GO:0060264),1/5,0.043960206972896584,0.20187551357456393,0,0,27.832865168539325,86.9629645143461,RPS19
regulation of ribonuclease activity (GO:0060700),1/5,0.043960206972896584,0.20187551357456393,0,0,27.832865168539325,86.9629645143461,NPM1
"fructose 2,6-bisphosphate metabolic process (GO:0006003)",1/5,0.043960206972896584,0.20187551357456393,0,0,27.832865168539325,86.9629645143461,PFKFB2
positive regulation of deoxyribonuclease activity (GO:0032077),1/5,0.043960206972896584,0.20187551357456393,0,0,27.832865168539325,86.9629645143461,RPS3
glomerular visceral epithelial cell migration (GO:0090521),1/5,0.043960206972896584,0.20187551357456393,0,0,27.832865168539325,86.9629645143461,KANK2
positive regulation of DNA demethylation (GO:1901537),1/5,0.043960206972896584,0.20187551357456393,0,0,27.832865168539325,86.9629645143461,USP9X
regulation of vitamin D receptor signaling pathway (GO:0070562),1/5,0.043960206972896584,0.20187551357456393,0,0,27.832865168539325,86.9629645143461,KANK2
rescue of stalled ribosome (GO:0072344),1/5,0.043960206972896584,0.20187551357456393,0,0,27.832865168539325,86.9629645143461,RACK1
positive regulation of Golgi to plasma membrane protein transport (GO:0042998),1/5,0.043960206972896584,0.20187551357456393,0,0,27.832865168539325,86.9629645143461,RACK1
positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902255),1/5,0.043960206972896584,0.20187551357456393,0,0,27.832865168539325,86.9629645143461,RPS7
rRNA transport (GO:0051029),1/5,0.043960206972896584,0.20187551357456393,0,0,27.832865168539325,86.9629645143461,NPM1
positive regulation of mitochondrial depolarization (GO:0051901),1/5,0.043960206972896584,0.20187551357456393,0,0,27.832865168539325,86.9629645143461,RACK1
positive regulation of protein localization to cell cortex (GO:1904778),1/5,0.043960206972896584,0.20187551357456393,0,0,27.832865168539325,86.9629645143461,NUMA1
mature ribosome assembly (GO:0042256),1/5,0.043960206972896584,0.20187551357456393,0,0,27.832865168539325,86.9629645143461,DDX3X
positive regulation of translation in response to stress (GO:0032056),1/5,0.043960206972896584,0.20187551357456393,0,0,27.832865168539325,86.9629645143461,DDX3X
monocyte extravasation (GO:0035696),1/5,0.043960206972896584,0.20187551357456393,0,0,27.832865168539325,86.9629645143461,PECAM1
protein K29-linked deubiquitination (GO:0035523),1/5,0.043960206972896584,0.20187551357456393,0,0,27.832865168539325,86.9629645143461,TNFAIP3
negative regulation of transcription by RNA polymerase II (GO:0000122),11/684,0.044111910856000844,0.20191871453117805,0,0,1.8629095025826081,5.814187960333461,KANK2;RPS14;DDX5;RPL10;USP9X;RPL23;ARID5B;MDM4;RPS27A;UBA52;SMARCA2
negative regulation of innate immune response (GO:0045824),2/38,0.04537568805640871,0.20505764761797438,0,0,6.209981167608286,19.206098244758902,RPS19;TNFAIP3
negative regulation of proteasomal protein catabolic process (GO:1901799),2/38,0.04537568805640871,0.20505764761797438,0,0,6.209981167608286,19.206098244758902,HSP90AB1;RPL11
connective tissue development (GO:0061448),2/38,0.04537568805640871,0.20505764761797438,0,0,6.209981167608286,19.206098244758902,ARID5B;CD44
regulation of phosphoprotein phosphatase activity (GO:0043666),2/38,0.04537568805640871,0.20505764761797438,0,0,6.209981167608286,19.206098244758902,HSP90AB1;CALM1
"negative regulation of transcription, DNA-templated (GO:0045892)",14/948,0.04580039557335726,0.20589022058736942,0,0,1.7157744468236973,5.290526252617382,KANK2;HSPA8;DDX5;RPL10;USP9X;RPL23;ARID5B;PTPRK;SMARCA2;RPS14;CENPF;MDM4;RPS27A;UBA52
regulation of cell growth (GO:0001558),5/217,0.045850112547997694,0.20589022058736942,0,0,2.6579104315766644,8.192683645094549,CDC42;DDX3X;RACK1;SMARCA2;EIF4G2
regulation of cellular component biogenesis (GO:0044087),2/39,0.04755355101522341,0.20826694102037663,0,0,6.04183844861811,18.40282856003495,HSPA8;HSP90AA1
regulation of exit from mitosis (GO:0007096),2/39,0.04755355101522341,0.20826694102037663,0,0,6.04183844861811,18.40282856003495,RPS27A;UBA52
regulation of intracellular transport (GO:0032386),2/39,0.04755355101522341,0.20826694102037663,0,0,6.04183844861811,18.40282856003495,DYNC1H1;NUMA1
"nucleotide-excision repair, DNA incision (GO:0033683)",2/39,0.04755355101522341,0.20826694102037663,0,0,6.04183844861811,18.40282856003495,RPS27A;UBA52
regulation of nitric-oxide synthase activity (GO:0050999),2/39,0.04755355101522341,0.20826694102037663,0,0,6.04183844861811,18.40282856003495,HSP90AA1;CALM1
endothelial cell migration (GO:0043542),2/39,0.04755355101522341,0.20826694102037663,0,0,6.04183844861811,18.40282856003495,NR4A1;MYH9
regulation of protein targeting to mitochondrion (GO:1903214),2/39,0.04755355101522341,0.20826694102037663,0,0,6.04183844861811,18.40282856003495,HPS4;HUWE1
positive regulation of intracellular transport (GO:0032388),2/39,0.04755355101522341,0.20826694102037663,0,0,6.04183844861811,18.40282856003495,DYNC1H1;NUMA1
negative regulation of protein phosphorylation (GO:0001933),4/152,0.047895650354634105,0.2087515213713439,0,0,3.038301158301158,9.232578657632263,PRKDC;RACK1;LDLRAD4;CALM1
toll-like receptor signaling pathway (GO:0002224),3/91,0.048341053709439905,0.2087515213713439,0,0,3.8222494834710745,11.579405837099804,RPS27A;UBA52;HSPD1
T cell activation (GO:0042110),3/92,0.04965331394108284,0.2087515213713439,0,0,3.779111338100102,11.347500370540494,IRF4;CD44;HSPD1
Wnt signaling pathway (GO:0016055),3/92,0.04965331394108284,0.2087515213713439,0,0,3.779111338100102,11.347500370540494,DDX3X;RPS27A;UBA52
nucleocytoplasmic transport (GO:0006913),2/40,0.049768906381139504,0.2087515213713439,0,0,5.882545346416889,17.649782343617474,NPM1;BACH2
regulation of microtubule polymerization (GO:0031113),2/40,0.049768906381139504,0.2087515213713439,0,0,5.882545346416889,17.649782343617474,NUMA1;RPS3
positive regulation of NF-kappaB transcription factor activity (GO:0051092),4/155,0.050796058257726075,0.2087515213713439,0,0,2.9774834437086093,8.872711653865744,NPM1;RPS3;RPS27A;UBA52
positive regulation of peptidyl-serine phosphorylation (GO:0033138),3/93,0.05098287651410663,0.2087515213713439,0,0,3.736931818181818,11.122101086595492,HSP90AA1;HSP90AB1;CD44
carbohydrate catabolic process (GO:0016052),2/41,0.05202091700987645,0.2087515213713439,0,0,5.73142112125163,16.942707800833247,PFKFB2;PGK1
JNK cascade (GO:0007254),2/41,0.05202091700987645,0.2087515213713439,0,0,5.73142112125163,16.942707800833247,RPS27A;UBA52
hemopoiesis (GO:0030097),3/94,0.05232964715126968,0.2087515213713439,0,0,3.6956793206793206,10.902964310679279,CD164;PRRC2C;ZFP36L2
axo-dendritic transport (GO:0008088),1/6,0.05251888169807595,0.2087515213713439,0,0,22.265168539325842,65.6061564818719,HSPA8
regulation of DNA demethylation (GO:1901535),1/6,0.05251888169807595,0.2087515213713439,0,0,22.265168539325842,65.6061564818719,USP9X
cellular response to granulocyte macrophage colony-stimulating factor stimulus (GO:0097011),1/6,0.05251888169807595,0.2087515213713439,0,0,22.265168539325842,65.6061564818719,ZFP36L2
negative regulation of toll-like receptor 2 signaling pathway (GO:0034136),1/6,0.05251888169807595,0.2087515213713439,0,0,22.265168539325842,65.6061564818719,TNFAIP3
regulation of keratinocyte apoptotic process (GO:1902172),1/6,0.05251888169807595,0.2087515213713439,0,0,22.265168539325842,65.6061564818719,GSN
neutrophil extravasation (GO:0072672),1/6,0.05251888169807595,0.2087515213713439,0,0,22.265168539325842,65.6061564818719,PECAM1
detection of virus (GO:0009597),1/6,0.05251888169807595,0.2087515213713439,0,0,22.265168539325842,65.6061564818719,SERINC5
regulation of relaxation of cardiac muscle (GO:1901897),1/6,0.05251888169807595,0.2087515213713439,0,0,22.265168539325842,65.6061564818719,PDE4B
positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904925),1/6,0.05251888169807595,0.2087515213713439,0,0,22.265168539325842,65.6061564818719,HUWE1
regulation of sarcomere organization (GO:0060297),1/6,0.05251888169807595,0.2087515213713439,0,0,22.265168539325842,65.6061564818719,AKAP13
regulation of T-helper cell differentiation (GO:0045622),1/6,0.05251888169807595,0.2087515213713439,0,0,22.265168539325842,65.6061564818719,IRF4
glomerulus vasculature development (GO:0072012),1/6,0.05251888169807595,0.2087515213713439,0,0,22.265168539325842,65.6061564818719,PECAM1
regulation of type B pancreatic cell proliferation (GO:0061469),1/6,0.05251888169807595,0.2087515213713439,0,0,22.265168539325842,65.6061564818719,NR4A1
response to granulocyte macrophage colony-stimulating factor (GO:0097012),1/6,0.05251888169807595,0.2087515213713439,0,0,22.265168539325842,65.6061564818719,ZFP36L2
positive regulation of immune response to tumor cell (GO:0002839),1/6,0.05251888169807595,0.2087515213713439,0,0,22.265168539325842,65.6061564818719,HSPD1
L-serine biosynthetic process (GO:0006564),1/6,0.05251888169807595,0.2087515213713439,0,0,22.265168539325842,65.6061564818719,SERINC5
T-helper 17 cell lineage commitment (GO:0072540),1/6,0.05251888169807595,0.2087515213713439,0,0,22.265168539325842,65.6061564818719,IRF4
melanosome assembly (GO:1903232),1/6,0.05251888169807595,0.2087515213713439,0,0,22.265168539325842,65.6061564818719,HPS4
positive regulation of T cell mediated immune response to tumor cell (GO:0002842),1/6,0.05251888169807595,0.2087515213713439,0,0,22.265168539325842,65.6061564818719,HSPD1
positive regulation of toll-like receptor 7 signaling pathway (GO:0034157),1/6,0.05251888169807595,0.2087515213713439,0,0,22.265168539325842,65.6061564818719,DDX3X
protection from natural killer cell mediated cytotoxicity (GO:0042270),1/6,0.05251888169807595,0.2087515213713439,0,0,22.265168539325842,65.6061564818719,HLA-B
negative regulation of actin filament depolymerization (GO:0030835),1/6,0.05251888169807595,0.2087515213713439,0,0,22.265168539325842,65.6061564818719,GSN
cellular response to growth factor stimulus (GO:0071363),4/158,0.0537909662670216,0.21261666053733608,0,0,2.9190352504638217,8.531317613383845,NR4A1;RACK1;ZFP36L2;CD44
skeletal system development (GO:0001501),4/158,0.0537909662670216,0.21261666053733608,0,0,2.9190352504638217,8.531317613383845,AKAP13;GNAS;RPL13;CD44
regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),2/42,0.054308757553373756,0.2134740359230952,0,0,5.587853107344633,16.277806045203583,DDX3X;TNFAIP3
translesion synthesis (GO:0019985),2/42,0.054308757553373756,0.2134740359230952,0,0,5.587853107344633,16.277806045203583,RPS27A;UBA52
positive regulation of cold-induced thermogenesis (GO:0120162),3/97,0.05647222758402363,0.2153257082527456,0,0,3.5771881044487426,10.280861180179246,DYNC1H1;IRF4;GNAS
cellular glucose homeostasis (GO:0001678),2/43,0.056631614380789605,0.2153257082527456,0,0,5.451288411189196,15.651673280610565,TRA2B;RACK1
DNA synthesis involved in DNA repair (GO:0000731),2/43,0.056631614380789605,0.2153257082527456,0,0,5.451288411189196,15.651673280610565,RPS27A;UBA52
substantia nigra development (GO:0021762),2/43,0.056631614380789605,0.2153257082527456,0,0,5.451288411189196,15.651673280610565,CDC42;CALM1
negative regulation of cellular macromolecule biosynthetic process (GO:2000113),9/547,0.05802629854687346,0.2153257082527456,0,0,1.8975180406735184,5.401966213043001,HSPA8;CENPF;DDX3X;RACK1;RPS3;ARID5B;RPL13A;PTPRK;SMARCA2
homotypic cell-cell adhesion (GO:0034109),2/44,0.05898868539875153,0.2153257082527456,0,0,5.321226795803067,15.061251546937442,GNAS;MYH9
intracellular steroid hormone receptor signaling pathway (GO:0030518),2/44,0.05898868539875153,0.2153257082527456,0,0,5.321226795803067,15.061251546937442,DDX17;DDX5
mRNA catabolic process (GO:0006402),2/44,0.05898868539875153,0.2153257082527456,0,0,5.321226795803067,15.061251546937442,DDX5;ZFP36L2
adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191),1/7,0.06100136343735288,0.2153257082527456,0,0,18.553370786516854,51.89116324509466,GNAS
negative regulation of cell cycle phase transition (GO:1901988),1/7,0.06100136343735288,0.2153257082527456,0,0,18.553370786516854,51.89116324509466,ZFP36L2
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),1/7,0.06100136343735288,0.2153257082527456,0,0,18.553370786516854,51.89116324509466,HLA-B
"antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",1/7,0.06100136343735288,0.2153257082527456,0,0,18.553370786516854,51.89116324509466,HLA-B
negative regulation of DNA repair (GO:0045738),1/7,0.06100136343735288,0.2153257082527456,0,0,18.553370786516854,51.89116324509466,RPS3
autophagosome membrane docking (GO:0016240),1/7,0.06100136343735288,0.2153257082527456,0,0,18.553370786516854,51.89116324509466,CALM1
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901029),1/7,0.06100136343735288,0.2153257082527456,0,0,18.553370786516854,51.89116324509466,SLC25A5
Cdc42 protein signal transduction (GO:0032488),1/7,0.06100136343735288,0.2153257082527456,0,0,18.553370786516854,51.89116324509466,CDC42
negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),1/7,0.06100136343735288,0.2153257082527456,0,0,18.553370786516854,51.89116324509466,NPM1
definitive hemopoiesis (GO:0060216),1/7,0.06100136343735288,0.2153257082527456,0,0,18.553370786516854,51.89116324509466,ZFP36L2
delamination (GO:0060232),1/7,0.06100136343735288,0.2153257082527456,0,0,18.553370786516854,51.89116324509466,AKNA
regulation of muscle organ development (GO:0048634),1/7,0.06100136343735288,0.2153257082527456,0,0,18.553370786516854,51.89116324509466,CENPF
positive regulation of catecholamine secretion (GO:0033605),1/7,0.06100136343735288,0.2153257082527456,0,0,18.553370786516854,51.89116324509466,GRK2
regulation of T cell mediated immune response to tumor cell (GO:0002840),1/7,0.06100136343735288,0.2153257082527456,0,0,18.553370786516854,51.89116324509466,HSPD1
regulation of T cell tolerance induction (GO:0002664),1/7,0.06100136343735288,0.2153257082527456,0,0,18.553370786516854,51.89116324509466,HLA-B
G-quadruplex DNA unwinding (GO:0044806),1/7,0.06100136343735288,0.2153257082527456,0,0,18.553370786516854,51.89116324509466,HNRNPA2B1
regulation of toll-like receptor 7 signaling pathway (GO:0034155),1/7,0.06100136343735288,0.2153257082527456,0,0,18.553370786516854,51.89116324509466,DDX3X
regulation of transforming growth factor beta activation (GO:1901388),1/7,0.06100136343735288,0.2153257082527456,0,0,18.553370786516854,51.89116324509466,HSP90AB1
glutamine transport (GO:0006868),1/7,0.06100136343735288,0.2153257082527456,0,0,18.553370786516854,51.89116324509466,SLC38A1
positive regulation of gastrulation (GO:2000543),1/7,0.06100136343735288,0.2153257082527456,0,0,18.553370786516854,51.89116324509466,RACK1
hemostasis (GO:0007599),1/7,0.06100136343735288,0.2153257082527456,0,0,18.553370786516854,51.89116324509466,HPS4
ribosomal large subunit export from nucleus (GO:0000055),1/7,0.06100136343735288,0.2153257082527456,0,0,18.553370786516854,51.89116324509466,NPM1
ribosomal small subunit export from nucleus (GO:0000056),1/7,0.06100136343735288,0.2153257082527456,0,0,18.553370786516854,51.89116324509466,NPM1
positive regulation of membrane depolarization (GO:1904181),1/7,0.06100136343735288,0.2153257082527456,0,0,18.553370786516854,51.89116324509466,RACK1
rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),1/7,0.06100136343735288,0.2153257082527456,0,0,18.553370786516854,51.89116324509466,NPM1
positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779),1/7,0.06100136343735288,0.2153257082527456,0,0,18.553370786516854,51.89116324509466,HUWE1
somatic recombination of immunoglobulin gene segments (GO:0016447),1/7,0.06100136343735288,0.2153257082527456,0,0,18.553370786516854,51.89116324509466,PRKDC
positive regulation of pinocytosis (GO:0048549),1/7,0.06100136343735288,0.2153257082527456,0,0,18.553370786516854,51.89116324509466,CDC42
T-helper 17 cell differentiation (GO:0072539),1/7,0.06100136343735288,0.2153257082527456,0,0,18.553370786516854,51.89116324509466,IRF4
tachykinin receptor signaling pathway (GO:0007217),1/7,0.06100136343735288,0.2153257082527456,0,0,18.553370786516854,51.89116324509466,GRK2
mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),1/7,0.06100136343735288,0.2153257082527456,0,0,18.553370786516854,51.89116324509466,CALM1
modulation by symbiont of host apoptotic process (GO:0052150),1/7,0.06100136343735288,0.2153257082527456,0,0,18.553370786516854,51.89116324509466,RNF213
protein localization to cytoplasmic stress granule (GO:1903608),1/7,0.06100136343735288,0.2153257082527456,0,0,18.553370786516854,51.89116324509466,DDX3X
regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),3/102,0.06371119774927579,0.22190071071168904,0,0,3.395661157024793,9.349596257929022,HSP90AB1;RPL11;RACK1
regulation of protein catabolic process (GO:0042176),3/102,0.06371119774927579,0.22190071071168904,0,0,3.395661157024793,9.349596257929022,HUWE1;TNFAIP3;MDM4
regulation of cellular protein localization (GO:1903827),2/46,0.06380231851329748,0.22190071071168904,0,0,5.078839239856189,13.976791632547458,HSP90AA1;HSP90AB1
regulation of telomerase activity (GO:0051972),2/46,0.06380231851329748,0.22190071071168904,0,0,5.078839239856189,13.976791632547458,HSP90AA1;HSP90AB1
positive regulation of organelle assembly (GO:1902117),2/46,0.06380231851329748,0.22190071071168904,0,0,5.078839239856189,13.976791632547458,DYNC1H1;NUMA1
postreplication repair (GO:0006301),2/46,0.06380231851329748,0.22190071071168904,0,0,5.078839239856189,13.976791632547458,RPS27A;UBA52
chromatin remodeling (GO:0006338),3/103,0.06520820996706948,0.2223259931298301,0,0,3.3615340909090907,9.177559186895547,NPM1;BAZ2A;SMARCA2
regulation of T cell activation (GO:0050863),2/47,0.06625733292274494,0.2223259931298301,0,0,4.965725047080979,13.47801628277205,PAG1;HSPD1
translational elongation (GO:0006414),3/104,0.06672136193702338,0.2223259931298301,0,0,3.3280828082808283,9.009885981875579,EEF1B2;RACK1;EEF2
membrane organization (GO:0061024),5/242,0.06681895397751746,0.2223259931298301,0,0,2.374508948057617,6.424871506331437,HSPA8;HUWE1;IL7R;RPS27A;UBA52
nucleotide-excision repair (GO:0006289),3/105,0.06825053580347781,0.2223259931298301,0,0,3.2952874331550803,8.846429765798444,RPS27A;UBA52;HMGN1
regulation of interleukin-10 production (GO:0032653),2/48,0.0687434658510421,0.2223259931298301,0,0,4.8575288626873006,13.005419485341791,IRF4;HSPD1
nucleus organization (GO:0006997),2/48,0.0687434658510421,0.2223259931298301,0,0,4.8575288626873006,13.005419485341791,NUMA1;RPS19
actin filament reorganization (GO:0090527),1/8,0.06940832625547197,0.2223259931298301,0,0,15.902086677367576,42.422766986769005,GSN
"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",1/8,0.06940832625547197,0.2223259931298301,0,0,15.902086677367576,42.422766986769005,HLA-B
cardiac atrium development (GO:0003230),1/8,0.06940832625547197,0.2223259931298301,0,0,15.902086677367576,42.422766986769005,MDM4
negative regulation of mitochondrial fusion (GO:0010637),1/8,0.06940832625547197,0.2223259931298301,0,0,15.902086677367576,42.422766986769005,HUWE1
regulation of chemokine (C-C motif) ligand 5 production (GO:0071649),1/8,0.06940832625547197,0.2223259931298301,0,0,15.902086677367576,42.422766986769005,DDX3X
negative regulation of nitrogen compound metabolic process (GO:0051172),1/8,0.06940832625547197,0.2223259931298301,0,0,15.902086677367576,42.422766986769005,HSP90AB1
cellular response to epinephrine stimulus (GO:0071872),1/8,0.06940832625547197,0.2223259931298301,0,0,15.902086677367576,42.422766986769005,PDE4B
regulation of Golgi to plasma membrane protein transport (GO:0042996),1/8,0.06940832625547197,0.2223259931298301,0,0,15.902086677367576,42.422766986769005,RACK1
regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),1/8,0.06940832625547197,0.2223259931298301,0,0,15.902086677367576,42.422766986769005,RPS7
dendritic spine maintenance (GO:0097062),1/8,0.06940832625547197,0.2223259931298301,0,0,15.902086677367576,42.422766986769005,INSR
regulation of protein K63-linked ubiquitination (GO:1900044),1/8,0.06940832625547197,0.2223259931298301,0,0,15.902086677367576,42.422766986769005,DDX3X
regulation of protein localization to cell cortex (GO:1904776),1/8,0.06940832625547197,0.2223259931298301,0,0,15.902086677367576,42.422766986769005,NUMA1
positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),1/8,0.06940832625547197,0.2223259931298301,0,0,15.902086677367576,42.422766986769005,WASF2
regulation of striated muscle tissue development (GO:0016202),1/8,0.06940832625547197,0.2223259931298301,0,0,15.902086677367576,42.422766986769005,CENPF
positive regulation of chromosome segregation (GO:0051984),1/8,0.06940832625547197,0.2223259931298301,0,0,15.902086677367576,42.422766986769005,NUMA1
regulation of toll-like receptor 3 signaling pathway (GO:0034139),1/8,0.06940832625547197,0.2223259931298301,0,0,15.902086677367576,42.422766986769005,TNFAIP3
positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),1/8,0.06940832625547197,0.2223259931298301,0,0,15.902086677367576,42.422766986769005,GSN
regulation of vascular wound healing (GO:0061043),1/8,0.06940832625547197,0.2223259931298301,0,0,15.902086677367576,42.422766986769005,TNFAIP3
response to epinephrine (GO:0071871),1/8,0.06940832625547197,0.2223259931298301,0,0,15.902086677367576,42.422766986769005,PDE4B
histone H3-K4 monomethylation (GO:0097692),1/8,0.06940832625547197,0.2223259931298301,0,0,15.902086677367576,42.422766986769005,KMT2C
positive regulation of leukocyte differentiation (GO:1902107),1/8,0.06940832625547197,0.2223259931298301,0,0,15.902086677367576,42.422766986769005,PRKDC
RNA secondary structure unwinding (GO:0010501),1/8,0.06940832625547197,0.2223259931298301,0,0,15.902086677367576,42.422766986769005,DDX3X
kidney epithelium development (GO:0072073),1/8,0.06940832625547197,0.2223259931298301,0,0,15.902086677367576,42.422766986769005,KANK2
leukocyte aggregation (GO:0070486),1/8,0.06940832625547197,0.2223259931298301,0,0,15.902086677367576,42.422766986769005,CD44
T-helper cell lineage commitment (GO:0002295),1/8,0.06940832625547197,0.2223259931298301,0,0,15.902086677367576,42.422766986769005,IRF4
positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316),1/8,0.06940832625547197,0.2223259931298301,0,0,15.902086677367576,42.422766986769005,CALM1
negative regulation by symbiont of host apoptotic process (GO:0033668),1/8,0.06940832625547197,0.2223259931298301,0,0,15.902086677367576,42.422766986769005,RNF213
negative regulation by symbiont of host programmed cell death (GO:0052041),1/8,0.06940832625547197,0.2223259931298301,0,0,15.902086677367576,42.422766986769005,RNF213
cellular response to peptide hormone stimulus (GO:0071375),3/106,0.06979561200457982,0.2225617380550534,0,0,3.2631288614298324,8.687049890103093,NR4A1;PRKDC;INSR
chromosome organization (GO:0051276),3/106,0.06979561200457982,0.2225617380550534,0,0,3.2631288614298324,8.687049890103093,RPS27A;UBA52;HMGN1
positive regulation of DNA-binding transcription factor activity (GO:0051091),5/246,0.07059777760542084,0.22461490229168649,0,0,2.334621071207135,6.188512244881016,NPM1;RPS3;ARID5B;RPS27A;UBA52
regulation of interferon-beta production (GO:0032648),2/49,0.07125997090554113,0.22470644158880637,0,0,4.753936771246544,12.557146172061003,HSP90AA1;DDX3X
regulation of smooth muscle cell proliferation (GO:0048660),2/49,0.07125997090554113,0.22470644158880637,0,0,4.753936771246544,12.557146172061003,PRKDC;TNFAIP3
response to glucose (GO:0009749),2/49,0.07125997090554113,0.22470644158880637,0,0,4.753936771246544,12.557146172061003,TRA2B;RACK1
response to hydrogen peroxide (GO:0042542),2/49,0.07125997090554113,0.22470644158880637,0,0,4.753936771246544,12.557146172061003,RPS3;TNFAIP3
negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),3/108,0.07293298476659718,0.22947207402173261,0,0,3.2006493506493507,8.379985823509301,LDLRAD4;RPS27A;UBA52
actin polymerization or depolymerization (GO:0008154),2/50,0.07380611238780652,0.23119398118829457,0,0,4.654661016949152,12.131506903576025,PREX1;GSN
positive regulation of cell morphogenesis involved in differentiation (GO:0010770),2/50,0.07380611238780652,0.23119398118829457,0,0,4.654661016949152,12.131506903576025,CDC42;PRKDC
protein modification by small protein conjugation (GO:0032446),7/409,0.07539595566621671,0.23228351531477784,0,0,1.9659406456091635,5.08195980048521,RNF213;PRKDC;USP9X;RACK1;HUWE1;RPS27A;UBA52
regulation of interleukin-6 production (GO:0032675),3/110,0.07613249119765067,0.23228351531477784,0,0,3.1405055225148684,8.087681537043645,HLA-B;TNFAIP3;HSPD1
negative regulation of protein ubiquitination (GO:0031397),2/51,0.07638116523479245,0.23228351531477784,0,0,4.559437334255736,11.72696009837237,RPS3;TNFAIP3
regulation of interleukin-12 production (GO:0032655),2/51,0.07638116523479245,0.23228351531477784,0,0,4.559437334255736,11.72696009837237,HLA-B;HSPD1
DNA duplex unwinding (GO:0032508),2/51,0.07638116523479245,0.23228351531477784,0,0,4.559437334255736,11.72696009837237,RPS27A;UBA52
positive regulation of phosphorylation (GO:0042327),5/253,0.07748894942333065,0.23228351531477784,0,0,2.2679134223210977,5.800460593107728,PFKFB2;HSP90AA1;INSR;RACK1;PECAM1
actin-mediated cell contraction (GO:0070252),1/9,0.07774043838709395,0.23228351531477784,0,0,13.913623595505618,35.54067786656654,GSN
negative regulation of bone resorption (GO:0045779),1/9,0.07774043838709395,0.23228351531477784,0,0,13.913623595505618,35.54067786656654,TNFAIP3
astral microtubule organization (GO:0030953),1/9,0.07774043838709395,0.23228351531477784,0,0,13.913623595505618,35.54067786656654,NUMA1
negative regulation of leukocyte proliferation (GO:0070664),1/9,0.07774043838709395,0.23228351531477784,0,0,13.913623595505618,35.54067786656654,TNFAIP3
negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),1/9,0.07774043838709395,0.23228351531477784,0,0,13.913623595505618,35.54067786656654,LDLRAD4
regulation of pinocytosis (GO:0048548),1/9,0.07774043838709395,0.23228351531477784,0,0,13.913623595505618,35.54067786656654,CDC42
plasminogen activation (GO:0031639),1/9,0.07774043838709395,0.23228351531477784,0,0,13.913623595505618,35.54067786656654,PGK1
endothelial cell chemotaxis (GO:0035767),1/9,0.07774043838709395,0.23228351531477784,0,0,13.913623595505618,35.54067786656654,NR4A1
epithelial cell apoptotic process (GO:1904019),1/9,0.07774043838709395,0.23228351531477784,0,0,13.913623595505618,35.54067786656654,GSN
regulation of respiratory burst (GO:0060263),1/9,0.07774043838709395,0.23228351531477784,0,0,13.913623595505618,35.54067786656654,INSR
positive regulation of autophagy of mitochondrion (GO:1903599),1/9,0.07774043838709395,0.23228351531477784,0,0,13.913623595505618,35.54067786656654,SLC25A5
kinetochore assembly (GO:0051382),1/9,0.07774043838709395,0.23228351531477784,0,0,13.913623595505618,35.54067786656654,CENPF
positive regulation of NLRP3 inflammasome complex assembly (GO:1900227),1/9,0.07774043838709395,0.23228351531477784,0,0,13.913623595505618,35.54067786656654,DDX3X
positive regulation of protein polyubiquitination (GO:1902916),1/9,0.07774043838709395,0.23228351531477784,0,0,13.913623595505618,35.54067786656654,DDX3X
positive regulation of sequestering of triglyceride (GO:0010890),1/9,0.07774043838709395,0.23228351531477784,0,0,13.913623595505618,35.54067786656654,PLIN2
regulation of Wnt signaling pathway (GO:0030111),3/111,0.07775522887563036,0.23228351531477784,0,0,3.1112689393939394,7.94677038749537,MACF1;RACK1;TNFAIP3
negative regulation of protein metabolic process (GO:0051248),2/52,0.07898441482019655,0.2339851453650499,0,0,4.468022598870056,11.342096486388334,HSP90AB1;MDM4
regulation of intrinsic apoptotic signaling pathway (GO:2001242),2/52,0.07898441482019655,0.2339851453650499,0,0,4.468022598870056,11.342096486388334,DDX3X;RACK1
positive regulation of developmental growth (GO:0048639),2/52,0.07898441482019655,0.2339851453650499,0,0,4.468022598870056,11.342096486388334,MACF1;INSR
sprouting angiogenesis (GO:0002040),2/52,0.07898441482019655,0.2339851453650499,0,0,4.468022598870056,11.342096486388334,NR4A1;RNF213
negative regulation of cysteine-type endopeptidase activity (GO:2000117),2/53,0.0816151569043371,0.24027366731795508,0,0,4.380192755068129,10.97562545507234,DDX3X;CD44
heart morphogenesis (GO:0003007),2/53,0.0816151569043371,0.24027366731795508,0,0,4.380192755068129,10.97562545507234,INSR;MDM4
positive regulation of NIK/NF-kappaB signaling (GO:1901224),2/53,0.0816151569043371,0.24027366731795508,0,0,4.380192755068129,10.97562545507234,DDX3X;RPS3
negative regulation of cell motility (GO:2000146),3/114,0.0827138311051511,0.24250191392192025,0,0,3.026719901719902,7.543701179796293,TP53INP1;LDLRAD4;PTPRK
positive regulation of cellular component organization (GO:0051130),3/114,0.0827138311051511,0.24250191392192025,0,0,3.026719901719902,7.543701179796293,INSR;RACK1;RPS3
cytoplasmic microtubule organization (GO:0031122),2/54,0.08427269744647232,0.24309098839035578,0,0,4.29574098218166,10.626363041553466,DYNC1H1;NUMA1
cellular component assembly (GO:0022607),5/261,0.08579340103081501,0.24309098839035578,0,0,2.196143139367816,5.393317281120295,CDC42;GSN;STAG3;MDM4;YWHAZ
regulation of actin filament-based movement (GO:1903115),1/10,0.0859983623481033,0.24309098839035578,0,0,12.367041198501873,30.34163310031636,PDE4B
regulation of attachment of spindle microtubules to kinetochore (GO:0051988),1/10,0.0859983623481033,0.24309098839035578,0,0,12.367041198501873,30.34163310031636,CDC42
B cell homeostasis (GO:0001782),1/10,0.0859983623481033,0.24309098839035578,0,0,12.367041198501873,30.34163310031636,TNFAIP3
regulation of endoplasmic reticulum unfolded protein response (GO:1900101),1/10,0.0859983623481033,0.24309098839035578,0,0,12.367041198501873,30.34163310031636,RACK1
negative regulation of toll-like receptor 4 signaling pathway (GO:0034144),1/10,0.0859983623481033,0.24309098839035578,0,0,12.367041198501873,30.34163310031636,TNFAIP3
negative regulation of transforming growth factor beta production (GO:0071635),1/10,0.0859983623481033,0.24309098839035578,0,0,12.367041198501873,30.34163310031636,HSP90AB1
negative regulation of voltage-gated calcium channel activity (GO:1901386),1/10,0.0859983623481033,0.24309098839035578,0,0,12.367041198501873,30.34163310031636,CALM1
neuron projection maintenance (GO:1990535),1/10,0.0859983623481033,0.24309098839035578,0,0,12.367041198501873,30.34163310031636,INSR
nucleic acid transport (GO:0050657),1/10,0.0859983623481033,0.24309098839035578,0,0,12.367041198501873,30.34163310031636,HNRNPA2B1
regulation of podosome assembly (GO:0071801),1/10,0.0859983623481033,0.24309098839035578,0,0,12.367041198501873,30.34163310031636,GSN
endothelium development (GO:0003158),1/10,0.0859983623481033,0.24309098839035578,0,0,12.367041198501873,30.34163310031636,PECAM1
granulocyte activation (GO:0036230),1/10,0.0859983623481033,0.24309098839035578,0,0,12.367041198501873,30.34163310031636,PREX1
sequestering of actin monomers (GO:0042989),1/10,0.0859983623481033,0.24309098839035578,0,0,12.367041198501873,30.34163310031636,GSN
L-serine metabolic process (GO:0006563),1/10,0.0859983623481033,0.24309098839035578,0,0,12.367041198501873,30.34163310031636,SERINC5
primary miRNA processing (GO:0031053),1/10,0.0859983623481033,0.24309098839035578,0,0,12.367041198501873,30.34163310031636,HNRNPA2B1
protein K11-linked deubiquitination (GO:0035871),1/10,0.0859983623481033,0.24309098839035578,0,0,12.367041198501873,30.34163310031636,TNFAIP3
protein targeting to mitochondrion (GO:0006626),2/55,0.08695635252175661,0.24337488013485725,0,0,4.214476068649398,10.293221333277879,HSP90AA1;HSPD1
pyruvate metabolic process (GO:0006090),2/55,0.08695635252175661,0.24337488013485725,0,0,4.214476068649398,10.293221333277879,PFKFB2;PGK1
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),2/55,0.08695635252175661,0.24337488013485725,0,0,4.214476068649398,10.293221333277879,DDX3X;CD44
interstrand cross-link repair (GO:0036297),2/55,0.08695635252175661,0.24337488013485725,0,0,4.214476068649398,10.293221333277879,RPS27A;UBA52
positive regulation of response to DNA damage stimulus (GO:2001022),2/55,0.08695635252175661,0.24337488013485725,0,0,4.214476068649398,10.293221333277879,DDX5;RPS3
protein-containing complex disassembly (GO:0032984),2/56,0.08966544813292757,0.24980435343821444,0,0,4.136220966729441,9.975199099500824,HSPA8;RPL23
mitochondrial transport (GO:0006839),2/56,0.08966544813292757,0.24980435343821444,0,0,4.136220966729441,9.975199099500824,HSP90AA1;SLC25A5
protein deubiquitination (GO:0016579),5/267,0.09231730370251684,0.24980435343821444,0,0,2.14519171711854,5.1109700698469265,USP9X;TNFAIP3;MDM4;RPS27A;UBA52
regulation of mitotic nuclear division (GO:0007088),2/57,0.09239932018804421,0.24980435343821444,0,0,4.060811504879301,9.671373478950164,INSR;MKI67
positive regulation of interferon-gamma production (GO:0032729),2/57,0.09239932018804421,0.24980435343821444,0,0,4.060811504879301,9.671373478950164,PDE4B;HSPD1
actin filament depolymerization (GO:0030042),1/11,0.09418275481990468,0.24980435343821444,0,0,11.129775280898876,26.29429648508577,GSN
negative regulation of bone remodeling (GO:0046851),1/11,0.09418275481990468,0.24980435343821444,0,0,11.129775280898876,26.29429648508577,TNFAIP3
negative regulation of centrosome duplication (GO:0010826),1/11,0.09418275481990468,0.24980435343821444,0,0,11.129775280898876,26.29429648508577,NPM1
rDNA heterochromatin assembly (GO:0000183),1/11,0.09418275481990468,0.24980435343821444,0,0,11.129775280898876,26.29429648508577,BAZ2A
negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),1/11,0.09418275481990468,0.24980435343821444,0,0,11.129775280898876,26.29429648508577,KANK2
regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),1/11,0.09418275481990468,0.24980435343821444,0,0,11.129775280898876,26.29429648508577,GSN
cell proliferation in forebrain (GO:0021846),1/11,0.09418275481990468,0.24980435343821444,0,0,11.129775280898876,26.29429648508577,AKNA
negative regulation of oxidative stress-induced neuron death (GO:1903204),1/11,0.09418275481990468,0.24980435343821444,0,0,11.129775280898876,26.29429648508577,RACK1
regulation of lamellipodium morphogenesis (GO:2000392),1/11,0.09418275481990468,0.24980435343821444,0,0,11.129775280898876,26.29429648508577,CD44
regulation of mitochondrial depolarization (GO:0051900),1/11,0.09418275481990468,0.24980435343821444,0,0,11.129775280898876,26.29429648508577,RACK1
regulation of mitochondrial fusion (GO:0010635),1/11,0.09418275481990468,0.24980435343821444,0,0,11.129775280898876,26.29429648508577,HUWE1
desensitization of G protein-coupled receptor signaling pathway (GO:0002029),1/11,0.09418275481990468,0.24980435343821444,0,0,11.129775280898876,26.29429648508577,GRK2
establishment of epithelial cell apical/basal polarity (GO:0045198),1/11,0.09418275481990468,0.24980435343821444,0,0,11.129775280898876,26.29429648508577,CDC42
regulation of synapse maturation (GO:0090128),1/11,0.09418275481990468,0.24980435343821444,0,0,11.129775280898876,26.29429648508577,YWHAZ
positive regulation of ceramide biosynthetic process (GO:2000304),1/11,0.09418275481990468,0.24980435343821444,0,0,11.129775280898876,26.29429648508577,RACK1
regulation of toll-like receptor 2 signaling pathway (GO:0034135),1/11,0.09418275481990468,0.24980435343821444,0,0,11.129775280898876,26.29429648508577,TNFAIP3
Golgi inheritance (GO:0048313),1/11,0.09418275481990468,0.24980435343821444,0,0,11.129775280898876,26.29429648508577,YWHAZ
positive regulation of interleukin-13 production (GO:0032736),1/11,0.09418275481990468,0.24980435343821444,0,0,11.129775280898876,26.29429648508577,IRF4
isotype switching (GO:0045190),1/11,0.09418275481990468,0.24980435343821444,0,0,11.129775280898876,26.29429648508577,HSPD1
positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),1/11,0.09418275481990468,0.24980435343821444,0,0,11.129775280898876,26.29429648508577,DDX5
positive regulation of sphingolipid biosynthetic process (GO:0090154),1/11,0.09418275481990468,0.24980435343821444,0,0,11.129775280898876,26.29429648508577,RACK1
V(D)J recombination (GO:0033151),1/11,0.09418275481990468,0.24980435343821444,0,0,11.129775280898876,26.29429648508577,PRKDC
monocyte differentiation (GO:0030224),1/11,0.09418275481990468,0.24980435343821444,0,0,11.129775280898876,26.29429648508577,MYH9
regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),2/58,0.09515731427231448,0.25191833759778776,0,0,3.988095238095238,9.380892604426993,RACK1;TNFAIP3
protein polymerization (GO:0051258),2/59,0.0979387856231542,0.25783884378340594,0,0,3.9179304192685103,9.102969027334012,PREX1;GSN
positive regulation of apoptotic signaling pathway (GO:2001235),2/59,0.0979387856231542,0.25783884378340594,0,0,3.9179304192685103,9.102969027334012,RACK1;RPS3
response to reactive oxygen species (GO:0000302),2/59,0.0979387856231542,0.25783884378340594,0,0,3.9179304192685103,9.102969027334012,RPS3;PTPRK
regulation of intracellular signal transduction (GO:1902531),7/437,0.09838141208010047,0.25852448841048625,0,0,1.835275824770146,4.255827339707058,CDC42;RPL5;PREX1;AKAP13;RPL11;TP53INP1;MDM4
protein targeting (GO:0006605),3/125,0.10200373711074842,0.2589756228380796,0,0,2.7522820417287632,6.282760348313718,NACA;RPL11;HPS4
adipose tissue development (GO:0060612),1/12,0.10229426679107169,0.2589756228380796,0,0,10.117466802860061,23.06682926467287,ARID5B
regulation of actin nucleation (GO:0051125),1/12,0.10229426679107169,0.2589756228380796,0,0,10.117466802860061,23.06682926467287,GSN
ATP transport (GO:0015867),1/12,0.10229426679107169,0.2589756228380796,0,0,10.117466802860061,23.06682926467287,SLC25A5
negative regulation of heart contraction (GO:0045822),1/12,0.10229426679107169,0.2589756228380796,0,0,10.117466802860061,23.06682926467287,GRK2
"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",1/12,0.10229426679107169,0.2589756228380796,0,0,10.117466802860061,23.06682926467287,IRF4
regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),1/12,0.10229426679107169,0.2589756228380796,0,0,10.117466802860061,23.06682926467287,CALM1
cardiocyte differentiation (GO:0035051),1/12,0.10229426679107169,0.2589756228380796,0,0,10.117466802860061,23.06682926467287,AKAP13
regulation of dendritic cell differentiation (GO:2001198),1/12,0.10229426679107169,0.2589756228380796,0,0,10.117466802860061,23.06682926467287,HLA-B
negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),1/12,0.10229426679107169,0.2589756228380796,0,0,10.117466802860061,23.06682926467287,CALM1
negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),1/12,0.10229426679107169,0.2589756228380796,0,0,10.117466802860061,23.06682926467287,CALM1
cellular response to thyroid hormone stimulus (GO:0097067),1/12,0.10229426679107169,0.2589756228380796,0,0,10.117466802860061,23.06682926467287,KLF9
neurotransmitter uptake (GO:0001504),1/12,0.10229426679107169,0.2589756228380796,0,0,10.117466802860061,23.06682926467287,SLC38A1
P-body assembly (GO:0033962),1/12,0.10229426679107169,0.2589756228380796,0,0,10.117466802860061,23.06682926467287,DYNC1H1
regulation of pseudopodium assembly (GO:0031272),1/12,0.10229426679107169,0.2589756228380796,0,0,10.117466802860061,23.06682926467287,CDC42
histone H3-K9 demethylation (GO:0033169),1/12,0.10229426679107169,0.2589756228380796,0,0,10.117466802860061,23.06682926467287,JMJD1C
serine family amino acid biosynthetic process (GO:0009070),1/12,0.10229426679107169,0.2589756228380796,0,0,10.117466802860061,23.06682926467287,SERINC5
positive regulation of pseudopodium assembly (GO:0031274),1/12,0.10229426679107169,0.2589756228380796,0,0,10.117466802860061,23.06682926467287,CDC42
mitotic G1/S transition checkpoint signaling (GO:0044819),1/12,0.10229426679107169,0.2589756228380796,0,0,10.117466802860061,23.06682926467287,PRKDC
mRNA transcription (GO:0009299),1/12,0.10229426679107169,0.2589756228380796,0,0,10.117466802860061,23.06682926467287,DDX5
negative regulation of intracellular signal transduction (GO:1902532),4/198,0.10242382439042166,0.2589756228380796,0,0,2.312459499263623,5.269253309496851,DDX3X;ITPR1;RACK1;TNFAIP3
protein modification by small protein removal (GO:0070646),5/276,0.10256821707892937,0.2589756228380796,0,0,2.0729948678797134,4.720680234944452,USP9X;TNFAIP3;MDM4;RPS27A;UBA52
pattern recognition receptor signaling pathway (GO:0002221),2/61,0.10356962835049488,0.26033281601780944,0,0,3.7847361869194676,8.581931521729318,RPS27A;UBA52
positive regulation of DNA biosynthetic process (GO:2000573),2/61,0.10356962835049488,0.26033281601780944,0,0,3.7847361869194676,8.581931521729318,HSP90AA1;HSP90AB1
negative regulation of cell growth (GO:0030308),3/126,0.10383958693874569,0.26033281601780944,0,0,2.729767184035477,6.182671543897019,DDX3X;RACK1;SMARCA2
negative regulation of growth (GO:0045926),3/126,0.10383958693874569,0.26033281601780944,0,0,2.729767184035477,6.182671543897019,DDX3X;RACK1;SMARCA2
I-kappaB kinase/NF-kappaB signaling (GO:0007249),2/62,0.10641775715904943,0.26536152246436384,0,0,3.7214689265536722,8.33751506833559,RPS27A;UBA52
stress-activated MAPK cascade (GO:0051403),2/62,0.10641775715904943,0.26536152246436384,0,0,3.7214689265536722,8.33751506833559,RPS27A;UBA52
microtubule cytoskeleton organization involved in mitosis (GO:1902850),3/128,0.10755041380419353,0.26536152246436384,0,0,2.6858181818181817,5.988825499017323,DYNC1H1;CENPF;RPS27
actin cytoskeleton reorganization (GO:0031532),2/63,0.10928687787141862,0.26536152246436384,0,0,3.6602760025933128,8.10304195503642,GSN;MYH9
positive regulation of DNA metabolic process (GO:0051054),2/63,0.10928687787141862,0.26536152246436384,0,0,3.6602760025933128,8.10304195503642,USP9X;RPS3
negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),1/13,0.11033354351936198,0.26536152246436384,0,0,9.273876404494382,20.441916907043897,RACK1
negative regulation of hydrogen peroxide-induced cell death (GO:1903206),1/13,0.11033354351936198,0.26536152246436384,0,0,9.273876404494382,20.441916907043897,RACK1
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),1/13,0.11033354351936198,0.26536152246436384,0,0,9.273876404494382,20.441916907043897,CD44
regulation of cell communication by electrical coupling (GO:0010649),1/13,0.11033354351936198,0.26536152246436384,0,0,9.273876404494382,20.441916907043897,CALM1
cellular component maintenance (GO:0043954),1/13,0.11033354351936198,0.26536152246436384,0,0,9.273876404494382,20.441916907043897,INSR
negative regulation of stem cell differentiation (GO:2000737),1/13,0.11033354351936198,0.26536152246436384,0,0,9.273876404494382,20.441916907043897,ZFP36L2
detection of calcium ion (GO:0005513),1/13,0.11033354351936198,0.26536152246436384,0,0,9.273876404494382,20.441916907043897,CALM1
regulation of protein acetylation (GO:1901983),1/13,0.11033354351936198,0.26536152246436384,0,0,9.273876404494382,20.441916907043897,DDX3X
plasma membrane repair (GO:0001778),1/13,0.11033354351936198,0.26536152246436384,0,0,9.273876404494382,20.441916907043897,MYH9
regulation of receptor signaling pathway via STAT (GO:1904892),1/13,0.11033354351936198,0.26536152246436384,0,0,9.273876404494382,20.441916907043897,IL7R
relaxation of cardiac muscle (GO:0055119),1/13,0.11033354351936198,0.26536152246436384,0,0,9.273876404494382,20.441916907043897,GSN
Golgi ribbon formation (GO:0090161),1/13,0.11033354351936198,0.26536152246436384,0,0,9.273876404494382,20.441916907043897,MYO18A
response to thyroid hormone (GO:0097066),1/13,0.11033354351936198,0.26536152246436384,0,0,9.273876404494382,20.441916907043897,KLF9
ribosomal subunit export from nucleus (GO:0000054),1/13,0.11033354351936198,0.26536152246436384,0,0,9.273876404494382,20.441916907043897,NPM1
kinetochore organization (GO:0051383),1/13,0.11033354351936198,0.26536152246436384,0,0,9.273876404494382,20.441916907043897,CENPF
spliceosomal tri-snRNP complex assembly (GO:0000244),1/13,0.11033354351936198,0.26536152246436384,0,0,9.273876404494382,20.441916907043897,PRPF8
positive regulation of protein acetylation (GO:1901985),1/13,0.11033354351936198,0.26536152246436384,0,0,9.273876404494382,20.441916907043897,DDX3X
positive regulation of protein localization to cell surface (GO:2000010),1/13,0.11033354351936198,0.26536152246436384,0,0,9.273876404494382,20.441916907043897,HSP90AB1
transport along microtubule (GO:0010970),1/13,0.11033354351936198,0.26536152246436384,0,0,9.273876404494382,20.441916907043897,CDC42
negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),2/64,0.11217639200192459,0.2679769364490421,0,0,3.6010570439219975,7.87797026151256,DDX3X;TPT1
regulation of innate immune response (GO:0045088),2/64,0.11217639200192459,0.2679769364490421,0,0,3.6010570439219975,7.87797026151256,HSP90AB1;TNFAIP3
pre-replicative complex assembly (GO:0036388),2/64,0.11217639200192459,0.2679769364490421,0,0,3.6010570439219975,7.87797026151256,RPS27A;UBA52
protein catabolic process (GO:0030163),2/64,0.11217639200192459,0.2679769364490421,0,0,3.6010570439219975,7.87797026151256,HSPA8;HSP90AA1
BMP signaling pathway (GO:0030509),2/65,0.1150857100359677,0.27075715764716907,0,0,3.5437180521926286,7.6617952767099595,DDX5;USP9X
cellular response to type I interferon (GO:0071357),2/65,0.1150857100359677,0.27075715764716907,0,0,3.5437180521926286,7.6617952767099595,IRF4;HLA-B
type I interferon signaling pathway (GO:0060337),2/65,0.1150857100359677,0.27075715764716907,0,0,3.5437180521926286,7.6617952767099595,IRF4;HLA-B
mitotic G1 DNA damage checkpoint signaling (GO:0031571),2/65,0.1150857100359677,0.27075715764716907,0,0,3.5437180521926286,7.6617952767099595,PRKDC;MDM4
positive regulation of transcription by RNA polymerase II (GO:0045944),12/908,0.11522604050466995,0.27075715764716907,0,0,1.5177234816082121,3.2795872191134023,DDX17;NR4A1;NPM1;AKNA;DDX3X;PRKDC;IRF4;KMT2C;TCF4;RPS27A;UBA52;SMARCA2
regulation of protein kinase B signaling (GO:0051896),4/207,0.11545197282283289,0.27075715764716907,0,0,2.2089232934553134,4.768845945555962,HSP90AA1;HSP90AB1;INSR;RACK1
cellular component disassembly (GO:0022411),2/66,0.11801425120020419,0.27075715764716907,0,0,3.4881709039548023,7.454046425760574,GSN;CD44
extracellular matrix disassembly (GO:0022617),2/66,0.11801425120020419,0.27075715764716907,0,0,3.4881709039548023,7.454046425760574,GSN;CD44
"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",1/14,0.11830122462385118,0.27075715764716907,0,0,8.560069144338808,18.27164868713807,CD44
atrial septum development (GO:0003283),1/14,0.11830122462385118,0.27075715764716907,0,0,8.560069144338808,18.27164868713807,MDM4
atrioventricular valve development (GO:0003171),1/14,0.11830122462385118,0.27075715764716907,0,0,8.560069144338808,18.27164868713807,MDM4
regulation of cell projection organization (GO:0031344),1/14,0.11830122462385118,0.27075715764716907,0,0,8.560069144338808,18.27164868713807,MACF1
regulation of chromatin organization (GO:1902275),1/14,0.11830122462385118,0.27075715764716907,0,0,8.560069144338808,18.27164868713807,MKI67
regulation of gastrulation (GO:0010470),1/14,0.11830122462385118,0.27075715764716907,0,0,8.560069144338808,18.27164868713807,RACK1
regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),1/14,0.11830122462385118,0.27075715764716907,0,0,8.560069144338808,18.27164868713807,CD44
defense response to protozoan (GO:0042832),1/14,0.11830122462385118,0.27075715764716907,0,0,8.560069144338808,18.27164868713807,IRF4
detection of bacterium (GO:0016045),1/14,0.11830122462385118,0.27075715764716907,0,0,8.560069144338808,18.27164868713807,HLA-B
polarized epithelial cell differentiation (GO:0030859),1/14,0.11830122462385118,0.27075715764716907,0,0,8.560069144338808,18.27164868713807,CDC42
regulation of response to interferon-gamma (GO:0060330),1/14,0.11830122462385118,0.27075715764716907,0,0,8.560069144338808,18.27164868713807,HSP90AB1
relaxation of muscle (GO:0090075),1/14,0.11830122462385118,0.27075715764716907,0,0,8.560069144338808,18.27164868713807,GSN
renal absorption (GO:0070293),1/14,0.11830122462385118,0.27075715764716907,0,0,8.560069144338808,18.27164868713807,GSN
positive regulation of glycogen biosynthetic process (GO:0045725),1/14,0.11830122462385118,0.27075715764716907,0,0,8.560069144338808,18.27164868713807,INSR
positive regulation of protein-containing complex disassembly (GO:0043243),1/14,0.11830122462385118,0.27075715764716907,0,0,8.560069144338808,18.27164868713807,INSR
T cell differentiation in thymus (GO:0033077),1/14,0.11830122462385118,0.27075715764716907,0,0,8.560069144338808,18.27164868713807,ZFP36L2
"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",1/14,0.11830122462385118,0.27075715764716907,0,0,8.560069144338808,18.27164868713807,RPL7
positive regulation of T cell receptor signaling pathway (GO:0050862),1/14,0.11830122462385118,0.27075715764716907,0,0,8.560069144338808,18.27164868713807,RPS3
positive regulation of catabolic process (GO:0009896),2/67,0.12096144347910907,0.2763998201237613,0,0,3.4343328987396786,7.254284485750352,HUWE1;TNFAIP3
negative regulation of inflammatory response (GO:0050728),4/212,0.12298993818881337,0.27849903990660263,0,0,2.155274725274725,4.516707362565922,GPR176;RPS19;TNFAIP3;MYH9
cellular response to arsenic-containing substance (GO:0071243),1/15,0.12619794408734708,0.27849903990660263,0,0,7.948234349919743,16.452079052841352,DDX3X
regulation of lymphocyte activation (GO:0051249),1/15,0.12619794408734708,0.27849903990660263,0,0,7.948234349919743,16.452079052841352,PAG1
contractile actin filament bundle assembly (GO:0030038),1/15,0.12619794408734708,0.27849903990660263,0,0,7.948234349919743,16.452079052841352,PDLIM1
regulation of neuron projection arborization (GO:0150011),1/15,0.12619794408734708,0.27849903990660263,0,0,7.948234349919743,16.452079052841352,MACF1
regulation of non-canonical Wnt signaling pathway (GO:2000050),1/15,0.12619794408734708,0.27849903990660263,0,0,7.948234349919743,16.452079052841352,RNF213
"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",1/15,0.12619794408734708,0.27849903990660263,0,0,7.948234349919743,16.452079052841352,ZFP36L2
establishment of apical/basal cell polarity (GO:0035089),1/15,0.12619794408734708,0.27849903990660263,0,0,7.948234349919743,16.452079052841352,CDC42
establishment of spindle localization (GO:0051293),1/15,0.12619794408734708,0.27849903990660263,0,0,7.948234349919743,16.452079052841352,DYNC1H1
regulation of sequestering of triglyceride (GO:0010889),1/15,0.12619794408734708,0.27849903990660263,0,0,7.948234349919743,16.452079052841352,PLIN2
"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",1/15,0.12619794408734708,0.27849903990660263,0,0,7.948234349919743,16.452079052841352,DDX5
glucan catabolic process (GO:0009251),1/15,0.12619794408734708,0.27849903990660263,0,0,7.948234349919743,16.452079052841352,CALM1
glycogen catabolic process (GO:0005980),1/15,0.12619794408734708,0.27849903990660263,0,0,7.948234349919743,16.452079052841352,CALM1
positive regulation of glycogen metabolic process (GO:0070875),1/15,0.12619794408734708,0.27849903990660263,0,0,7.948234349919743,16.452079052841352,INSR
positive regulation of heterotypic cell-cell adhesion (GO:0034116),1/15,0.12619794408734708,0.27849903990660263,0,0,7.948234349919743,16.452079052841352,CD44
response to muscle stretch (GO:0035994),1/15,0.12619794408734708,0.27849903990660263,0,0,7.948234349919743,16.452079052841352,GSN
positive regulation of keratinocyte differentiation (GO:0045618),1/15,0.12619794408734708,0.27849903990660263,0,0,7.948234349919743,16.452079052841352,NUMA1
"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",1/15,0.12619794408734708,0.27849903990660263,0,0,7.948234349919743,16.452079052841352,ZFP36L2
stress fiber assembly (GO:0043149),1/15,0.12619794408734708,0.27849903990660263,0,0,7.948234349919743,16.452079052841352,PDLIM1
macrophage differentiation (GO:0030225),1/15,0.12619794408734708,0.27849903990660263,0,0,7.948234349919743,16.452079052841352,CDC42
synaptonemal complex assembly (GO:0007130),1/15,0.12619794408734708,0.27849903990660263,0,0,7.948234349919743,16.452079052841352,STAG3
synaptonemal complex organization (GO:0070193),1/15,0.12619794408734708,0.27849903990660263,0,0,7.948234349919743,16.452079052841352,STAG3
cellular response to decreased oxygen levels (GO:0036294),2/69,0.12690953604102337,0.27920097929025145,0,0,3.3314782022092926,6.877106358437442,PGK1;MDM4
positive regulation of protein transport (GO:0051222),2/69,0.12690953604102337,0.27920097929025145,0,0,3.3314782022092926,6.877106358437442,MYO18A;RACK1
regulation of cellular component organization (GO:0051128),3/139,0.12884396650243757,0.28174892553210784,0,0,2.4672042112299466,5.055679327339924,HSPA8;HSP90AA1;MKI67
DNA repair (GO:0006281),5/298,0.12987428664836065,0.28174892553210784,0,0,1.9151857518339805,3.9092547914480495,NPM1;PRKDC;HUWE1;RPS27A;UBA52
carbohydrate homeostasis (GO:0033500),2/70,0.12990933481109812,0.28174892553210784,0,0,3.2823197075440347,6.698947002127018,INSR;RPS6
cellular response to light stimulus (GO:0071482),2/70,0.12990933481109812,0.28174892553210784,0,0,3.2823197075440347,6.698947002127018,NPM1;PTPRK
kidney development (GO:0001822),2/70,0.12990933481109812,0.28174892553210784,0,0,3.2823197075440347,6.698947002127018,KANK2;CENPF
wound healing (GO:0042060),2/70,0.12990933481109812,0.28174892553210784,0,0,3.2823197075440347,6.698947002127018,MACF1;MYH9
regulation of small GTPase mediated signal transduction (GO:0051056),3/141,0.13286669498235648,0.28174892553210784,0,0,2.4312005928853755,4.907157028043206,CDC42;PREX1;AKAP13
cellular response to BMP stimulus (GO:0071773),2/71,0.13292558143559707,0.28174892553210784,0,0,3.2345860967821176,6.527284267436381,DDX5;USP9X
regulation of G1/S transition of mitotic cell cycle (GO:2000045),2/71,0.13292558143559707,0.28174892553210784,0,0,3.2345860967821176,6.527284267436381,KANK2;DDX3X
regulation of glycolytic process (GO:0006110),2/71,0.13292558143559707,0.28174892553210784,0,0,3.2345860967821176,6.527284267436381,PFKFB2;INSR
nucleic acid metabolic process (GO:0090304),2/71,0.13292558143559707,0.28174892553210784,0,0,3.2345860967821176,6.527284267436381,HNRNPH1;HNRNPA2B1
positive regulation of cellular protein localization (GO:1903829),2/71,0.13292558143559707,0.28174892553210784,0,0,3.2345860967821176,6.527284267436381,HSP90AB1;NUMA1
myeloid leukocyte differentiation (GO:0002573),2/71,0.13292558143559707,0.28174892553210784,0,0,3.2345860967821176,6.527284267436381,CDC42;MYH9
positive regulation of cell population proliferation (GO:0008284),7/474,0.13401576322979944,0.28174892553210784,0,0,1.6866440914297096,3.389813668512972,RPS4X;NPM1;RPL23;INSR;RPS6;IL7R;SLC25A5
3'-UTR-mediated mRNA destabilization (GO:0061158),1/16,0.1340243303271126,0.28174892553210784,0,0,7.417977528089888,14.908161099822989,ZFP36L2
negative regulation of immune effector process (GO:0002698),1/16,0.1340243303271126,0.28174892553210784,0,0,7.417977528089888,14.908161099822989,RPS19
regulation of ceramide biosynthetic process (GO:2000303),1/16,0.1340243303271126,0.28174892553210784,0,0,7.417977528089888,14.908161099822989,RACK1
negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),1/16,0.1340243303271126,0.28174892553210784,0,0,7.417977528089888,14.908161099822989,HLA-B
regulation of defense response to virus (GO:0050688),1/16,0.1340243303271126,0.28174892553210784,0,0,7.417977528089888,14.908161099822989,TNFAIP3
cellular polysaccharide catabolic process (GO:0044247),1/16,0.1340243303271126,0.28174892553210784,0,0,7.417977528089888,14.908161099822989,CALM1
cellular response to corticosteroid stimulus (GO:0071384),1/16,0.1340243303271126,0.28174892553210784,0,0,7.417977528089888,14.908161099822989,ZFP36L2
regulation of interleukin-13 production (GO:0032656),1/16,0.1340243303271126,0.28174892553210784,0,0,7.417977528089888,14.908161099822989,IRF4
neuron projection organization (GO:0106027),1/16,0.1340243303271126,0.28174892553210784,0,0,7.417977528089888,14.908161099822989,INSR
regulation of leukocyte activation (GO:0002694),1/16,0.1340243303271126,0.28174892553210784,0,0,7.417977528089888,14.908161099822989,MYO18A
neutrophil activation (GO:0042119),1/16,0.1340243303271126,0.28174892553210784,0,0,7.417977528089888,14.908161099822989,PREX1
nuclear transport (GO:0051169),1/16,0.1340243303271126,0.28174892553210784,0,0,7.417977528089888,14.908161099822989,NPM1
dendritic spine morphogenesis (GO:0060997),1/16,0.1340243303271126,0.28174892553210784,0,0,7.417977528089888,14.908161099822989,CDC42
epiboly involved in wound healing (GO:0090505),1/16,0.1340243303271126,0.28174892553210784,0,0,7.417977528089888,14.908161099822989,CD44
positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),1/16,0.1340243303271126,0.28174892553210784,0,0,7.417977528089888,14.908161099822989,PRKDC
retrograde axonal transport (GO:0008090),1/16,0.1340243303271126,0.28174892553210784,0,0,7.417977528089888,14.908161099822989,DYNC1H1
negative regulation of epithelial cell proliferation (GO:0050680),2/72,0.13595774576553085,0.28496904171534454,0,0,3.188216303470541,6.361802310889694,KLF9;PTPRK
positive regulation of secretion by cell (GO:1903532),2/72,0.13595774576553085,0.28496904171534454,0,0,3.188216303470541,6.361802310889694,GRK2;MYO18A
receptor-mediated endocytosis (GO:0006898),3/143,0.13693297602456547,0.28603292125298463,0,0,2.3962256493506495,4.764328473126039,HSP90AA1;GRK2;INSR
nitrogen compound transport (GO:0071705),3/143,0.13693297602456547,0.28603292125298463,0,0,2.3962256493506495,4.764328473126039,SLC38A1;CENPF;MYH9
positive regulation of cell motility (GO:2000147),4/221,0.13707003978296656,0.28603292125298463,0,0,2.0649374588545095,4.103574314173973,INSR;RACK1;PECAM1;SYNE2
negative regulation of cell migration (GO:0030336),3/144,0.13898207697794987,0.2883750422618526,0,0,2.379110251450677,4.694960667363675,TP53INP1;LDLRAD4;PTPRK
neurotransmitter transport (GO:0006836),2/73,0.139005305783726,0.2883750422618526,0,0,3.1431527015198535,6.2022046177467205,HSPA8;SLC38A1
defense response to Gram-negative bacterium (GO:0050829),2/73,0.139005305783726,0.2883750422618526,0,0,3.1431527015198535,6.2022046177467205,RPL30;RPS19
regulation of Rho protein signal transduction (GO:0035023),2/73,0.139005305783726,0.2883750422618526,0,0,3.1431527015198535,6.2022046177467205,KANK2;AKAP13
adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),1/17,0.14178100627369258,0.28947805453578385,0,0,6.954002808988764,13.584447140756783,AKAP13
regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),1/17,0.14178100627369258,0.28947805453578385,0,0,6.954002808988764,13.584447140756783,WASF2
regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),1/17,0.14178100627369258,0.28947805453578385,0,0,6.954002808988764,13.584447140756783,CALM1
negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),1/17,0.14178100627369258,0.28947805453578385,0,0,6.954002808988764,13.584447140756783,CD44
negative regulation of peptidyl-threonine phosphorylation (GO:0010801),1/17,0.14178100627369258,0.28947805453578385,0,0,6.954002808988764,13.584447140756783,CALM1
negative regulation of phagocytosis (GO:0050765),1/17,0.14178100627369258,0.28947805453578385,0,0,6.954002808988764,13.584447140756783,RACK1
negative regulation of viral entry into host cell (GO:0046597),1/17,0.14178100627369258,0.28947805453578385,0,0,6.954002808988764,13.584447140756783,GSN
regulation of NLRP3 inflammasome complex assembly (GO:1900225),1/17,0.14178100627369258,0.28947805453578385,0,0,6.954002808988764,13.584447140756783,DDX3X
positive regulation of macrophage activation (GO:0043032),1/17,0.14178100627369258,0.28947805453578385,0,0,6.954002808988764,13.584447140756783,HSPD1
maturation of 5.8S rRNA (GO:0000460),1/17,0.14178100627369258,0.28947805453578385,0,0,6.954002808988764,13.584447140756783,PRKDC
mesenchyme morphogenesis (GO:0072132),1/17,0.14178100627369258,0.28947805453578385,0,0,6.954002808988764,13.584447140756783,MDM4
regulation of stress fiber assembly (GO:0051492),2/74,0.14206774740000794,0.2896467436215679,0,0,3.099340866290019,6.0482125791464725,CDC42;WASF2
nucleic acid phosphodiester bond hydrolysis (GO:0090305),2/75,0.1451445644388703,0.2941691098975779,0,0,3.056729355313056,5.89956418739877,RPS27A;UBA52
regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),2/75,0.1451445644388703,0.2941691098975779,0,0,3.056729355313056,5.89956418739877,RPS27A;UBA52
integrin-mediated signaling pathway (GO:0007229),2/75,0.1451445644388703,0.2941691098975779,0,0,3.056729355313056,5.89956418739877,CDC42;MYH9
positive regulation of intracellular protein transport (GO:0090316),3/148,0.14728141258385383,0.2941691098975779,0,0,2.3130094043887146,4.430361692427891,HPS4;HUWE1;YWHAZ
regulation of cell division (GO:0051302),2/76,0.14823525844954732,0.2941691098975779,0,0,3.0152695067949304,5.756012845958728,RACK1;CALM1
RNA transport (GO:0050658),2/76,0.14823525844954732,0.2941691098975779,0,0,3.0152695067949304,5.756012845958728,HNRNPA2B1;SRSF3
regulation of G2/M transition of mitotic cell cycle (GO:0010389),3/149,0.14938123589304297,0.2941691098975779,0,0,2.2970501245330013,4.367274843005407,DYNC1H1;HSP90AA1;CENPF
positive regulation of hydrolase activity (GO:0051345),3/149,0.14938123589304297,0.2941691098975779,0,0,2.2970501245330013,4.367274843005407,RACK1;RPS3;CALM1
adenine nucleotide transport (GO:0051503),1/18,0.1494685893137094,0.2941691098975779,0,0,6.544613350958361,12.439143799224476,SLC25A5
regulation of B cell differentiation (GO:0045577),1/18,0.1494685893137094,0.2941691098975779,0,0,6.544613350958361,12.439143799224476,ZFP36L2
negative regulation of leukocyte cell-cell adhesion (GO:1903038),1/18,0.1494685893137094,0.2941691098975779,0,0,6.544613350958361,12.439143799224476,PAG1
regulation of cellular protein catabolic process (GO:1903362),1/18,0.1494685893137094,0.2941691098975779,0,0,6.544613350958361,12.439143799224476,HSP90AA1
cell migration involved in sprouting angiogenesis (GO:0002042),1/18,0.1494685893137094,0.2941691098975779,0,0,6.544613350958361,12.439143799224476,NR4A1
regulation of establishment or maintenance of cell polarity (GO:0032878),1/18,0.1494685893137094,0.2941691098975779,0,0,6.544613350958361,12.439143799224476,RACK1
cellular response to dsRNA (GO:0071359),1/18,0.1494685893137094,0.2941691098975779,0,0,6.544613350958361,12.439143799224476,NPM1
negative regulation of signal transduction by p53 class mediator (GO:1901797),1/18,0.1494685893137094,0.2941691098975779,0,0,6.544613350958361,12.439143799224476,CD44
regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),1/18,0.1494685893137094,0.2941691098975779,0,0,6.544613350958361,12.439143799224476,SLC25A5
regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),1/18,0.1494685893137094,0.2941691098975779,0,0,6.544613350958361,12.439143799224476,DDX5
regulation of protein-containing complex disassembly (GO:0043244),1/18,0.1494685893137094,0.2941691098975779,0,0,6.544613350958361,12.439143799224476,INSR
positive regulation of cell cycle phase transition (GO:1901989),1/18,0.1494685893137094,0.2941691098975779,0,0,6.544613350958361,12.439143799224476,NPM1
G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),1/18,0.1494685893137094,0.2941691098975779,0,0,6.544613350958361,12.439143799224476,GRK2
regulation of telomere maintenance via telomere lengthening (GO:1904356),1/18,0.1494685893137094,0.2941691098975779,0,0,6.544613350958361,12.439143799224476,HNRNPA2B1
positive regulation of interleukin-4 production (GO:0032753),1/18,0.1494685893137094,0.2941691098975779,0,0,6.544613350958361,12.439143799224476,IRF4
hyaluronan catabolic process (GO:0030214),1/18,0.1494685893137094,0.2941691098975779,0,0,6.544613350958361,12.439143799224476,CD44
"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",1/18,0.1494685893137094,0.2941691098975779,0,0,6.544613350958361,12.439143799224476,TRA2B
cellular response to UV (GO:0034644),2/77,0.15133933869386323,0.2966167425505413,0,0,2.9749152542372883,5.617326275456748,NPM1;PTPRK
neutrophil migration (GO:1990266),2/77,0.15133933869386323,0.2966167425505413,0,0,2.9749152542372883,5.617326275456748,PDE4B;PECAM1
regulation of organelle assembly (GO:1902115),2/77,0.15133933869386323,0.2966167425505413,0,0,2.9749152542372883,5.617326275456748,NPM1;GSN
protein polyubiquitination (GO:0000209),5/314,0.15159949025587163,0.29671679541114737,0,0,1.8145296283896886,3.4231340380603648,RNF213;HUWE1;TNFAIP3;RPS27A;UBA52
negative regulation of apoptotic signaling pathway (GO:2001234),2/78,0.15445632203437157,0.29960676639360045,0,0,2.9356229556943205,5.48328551237446,DDX3X;SLC25A5
protein modification process (GO:0036211),2/78,0.15445632203437157,0.29960676639360045,0,0,2.9356229556943205,5.48328551237446,PRKDC;UBA52
actin filament organization (GO:0007015),3/152,0.1557383042237091,0.29960676639360045,0,0,2.25045759609518,4.184901924883057,CDC42;GSN;FAT1
actin filament capping (GO:0051693),1/19,0.15708769147064042,0.29960676639360045,0,0,6.180711610486892,11.440194862508468,GSN
atrioventricular valve morphogenesis (GO:0003181),1/19,0.15708769147064042,0.29960676639360045,0,0,6.180711610486892,11.440194862508468,MDM4
barbed-end actin filament capping (GO:0051016),1/19,0.15708769147064042,0.29960676639360045,0,0,6.180711610486892,11.440194862508468,GSN
regulation of centriole replication (GO:0046599),1/19,0.15708769147064042,0.29960676639360045,0,0,6.180711610486892,11.440194862508468,NPM1
cardiac muscle cell contraction (GO:0086003),1/19,0.15708769147064042,0.29960676639360045,0,0,6.180711610486892,11.440194862508468,GSN
cellular response to interleukin-7 (GO:0098761),1/19,0.15708769147064042,0.29960676639360045,0,0,6.180711610486892,11.440194862508468,IL7R
regulation of mitochondrial membrane permeability (GO:0046902),1/19,0.15708769147064042,0.29960676639360045,0,0,6.180711610486892,11.440194862508468,SLC25A5
DNA alkylation (GO:0006305),1/19,0.15708769147064042,0.29960676639360045,0,0,6.180711610486892,11.440194862508468,BAZ2A
DNA methylation or demethylation (GO:0044728),1/19,0.15708769147064042,0.29960676639360045,0,0,6.180711610486892,11.440194862508468,BAZ2A
endocardial cushion morphogenesis (GO:0003203),1/19,0.15708769147064042,0.29960676639360045,0,0,6.180711610486892,11.440194862508468,MDM4
positive regulation of actin cytoskeleton reorganization (GO:2000251),1/19,0.15708769147064042,0.29960676639360045,0,0,6.180711610486892,11.440194862508468,CDC42
positive regulation of cellular protein catabolic process (GO:1903364),1/19,0.15708769147064042,0.29960676639360045,0,0,6.180711610486892,11.440194862508468,HSP90AA1
positive regulation of leukocyte activation (GO:0002696),1/19,0.15708769147064042,0.29960676639360045,0,0,6.180711610486892,11.440194862508468,HSPD1
interleukin-7-mediated signaling pathway (GO:0038111),1/19,0.15708769147064042,0.29960676639360045,0,0,6.180711610486892,11.440194862508468,IL7R
striated muscle cell differentiation (GO:0051146),1/19,0.15708769147064042,0.29960676639360045,0,0,6.180711610486892,11.440194862508468,AKAP13
telomere capping (GO:0016233),1/19,0.15708769147064042,0.29960676639360045,0,0,6.180711610486892,11.440194862508468,PRKDC
positive regulation of Wnt signaling pathway (GO:0030177),3/153,0.15787603245981888,0.3007061611550107,0,0,2.235340909090909,4.12631672896407,MACF1;DDX3X;TNFAIP3
negative regulation of cell cycle (GO:0045786),2/80,0.1607271026046208,0.304908768176413,0,0,2.8600608431116905,5.228326693821361,NR4A1;PTPRK
negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),2/80,0.1607271026046208,0.304908768176413,0,0,2.8600608431116905,5.228326693821361,DDX3X;TNFAIP3
regulation of NIK/NF-kappaB signaling (GO:1901222),2/80,0.1607271026046208,0.304908768176413,0,0,2.8600608431116905,5.228326693821361,DDX3X;RPS3
activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),2/81,0.1638799705591553,0.3053890542475877,0,0,2.8237145104770076,5.107029378460973,RACK1;HSPD1
regulation of cell differentiation (GO:0045595),3/156,0.1643432642041671,0.3053890542475877,0,0,2.1911764705882355,3.9568220097271327,DDX17;DDX5;HSP90AB1
protein targeting to lysosome (GO:0006622),1/20,0.1646389193089532,0.3053890542475877,0,0,5.855115316380839,10.56263137333112,HSPA8
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),1/20,0.1646389193089532,0.3053890542475877,0,0,5.855115316380839,10.56263137333112,BACH2
protein-DNA complex disassembly (GO:0032986),1/20,0.1646389193089532,0.3053890542475877,0,0,5.855115316380839,10.56263137333112,RPL23
adrenergic receptor signaling pathway (GO:0071875),1/20,0.1646389193089532,0.3053890542475877,0,0,5.855115316380839,10.56263137333112,AKAP13
cardiac ventricle development (GO:0003231),1/20,0.1646389193089532,0.3053890542475877,0,0,5.855115316380839,10.56263137333112,MDM4
negative regulation of viral life cycle (GO:1903901),1/20,0.1646389193089532,0.3053890542475877,0,0,5.855115316380839,10.56263137333112,GSN
regulation of nuclear division (GO:0051783),1/20,0.1646389193089532,0.3053890542475877,0,0,5.855115316380839,10.56263137333112,MKI67
regulation of programmed necrotic cell death (GO:0062098),1/20,0.1646389193089532,0.3053890542475877,0,0,5.855115316380839,10.56263137333112,HSP90AA1
positive regulation of activated T cell proliferation (GO:0042104),1/20,0.1646389193089532,0.3053890542475877,0,0,5.855115316380839,10.56263137333112,RPS3
positive regulation of cyclin-dependent protein kinase activity (GO:1904031),1/20,0.1646389193089532,0.3053890542475877,0,0,5.855115316380839,10.56263137333112,HSP90AB1
positive regulation of embryonic development (GO:0040019),1/20,0.1646389193089532,0.3053890542475877,0,0,5.855115316380839,10.56263137333112,RACK1
positive regulation of epidermal cell differentiation (GO:0045606),1/20,0.1646389193089532,0.3053890542475877,0,0,5.855115316380839,10.56263137333112,NUMA1
hepaticobiliary system development (GO:0061008),1/20,0.1646389193089532,0.3053890542475877,0,0,5.855115316380839,10.56263137333112,ARID5B
positive regulation of lymphocyte differentiation (GO:0045621),1/20,0.1646389193089532,0.3053890542475877,0,0,5.855115316380839,10.56263137333112,PRKDC
miRNA metabolic process (GO:0010586),1/20,0.1646389193089532,0.3053890542475877,0,0,5.855115316380839,10.56263137333112,DDX17
mitotic spindle organization (GO:0007052),3/157,0.16651653269111824,0.3084686160426851,0,0,2.176837367178276,3.9023307528249433,DYNC1H1;CENPF;RPS27
positive regulation of protein ubiquitination (GO:0031398),2/82,0.16704388286514146,0.30904207273225,0,0,2.788276836158192,4.989617855621614,HUWE1;RPS2
positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),2/83,0.17021839286664514,0.31193149216670585,0,0,2.7537141661435447,4.875927330551114,CDC42;WASF2
acetylcholine receptor signaling pathway (GO:0095500),1/21,0.17212287411312943,0.31193149216670585,0,0,5.562078651685393,9.786736985653446,GRK2
actin filament-based transport (GO:0099515),1/21,0.17212287411312943,0.31193149216670585,0,0,5.562078651685393,9.786736985653446,SYNE2
purinergic nucleotide receptor signaling pathway (GO:0035590),1/21,0.17212287411312943,0.31193149216670585,0,0,5.562078651685393,9.786736985653446,HSP90AB1
regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),1/21,0.17212287411312943,0.31193149216670585,0,0,5.562078651685393,9.786736985653446,CALM1
regulation of cell-substrate junction assembly (GO:0090109),1/21,0.17212287411312943,0.31193149216670585,0,0,5.562078651685393,9.786736985653446,MACF1
negative regulation of peptidyl-serine phosphorylation (GO:0033137),1/21,0.17212287411312943,0.31193149216670585,0,0,5.562078651685393,9.786736985653446,RACK1
endocardial cushion development (GO:0003197),1/21,0.17212287411312943,0.31193149216670585,0,0,5.562078651685393,9.786736985653446,MDM4
positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),1/21,0.17212287411312943,0.31193149216670585,0,0,5.562078651685393,9.786736985653446,RPS3
focal adhesion assembly (GO:0048041),1/21,0.17212287411312943,0.31193149216670585,0,0,5.562078651685393,9.786736985653446,PTPRK
histone ubiquitination (GO:0016574),1/21,0.17212287411312943,0.31193149216670585,0,0,5.562078651685393,9.786736985653446,HUWE1
positive regulation of lipid storage (GO:0010884),1/21,0.17212287411312943,0.31193149216670585,0,0,5.562078651685393,9.786736985653446,PLIN2
innate immune response in mucosa (GO:0002227),1/21,0.17212287411312943,0.31193149216670585,0,0,5.562078651685393,9.786736985653446,RPL39
spindle assembly checkpoint signaling (GO:0071173),1/21,0.17212287411312943,0.31193149216670585,0,0,5.562078651685393,9.786736985653446,CENPF
mitotic spindle assembly checkpoint signaling (GO:0007094),1/21,0.17212287411312943,0.31193149216670585,0,0,5.562078651685393,9.786736985653446,CENPF
mitotic spindle checkpoint signaling (GO:0071174),1/21,0.17212287411312943,0.31193149216670585,0,0,5.562078651685393,9.786736985653446,CENPF
anaphase-promoting complex-dependent catabolic process (GO:0031145),2/84,0.17340306091179505,0.3122575424287274,0,0,2.719994488080474,4.765801792294471,RPS27A;UBA52
regulation of cytokinesis (GO:0032465),2/84,0.17340306091179505,0.3122575424287274,0,0,2.719994488080474,4.765801792294471,CDC42;CALM1
response to insulin (GO:0032868),2/84,0.17340306091179505,0.3122575424287274,0,0,2.719994488080474,4.765801792294471,PRKDC;INSR
spindle assembly (GO:0051225),2/84,0.17340306091179505,0.3122575424287274,0,0,2.719994488080474,4.765801792294471,NUMA1;RPS3
vascular transport (GO:0010232),2/84,0.17340306091179505,0.3122575424287274,0,0,2.719994488080474,4.765801792294471,SLC38A1;INSR
"positive regulation of transcription, DNA-templated (GO:0045893)",14/1183,0.17475850341963683,0.31429951375470805,0,0,1.3538014879332245,2.3615039484497213,DDX17;NPM1;AKNA;DDX3X;PRKDC;KMT2C;SMARCA2;NR4A1;IRF4;TP53INP1;TCF4;RPS27A;UBA52;HMGN1
positive regulation of protein kinase B signaling (GO:0051897),3/161,0.175293317519598,0.31486230070925264,0,0,2.1212960299194474,3.6938013389444357,HSP90AA1;HSP90AB1;INSR
B cell activation (GO:0042113),2/85,0.17659745430776388,0.3168037770704386,0,0,2.687087332380369,4.65909344882379,SLC25A5;HSPD1
negative regulation of B cell activation (GO:0050869),1/22,0.1795401518668945,0.3173356068053788,0,0,5.296950240770466,9.096751443014716,TNFAIP3
negative regulation of interleukin-2 production (GO:0032703),1/22,0.1795401518668945,0.3173356068053788,0,0,5.296950240770466,9.096751443014716,TNFAIP3
regulation of centrosome cycle (GO:0046605),1/22,0.1795401518668945,0.3173356068053788,0,0,5.296950240770466,9.096751443014716,NPM1
negative regulation of mitotic metaphase/anaphase transition (GO:0045841),1/22,0.1795401518668945,0.3173356068053788,0,0,5.296950240770466,9.096751443014716,CENPF
cellular response to osmotic stress (GO:0071470),1/22,0.1795401518668945,0.3173356068053788,0,0,5.296950240770466,9.096751443014716,DDX3X
positive regulation of axon extension (GO:0045773),1/22,0.1795401518668945,0.3173356068053788,0,0,5.296950240770466,9.096751443014716,MACF1
positive regulation of calcium ion transmembrane transporter activity (GO:1901021),1/22,0.1795401518668945,0.3173356068053788,0,0,5.296950240770466,9.096751443014716,CALM1
regulation of voltage-gated calcium channel activity (GO:1901385),1/22,0.1795401518668945,0.3173356068053788,0,0,5.296950240770466,9.096751443014716,PDE4B
positive regulation of translational initiation (GO:0045948),1/22,0.1795401518668945,0.3173356068053788,0,0,5.296950240770466,9.096751443014716,DDX3X
regulation of interferon-gamma production (GO:0032649),2/86,0.1798011471962823,0.3173356068053788,0,0,2.654963680387409,4.555662205814242,PDE4B;HSPD1
regulation of Ras protein signal transduction (GO:0046578),2/86,0.1798011471962823,0.3173356068053788,0,0,2.654963680387409,4.555662205814242,KANK2;AKAP13
glucose homeostasis (GO:0042593),2/86,0.1798011471962823,0.3173356068053788,0,0,2.654963680387409,4.555662205814242,INSR;RPS6
transport across blood-brain barrier (GO:0150104),2/86,0.1798011471962823,0.3173356068053788,0,0,2.654963680387409,4.555662205814242,SLC38A1;INSR
heart development (GO:0007507),3/164,0.1819597212332896,0.3204398799466014,0,0,2.081451157538114,3.546730179677327,PDLIM1;AKAP13;INSR
regulation of transcription by RNA polymerase II (GO:0006357),24/2206,0.1822262974641305,0.3204398799466014,0,0,1.2516956920256646,2.1310193903219217,DDX17;KANK2;DDX5;NPM1;AKNA;DDX3X;RPL10;PRKDC;USP9X;RPL23;KMT2C;JMJD1C;ARID5B;SMARCA2;BACH2;HSPD1;RPS14;NR4A1;IRF4;KLF9;TCF4;MDM4;RPS27A;UBA52
positive regulation of cytokine production (GO:0001819),5/335,0.1822374792930989,0.3204398799466014,0,0,1.6972309299895507,2.8894416506838247,PRKDC;IRF4;PDE4B;RPS3;HSPD1
regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),2/87,0.18301372051427856,0.3210639420087125,0,0,2.623595879029578,4.455375182818638,RPS27A;UBA52
metal ion transport (GO:0030001),2/88,0.18623476184424795,0.3210639420087125,0,0,2.5929575614242544,4.358106266540562,ITPR1;TPT1
negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),1/23,0.18689134326934218,0.3210639420087125,0,0,5.055924412665986,8.479937399462528,GRK2
negative regulation of smoothened signaling pathway (GO:0045879),1/23,0.18689134326934218,0.3210639420087125,0,0,5.055924412665986,8.479937399462528,RACK1
regulation of interferon-gamma-mediated signaling pathway (GO:0060334),1/23,0.18689134326934218,0.3210639420087125,0,0,5.055924412665986,8.479937399462528,HSP90AB1
regulation of interleukin-4 production (GO:0032673),1/23,0.18689134326934218,0.3210639420087125,0,0,5.055924412665986,8.479937399462528,IRF4
regulation of necroptotic process (GO:0060544),1/23,0.18689134326934218,0.3210639420087125,0,0,5.055924412665986,8.479937399462528,HSP90AA1
DNA methylation (GO:0006306),1/23,0.18689134326934218,0.3210639420087125,0,0,5.055924412665986,8.479937399462528,BAZ2A
ERK1 and ERK2 cascade (GO:0070371),1/23,0.18689134326934218,0.3210639420087125,0,0,5.055924412665986,8.479937399462528,ZFP36L2
regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),1/23,0.18689134326934218,0.3210639420087125,0,0,5.055924412665986,8.479937399462528,CALM1
positive regulation of cell cycle G2/M phase transition (GO:1902751),1/23,0.18689134326934218,0.3210639420087125,0,0,5.055924412665986,8.479937399462528,NPM1
regulation of toll-like receptor 4 signaling pathway (GO:0034143),1/23,0.18689134326934218,0.3210639420087125,0,0,5.055924412665986,8.479937399462528,TNFAIP3
positive regulation of epithelial cell apoptotic process (GO:1904037),1/23,0.18689134326934218,0.3210639420087125,0,0,5.055924412665986,8.479937399462528,GSN
positive regulation of JUN kinase activity (GO:0043507),1/23,0.18689134326934218,0.3210639420087125,0,0,5.055924412665986,8.479937399462528,RPS3
hyaluronan metabolic process (GO:0030212),1/23,0.18689134326934218,0.3210639420087125,0,0,5.055924412665986,8.479937399462528,CD44
positive regulation of mRNA processing (GO:0050685),1/23,0.18689134326934218,0.3210639420087125,0,0,5.055924412665986,8.479937399462528,TRA2B
positive regulation of receptor internalization (GO:0002092),1/23,0.18689134326934218,0.3210639420087125,0,0,5.055924412665986,8.479937399462528,INSR
membrane protein ectodomain proteolysis (GO:0006509),1/23,0.18689134326934218,0.3210639420087125,0,0,5.055924412665986,8.479937399462528,MYH9
vesicle transport along microtubule (GO:0047496),1/23,0.18689134326934218,0.3210639420087125,0,0,5.055924412665986,8.479937399462528,DYNC1H1
regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),2/89,0.18946386535986245,0.32469713157686575,0,0,2.563023572959283,4.263735695133735,DDX3X;CD44
regulation of type I interferon production (GO:0032479),2/89,0.18946386535986245,0.32469713157686575,0,0,2.563023572959283,4.263735695133735,PRKDC;TNFAIP3
positive regulation of signal transduction (GO:0009967),4/252,0.1900080241330731,0.32523689534961486,0,0,1.803963133640553,2.9958216881263757,MACF1;RPS3;TNFAIP3;IL7R
protein ubiquitination (GO:0016567),7/525,0.19202785676068043,0.3260795396885157,0,0,1.5165776241357636,2.502527228710561,RNF213;PRKDC;USP9X;RACK1;HUWE1;RPS27A;UBA52
negative regulation of protein kinase activity (GO:0006469),2/90,0.19270063180334426,0.3260795396885157,0,0,2.53376990241397,4.1721496719471,NPM1;SH3BP5
canonical glycolysis (GO:0061621),1/24,0.19417703385256926,0.3260795396885157,0,0,4.835857352222765,7.925897616026212,PGK1
cardiac muscle cell differentiation (GO:0055007),1/24,0.19417703385256926,0.3260795396885157,0,0,4.835857352222765,7.925897616026212,AKAP13
negative regulation of NIK/NF-kappaB signaling (GO:1901223),1/24,0.19417703385256926,0.3260795396885157,0,0,4.835857352222765,7.925897616026212,DDX3X
negative regulation of protein tyrosine kinase activity (GO:0061099),1/24,0.19417703385256926,0.3260795396885157,0,0,4.835857352222765,7.925897616026212,SH3BP5
cellular response to catecholamine stimulus (GO:0071870),1/24,0.19417703385256926,0.3260795396885157,0,0,4.835857352222765,7.925897616026212,PDE4B
negative regulation of stress fiber assembly (GO:0051497),1/24,0.19417703385256926,0.3260795396885157,0,0,4.835857352222765,7.925897616026212,WASF2
establishment of mitotic spindle orientation (GO:0000132),1/24,0.19417703385256926,0.3260795396885157,0,0,4.835857352222765,7.925897616026212,NUMA1
positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),1/24,0.19417703385256926,0.3260795396885157,0,0,4.835857352222765,7.925897616026212,HSP90AB1
glucose catabolic process to pyruvate (GO:0061718),1/24,0.19417703385256926,0.3260795396885157,0,0,4.835857352222765,7.925897616026212,PGK1
heterochromatin assembly (GO:0031507),1/24,0.19417703385256926,0.3260795396885157,0,0,4.835857352222765,7.925897616026212,BAZ2A
positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),1/24,0.19417703385256926,0.3260795396885157,0,0,4.835857352222765,7.925897616026212,HSP90AB1
"wound healing, spreading of cells (GO:0044319)",1/24,0.19417703385256926,0.3260795396885157,0,0,4.835857352222765,7.925897616026212,CD44
protein insertion into mitochondrial membrane (GO:0051204),1/24,0.19417703385256926,0.3260795396885157,0,0,4.835857352222765,7.925897616026212,HSP90AA1
protein K48-linked deubiquitination (GO:0071108),1/24,0.19417703385256926,0.3260795396885157,0,0,4.835857352222765,7.925897616026212,TNFAIP3
regulation of stem cell differentiation (GO:2000736),2/91,0.1959446682287322,0.3278838257270884,0,0,2.5051736177236084,4.0832400097441095,PRKDC;ZFP36L2
positive regulation of supramolecular fiber organization (GO:1902905),2/91,0.1959446682287322,0.3278838257270884,0,0,2.5051736177236084,4.0832400097441095,NUMA1;RPS3
positive regulation of transport (GO:0051050),2/91,0.1959446682287322,0.3278838257270884,0,0,2.5051736177236084,4.0832400097441095,DYNC1H1;NUMA1
positive regulation of multicellular organismal process (GO:0051240),5/345,0.19758131742365714,0.3302330853052644,0,0,1.6464672075726843,2.6699195311973374,DYNC1H1;RPS19;NUMA1;IRF4;GNAS
negative regulation of mitotic cell cycle phase transition (GO:1901991),2/92,0.19919558816513286,0.33115119796276815,0,0,2.4772128060263654,3.9969037944545462,KANK2;ZFP36L2
regulation of peptidyl-tyrosine phosphorylation (GO:0050730),2/92,0.19919558816513286,0.33115119796276815,0,0,2.4772128060263654,3.9969037944545462,PECAM1;CD44
positive regulation of cellular component biogenesis (GO:0044089),2/92,0.19919558816513286,0.33115119796276815,0,0,2.4772128060263654,3.9969037944545462,RACK1;RPS3
positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),2/92,0.19919558816513286,0.33115119796276815,0,0,2.4772128060263654,3.9969037944545462,HSP90AB1;NUMA1
regulation of cardiac muscle cell action potential (GO:0098901),1/25,0.2013978039759471,0.33115119796276815,0,0,4.634129213483146,7.426067881764699,CALM1
negative regulation of response to endoplasmic reticulum stress (GO:1903573),1/25,0.2013978039759471,0.33115119796276815,0,0,4.634129213483146,7.426067881764699,RACK1
negative regulation of sequestering of calcium ion (GO:0051283),1/25,0.2013978039759471,0.33115119796276815,0,0,4.634129213483146,7.426067881764699,ITPR1
regulation of heterotypic cell-cell adhesion (GO:0034114),1/25,0.2013978039759471,0.33115119796276815,0,0,4.634129213483146,7.426067881764699,CD44
regulation of rhodopsin mediated signaling pathway (GO:0022400),1/25,0.2013978039759471,0.33115119796276815,0,0,4.634129213483146,7.426067881764699,CALM1
regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),1/25,0.2013978039759471,0.33115119796276815,0,0,4.634129213483146,7.426067881764699,CALM1
"positive regulation of DNA-templated transcription, elongation (GO:0032786)",1/25,0.2013978039759471,0.33115119796276815,0,0,4.634129213483146,7.426067881764699,HMGN1
glycolytic process through glucose-6-phosphate (GO:0061620),1/25,0.2013978039759471,0.33115119796276815,0,0,4.634129213483146,7.426067881764699,PGK1
positive regulation of peptidyl-threonine phosphorylation (GO:0010800),1/25,0.2013978039759471,0.33115119796276815,0,0,4.634129213483146,7.426067881764699,CALM1
negative regulation of actin filament polymerization (GO:0030837),1/25,0.2013978039759471,0.33115119796276815,0,0,4.634129213483146,7.426067881764699,GSN
regulation of epithelial cell proliferation (GO:0050678),2/93,0.2024530112863993,0.3321165583993071,0,0,2.449866517663128,3.9130430785361145,NR4A1;PRKDC
regulation of heart contraction (GO:0008016),2/93,0.2024530112863993,0.3321165583993071,0,0,2.449866517663128,3.9130430785361145,ITPR1;CALM1
interleukin-1-mediated signaling pathway (GO:0070498),2/94,0.20571656352025466,0.3351511334188437,0,0,2.4231147138295257,3.8315645899386808,RPS27A;UBA52
regulation of actin filament bundle assembly (GO:0032231),1/26,0.20855422889981606,0.3351511334188437,0,0,4.448539325842697,6.973335316265452,CDC42
negative regulation of interleukin-1 beta production (GO:0032691),1/26,0.20855422889981606,0.3351511334188437,0,0,4.448539325842697,6.973335316265452,TNFAIP3
cellular response to drug (GO:0035690),1/26,0.20855422889981606,0.3351511334188437,0,0,4.448539325842697,6.973335316265452,PDE4B
regulation of glycogen biosynthetic process (GO:0005979),1/26,0.20855422889981606,0.3351511334188437,0,0,4.448539325842697,6.973335316265452,INSR
chaperone cofactor-dependent protein refolding (GO:0051085),1/26,0.20855422889981606,0.3351511334188437,0,0,4.448539325842697,6.973335316265452,HSPA8
DNA geometric change (GO:0032392),1/26,0.20855422889981606,0.3351511334188437,0,0,4.448539325842697,6.973335316265452,HNRNPA2B1
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),1/26,0.20855422889981606,0.3351511334188437,0,0,4.448539325842697,6.973335316265452,YWHAZ
endothelial cell development (GO:0001885),1/26,0.20855422889981606,0.3351511334188437,0,0,4.448539325842697,6.973335316265452,PECAM1
regulation of synapse organization (GO:0050807),1/26,0.20855422889981606,0.3351511334188437,0,0,4.448539325842697,6.973335316265452,YWHAZ
positive regulation of filopodium assembly (GO:0051491),1/26,0.20855422889981606,0.3351511334188437,0,0,4.448539325842697,6.973335316265452,CDC42
positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),1/26,0.20855422889981606,0.3351511334188437,0,0,4.448539325842697,6.973335316265452,DDX3X
positive regulation of glucose import (GO:0046326),1/26,0.20855422889981606,0.3351511334188437,0,0,4.448539325842697,6.973335316265452,INSR
histone lysine demethylation (GO:0070076),1/26,0.20855422889981606,0.3351511334188437,0,0,4.448539325842697,6.973335316265452,JMJD1C
positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),1/26,0.20855422889981606,0.3351511334188437,0,0,4.448539325842697,6.973335316265452,YWHAZ
TOR signaling (GO:0031929),1/26,0.20855422889981606,0.3351511334188437,0,0,4.448539325842697,6.973335316265452,RPS6
positive regulation of T cell mediated cytotoxicity (GO:0001916),1/26,0.20855422889981606,0.3351511334188437,0,0,4.448539325842697,6.973335316265452,HLA-B
mononuclear cell differentiation (GO:1903131),1/26,0.20855422889981606,0.3351511334188437,0,0,4.448539325842697,6.973335316265452,MYH9
ciliary basal body-plasma membrane docking (GO:0097711),2/95,0.20898587693530746,0.3354648861665173,0,0,2.396938217605249,3.752379463608497,DYNC1H1;HSP90AA1
defense response to bacterium (GO:0042742),3/176,0.20926186483299958,0.3355283459864705,0,0,1.9358906988964792,3.02805996598621,RPL30;RPS19;RPL39
positive regulation of developmental process (GO:0051094),3/177,0.2115781197650152,0.3388593137094318,0,0,1.9246669278996866,2.989317587503046,HSP90AB1;NUMA1;INSR
negative regulation of immune response (GO:0050777),3/178,0.2139000461132608,0.33887366669260366,0,0,1.9135714285714285,2.951198737389228,GPR176;TNFAIP3;MYH9
negative regulation of cation channel activity (GO:2001258),1/27,0.21564687880438416,0.33887366669260366,0,0,4.277225583405358,6.561747497292318,CALM1
negative regulation of endothelial cell apoptotic process (GO:2000352),1/27,0.21564687880438416,0.33887366669260366,0,0,4.277225583405358,6.561747497292318,TNFAIP3
regulation of cardiac muscle cell contraction (GO:0086004),1/27,0.21564687880438416,0.33887366669260366,0,0,4.277225583405358,6.561747497292318,PDE4B
negative regulation of insulin receptor signaling pathway (GO:0046627),1/27,0.21564687880438416,0.33887366669260366,0,0,4.277225583405358,6.561747497292318,PTPRE
positive regulation of BMP signaling pathway (GO:0030513),1/27,0.21564687880438416,0.33887366669260366,0,0,4.277225583405358,6.561747497292318,NUMA1
positive regulation of cellular component movement (GO:0051272),1/27,0.21564687880438416,0.33887366669260366,0,0,4.277225583405358,6.561747497292318,RPS19
positive regulation of erythrocyte differentiation (GO:0045648),1/27,0.21564687880438416,0.33887366669260366,0,0,4.277225583405358,6.561747497292318,PRKDC
release of sequestered calcium ion into cytosol (GO:0051209),1/27,0.21564687880438416,0.33887366669260366,0,0,4.277225583405358,6.561747497292318,ITPR1
positive regulation of gene silencing by miRNA (GO:2000637),1/27,0.21564687880438416,0.33887366669260366,0,0,4.277225583405358,6.561747497292318,DDX5
response to glucocorticoid (GO:0051384),1/27,0.21564687880438416,0.33887366669260366,0,0,4.277225583405358,6.561747497292318,ZFP36L2
positive regulation of muscle cell differentiation (GO:0051149),1/27,0.21564687880438416,0.33887366669260366,0,0,4.277225583405358,6.561747497292318,CDC42
L-alpha-amino acid transmembrane transport (GO:1902475),1/27,0.21564687880438416,0.33887366669260366,0,0,4.277225583405358,6.561747497292318,SLC38A1
positive regulation of nuclear division (GO:0051785),1/27,0.21564687880438416,0.33887366669260366,0,0,4.277225583405358,6.561747497292318,INSR
melanosome organization (GO:0032438),1/27,0.21564687880438416,0.33887366669260366,0,0,4.277225583405358,6.561747497292318,HPS4
positive regulation of toll-like receptor signaling pathway (GO:0034123),1/27,0.21564687880438416,0.33887366669260366,0,0,4.277225583405358,6.561747497292318,DDX3X
negative regulation of actin filament bundle assembly (GO:0032232),1/27,0.21564687880438416,0.33887366669260366,0,0,4.277225583405358,6.561747497292318,WASF2
negative regulation of signal transduction (GO:0009968),4/267,0.2176644770843523,0.3416658108215663,0,0,1.6997718631178707,2.5918129829626637,KANK2;PTPRE;RACK1;TNFAIP3
regulated exocytosis (GO:0045055),3/180,0.21856036738333104,0.3423376993110487,0,0,1.8917565485362096,2.8767809820659824,PECAM1;MYH9;CALM1
RNA splicing (GO:0008380),2/98,0.21882479395129495,0.3423376993110487,0,0,2.321680790960452,3.527756575787964,TRA2B;PRPF8
positive regulation of cell migration (GO:0030335),4/269,0.22143361743973966,0.3423376993110487,0,0,1.6867708894878706,2.5430304948812408,INSR;RACK1;PECAM1;SYNE2
response to UV (GO:0009411),2/99,0.22211359139114958,0.3423376993110487,0,0,2.297629448424486,3.456935964441036,NPM1;PTPRK
mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),2/99,0.22211359139114958,0.3423376993110487,0,0,2.297629448424486,3.456935964441036,HNRNPA2B1;SRSF3
negative regulation of calcium ion transmembrane transporter activity (GO:1901020),1/28,0.22267631886123884,0.3423376993110487,0,0,4.118601747815231,6.186288287936283,CALM1
negative regulation of cellular response to insulin stimulus (GO:1900077),1/28,0.22267631886123884,0.3423376993110487,0,0,4.118601747815231,6.186288287936283,PTPRE
regulation of calcium-mediated signaling (GO:0050848),1/28,0.22267631886123884,0.3423376993110487,0,0,4.118601747815231,6.186288287936283,ITPR1
"regulation of DNA-templated transcription, elongation (GO:0032784)",1/28,0.22267631886123884,0.3423376993110487,0,0,4.118601747815231,6.186288287936283,HMGN1
cellular response to epidermal growth factor stimulus (GO:0071364),1/28,0.22267631886123884,0.3423376993110487,0,0,4.118601747815231,6.186288287936283,ZFP36L2
neutral amino acid transport (GO:0015804),1/28,0.22267631886123884,0.3423376993110487,0,0,4.118601747815231,6.186288287936283,SLC38A1
regulation of multicellular organismal development (GO:2000026),1/28,0.22267631886123884,0.3423376993110487,0,0,4.118601747815231,6.186288287936283,INSR
regulation of protein transport (GO:0051223),1/28,0.22267631886123884,0.3423376993110487,0,0,4.118601747815231,6.186288287936283,HSPA8
positive regulation of defense response to virus by host (GO:0002230),1/28,0.22267631886123884,0.3423376993110487,0,0,4.118601747815231,6.186288287936283,HSP90AA1
glycogen metabolic process (GO:0005977),1/28,0.22267631886123884,0.3423376993110487,0,0,4.118601747815231,6.186288287936283,CALM1
leukocyte cell-cell adhesion (GO:0007159),1/28,0.22267631886123884,0.3423376993110487,0,0,4.118601747815231,6.186288287936283,PECAM1
mucosal immune response (GO:0002385),1/28,0.22267631886123884,0.3423376993110487,0,0,4.118601747815231,6.186288287936283,RPL39
protein depolymerization (GO:0051261),1/28,0.22267631886123884,0.3423376993110487,0,0,4.118601747815231,6.186288287936283,GSN
protein localization to cell surface (GO:0034394),1/28,0.22267631886123884,0.3423376993110487,0,0,4.118601747815231,6.186288287936283,PTPRK
cell-matrix adhesion (GO:0007160),2/100,0.22540639888064157,0.34615982685241387,0,0,2.274068949613744,3.3880222812859317,PTPRK;CD44
negative regulation of epithelial to mesenchymal transition (GO:0010719),1/29,0.22964310924650472,0.3481448419025536,0,0,3.971308186195827,5.8427032715556315,LDLRAD4
regulation of calcium ion transmembrane transporter activity (GO:1901019),1/29,0.22964310924650472,0.3481448419025536,0,0,3.971308186195827,5.8427032715556315,CALM1
regulation of double-strand break repair via nonhomologous end joining (GO:2001032),1/29,0.22964310924650472,0.3481448419025536,0,0,3.971308186195827,5.8427032715556315,PRKDC
establishment of endothelial barrier (GO:0061028),1/29,0.22964310924650472,0.3481448419025536,0,0,3.971308186195827,5.8427032715556315,PECAM1
establishment of mitotic spindle localization (GO:0040001),1/29,0.22964310924650472,0.3481448419025536,0,0,3.971308186195827,5.8427032715556315,NUMA1
regulation of T cell mediated cytotoxicity (GO:0001914),1/29,0.22964310924650472,0.3481448419025536,0,0,3.971308186195827,5.8427032715556315,HLA-B
positive regulation of dephosphorylation (GO:0035306),1/29,0.22964310924650472,0.3481448419025536,0,0,3.971308186195827,5.8427032715556315,CALM1
regulation of ubiquitin-protein transferase activity (GO:0051438),1/29,0.22964310924650472,0.3481448419025536,0,0,3.971308186195827,5.8427032715556315,RPS2
homologous chromosome pairing at meiosis (GO:0007129),1/29,0.22964310924650472,0.3481448419025536,0,0,3.971308186195827,5.8427032715556315,STAG3
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),1/29,0.22964310924650472,0.3481448419025536,0,0,3.971308186195827,5.8427032715556315,ITPR1
positive regulation of viral genome replication (GO:0045070),1/29,0.22964310924650472,0.3481448419025536,0,0,3.971308186195827,5.8427032715556315,DDX3X
production of miRNAs involved in gene silencing by miRNA (GO:0035196),1/29,0.22964310924650472,0.3481448419025536,0,0,3.971308186195827,5.8427032715556315,HNRNPA2B1
negative regulation of interleukin-1 production (GO:0032692),1/30,0.23654780520486846,0.3542692834270925,0,0,3.8341728012398297,5.52736250975957,TNFAIP3
regulation of catecholamine secretion (GO:0050433),1/30,0.23654780520486846,0.3542692834270925,0,0,3.8341728012398297,5.52736250975957,GRK2
CENP-A containing chromatin organization (GO:0061641),1/30,0.23654780520486846,0.3542692834270925,0,0,3.8341728012398297,5.52736250975957,NPM1
CENP-A containing nucleosome assembly (GO:0034080),1/30,0.23654780520486846,0.3542692834270925,0,0,3.8341728012398297,5.52736250975957,NPM1
regulation of protein localization to membrane (GO:1905475),1/30,0.23654780520486846,0.3542692834270925,0,0,3.8341728012398297,5.52736250975957,GSN
establishment of spindle orientation (GO:0051294),1/30,0.23654780520486846,0.3542692834270925,0,0,3.8341728012398297,5.52736250975957,NUMA1
extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),1/30,0.23654780520486846,0.3542692834270925,0,0,3.8341728012398297,5.52736250975957,DDX3X
regulation of type I interferon-mediated signaling pathway (GO:0060338),1/30,0.23654780520486846,0.3542692834270925,0,0,3.8341728012398297,5.52736250975957,HSP90AB1
Golgi to plasma membrane protein transport (GO:0043001),1/30,0.23654780520486846,0.3542692834270925,0,0,3.8341728012398297,5.52736250975957,MACF1
histone H3-K4 methylation (GO:0051568),1/30,0.23654780520486846,0.3542692834270925,0,0,3.8341728012398297,5.52736250975957,KMT2C
maintenance of blood-brain barrier (GO:0035633),1/30,0.23654780520486846,0.3542692834270925,0,0,3.8341728012398297,5.52736250975957,PECAM1
DNA metabolic process (GO:0006259),4/277,0.23667884474198994,0.3542692834270925,0,0,1.6366718995290424,2.358527910357895,NPM1;PRKDC;RPS27A;UBA52
mRNA transport (GO:0051028),2/104,0.238611153190711,0.3567852754242559,0,0,2.1844466600199404,3.1301373651067355,HNRNPA2B1;SRSF3
regulation of cellular macromolecule biosynthetic process (GO:2000112),6/468,0.24279477292464688,0.3597622584520325,0,0,1.4532692740785227,2.0571589692380443,RPL10;INSR;JMJD1C;BAZ2A;SMARCA2;RPL6
'de novo' posttranslational protein folding (GO:0051084),1/31,0.24339095709228417,0.3597622584520325,0,0,3.7061797752808987,5.23715168631318,HSPA8
activation of protein kinase B activity (GO:0032148),1/31,0.24339095709228417,0.3597622584520325,0,0,3.7061797752808987,5.23715168631318,INSR
negative regulation of interleukin-6 production (GO:0032715),1/31,0.24339095709228417,0.3597622584520325,0,0,3.7061797752808987,5.23715168631318,TNFAIP3
negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),1/31,0.24339095709228417,0.3597622584520325,0,0,3.7061797752808987,5.23715168631318,SH3BP5
regulation of developmental growth (GO:0048638),1/31,0.24339095709228417,0.3597622584520325,0,0,3.7061797752808987,5.23715168631318,INSR
negative regulation of response to biotic stimulus (GO:0002832),1/31,0.24339095709228417,0.3597622584520325,0,0,3.7061797752808987,5.23715168631318,TNFAIP3
organelle transport along microtubule (GO:0072384),1/31,0.24339095709228417,0.3597622584520325,0,0,3.7061797752808987,5.23715168631318,CDC42
positive regulation of Rho protein signal transduction (GO:0035025),1/31,0.24339095709228417,0.3597622584520325,0,0,3.7061797752808987,5.23715168631318,AKAP13
positive regulation of RNA splicing (GO:0033120),1/31,0.24339095709228417,0.3597622584520325,0,0,3.7061797752808987,5.23715168631318,TRA2B
positive regulation of ubiquitin-protein transferase activity (GO:0051443),1/31,0.24339095709228417,0.3597622584520325,0,0,3.7061797752808987,5.23715168631318,RPS2
RNA export from nucleus (GO:0006405),2/106,0.24522919478840335,0.3617258081130399,0,0,2.142220773576706,3.0110241509440856,HNRNPA2B1;SRSF3
positive regulation of protein serine/threonine kinase activity (GO:0071902),2/106,0.24522919478840335,0.3617258081130399,0,0,2.142220773576706,3.0110241509440856,DDX3X;CALM1
mRNA export from nucleus (GO:0006406),2/107,0.2485410566110434,0.3618711964322438,0,0,2.1217110573042777,2.953734169889853,HNRNPA2B1;SRSF3
protein transmembrane import into intracellular organelle (GO:0044743),1/32,0.25017311042990215,0.3618711964322438,0,0,3.5864443638999637,4.969385053851574,HSPD1
B cell proliferation (GO:0042100),1/32,0.25017311042990215,0.3618711964322438,0,0,3.5864443638999637,4.969385053851574,HSPD1
negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),1/32,0.25017311042990215,0.3618711964322438,0,0,3.5864443638999637,4.969385053851574,KANK2
regulation of cellular amide metabolic process (GO:0034248),1/32,0.25017311042990215,0.3618711964322438,0,0,3.5864443638999637,4.969385053851574,RPL10
regulation of centrosome duplication (GO:0010824),1/32,0.25017311042990215,0.3618711964322438,0,0,3.5864443638999637,4.969385053851574,NPM1
cellular response to topologically incorrect protein (GO:0035967),1/32,0.25017311042990215,0.3618711964322438,0,0,3.5864443638999637,4.969385053851574,HSPA8
regulation of intracellular estrogen receptor signaling pathway (GO:0033146),1/32,0.25017311042990215,0.3618711964322438,0,0,3.5864443638999637,4.969385053851574,KANK2
chromatin remodeling at centromere (GO:0031055),1/32,0.25017311042990215,0.3618711964322438,0,0,3.5864443638999637,4.969385053851574,NPM1
ERBB2 signaling pathway (GO:0038128),1/32,0.25017311042990215,0.3618711964322438,0,0,3.5864443638999637,4.969385053851574,HSP90AA1
establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),1/32,0.25017311042990215,0.3618711964322438,0,0,3.5864443638999637,4.969385053851574,CDC42
positive regulation of glucose transmembrane transport (GO:0010828),1/32,0.25017311042990215,0.3618711964322438,0,0,3.5864443638999637,4.969385053851574,INSR
hematopoietic progenitor cell differentiation (GO:0002244),1/32,0.25017311042990215,0.3618711964322438,0,0,3.5864443638999637,4.969385053851574,PRRC2C
liver development (GO:0001889),1/32,0.25017311042990215,0.3618711964322438,0,0,3.5864443638999637,4.969385053851574,ARID5B
superoxide metabolic process (GO:0006801),1/32,0.25017311042990215,0.3618711964322438,0,0,3.5864443638999637,4.969385053851574,PREX1
positive regulation of receptor signaling pathway via STAT (GO:1904894),1/32,0.25017311042990215,0.3618711964322438,0,0,3.5864443638999637,4.969385053851574,IL7R
positive regulation of telomere maintenance (GO:0032206),1/32,0.25017311042990215,0.3618711964322438,0,0,3.5864443638999637,4.969385053851574,HNRNPA2B1
mitochondrial membrane organization (GO:0007006),1/32,0.25017311042990215,0.3618711964322438,0,0,3.5864443638999637,4.969385053851574,SLC25A5
protein K63-linked deubiquitination (GO:0070536),1/32,0.25017311042990215,0.3618711964322438,0,0,3.5864443638999637,4.969385053851574,TNFAIP3
antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),1/33,0.2568948059086201,0.3697096648928316,0,0,3.474192415730337,4.721735283530793,HLA-B
apoptotic mitochondrial changes (GO:0008637),1/33,0.2568948059086201,0.3697096648928316,0,0,3.474192415730337,4.721735283530793,HSPD1
negative regulation of smooth muscle cell proliferation (GO:0048662),1/33,0.2568948059086201,0.3697096648928316,0,0,3.474192415730337,4.721735283530793,TNFAIP3
regulation of protein localization to cell surface (GO:2000008),1/33,0.2568948059086201,0.3697096648928316,0,0,3.474192415730337,4.721735283530793,HSP90AB1
lytic vacuole organization (GO:0080171),1/33,0.2568948059086201,0.3697096648928316,0,0,3.474192415730337,4.721735283530793,HPS4
response to tumor necrosis factor (GO:0034612),2/110,0.2584844759146423,0.3716205383210511,0,0,2.0624607658505965,2.790343679583139,RPS3;ZFP36L2
regulation of protein serine/threonine kinase activity (GO:0071900),2/111,0.26180060913667225,0.37423953246151404,0,0,2.0434354429067536,2.7385551662495224,DDX3X;CALM1
regulation of activated T cell proliferation (GO:0046006),1/34,0.2635565794018977,0.37423953246151404,0,0,3.368743615934627,4.492176530544659,RPS3
autophagosome maturation (GO:0097352),1/34,0.2635565794018977,0.37423953246151404,0,0,3.368743615934627,4.492176530544659,CALM1
cell-substrate junction assembly (GO:0007044),1/34,0.2635565794018977,0.37423953246151404,0,0,3.368743615934627,4.492176530544659,PTPRK
cellular response to vascular endothelial growth factor stimulus (GO:0035924),1/34,0.2635565794018977,0.37423953246151404,0,0,3.368743615934627,4.492176530544659,NR4A1
regulation of keratinocyte differentiation (GO:0045616),1/34,0.2635565794018977,0.37423953246151404,0,0,3.368743615934627,4.492176530544659,NUMA1
phosphatidylserine metabolic process (GO:0006658),1/34,0.2635565794018977,0.37423953246151404,0,0,3.368743615934627,4.492176530544659,SERINC5
female gamete generation (GO:0007292),1/34,0.2635565794018977,0.37423953246151404,0,0,3.368743615934627,4.492176530544659,USP9X
positive regulation of interleukin-12 production (GO:0032735),1/34,0.2635565794018977,0.37423953246151404,0,0,3.368743615934627,4.492176530544659,HSPD1
positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),1/34,0.2635565794018977,0.37423953246151404,0,0,3.368743615934627,4.492176530544659,YWHAZ
positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),1/34,0.2635565794018977,0.37423953246151404,0,0,3.368743615934627,4.492176530544659,CALM1
protein destabilization (GO:0031648),1/34,0.2635565794018977,0.37423953246151404,0,0,3.368743615934627,4.492176530544659,GSN
endomembrane system organization (GO:0010256),3/199,0.263734695180771,0.37423953246151404,0,0,1.7067196196660481,2.2747357473617402,CDC42;MYO18A;HUWE1
modification-dependent protein catabolic process (GO:0019941),3/201,0.26856412429205134,0.38069073230436773,0,0,1.6893078512396693,2.220874868088187,RNF213;RPS27A;UBA52
negative regulation of cell cycle G1/S phase transition (GO:1902807),1/35,0.2701589622484132,0.38069073230436773,0,0,3.2694976867151353,4.278937913532702,KANK2
regulation of JUN kinase activity (GO:0043506),1/35,0.2701589622484132,0.38069073230436773,0,0,3.2694976867151353,4.278937913532702,RPS3
regulation of muscle cell differentiation (GO:0051147),1/35,0.2701589622484132,0.38069073230436773,0,0,3.2694976867151353,4.278937913532702,CDC42
regulation of protein polymerization (GO:0032271),1/35,0.2701589622484132,0.38069073230436773,0,0,3.2694976867151353,4.278937913532702,HSP90AA1
positive regulation of cell cycle G1/S phase transition (GO:1902808),1/35,0.2701589622484132,0.38069073230436773,0,0,3.2694976867151353,4.278937913532702,DDX3X
regulation of T cell receptor signaling pathway (GO:0050856),1/35,0.2701589622484132,0.38069073230436773,0,0,3.2694976867151353,4.278937913532702,RPS3
histone modification (GO:0016570),2/114,0.2717501318546249,0.3819463232241233,0,0,1.9883979015334947,2.590628483210641,HUWE1;BAZ2A
calcium ion transport (GO:0006816),2/115,0.27506612742614794,0.3819463232241233,0,0,1.9707014649267536,2.543670592771085,ITPR1;TPT1
cellular response to molecule of bacterial origin (GO:0071219),2/115,0.27506612742614794,0.3819463232241233,0,0,1.9707014649267536,2.543670592771085,PDE4B;TNFAIP3
positive regulation of protein metabolic process (GO:0051247),2/115,0.27506612742614794,0.3819463232241233,0,0,1.9707014649267536,2.543670592771085,HUWE1;TNFAIP3
negative regulation of DNA metabolic process (GO:0051053),1/36,0.27670248081352977,0.3819463232241233,0,0,3.1759229534510434,4.080465276244197,RPS3
regulation of androgen receptor signaling pathway (GO:0060765),1/36,0.27670248081352977,0.3819463232241233,0,0,3.1759229534510434,4.080465276244197,DDX5
negative regulation of fat cell differentiation (GO:0045599),1/36,0.27670248081352977,0.3819463232241233,0,0,3.1759229534510434,4.080465276244197,ZFP36L2
axonal transport (GO:0098930),1/36,0.27670248081352977,0.3819463232241233,0,0,3.1759229534510434,4.080465276244197,DYNC1H1
regulation of embryonic development (GO:0045995),1/36,0.27670248081352977,0.3819463232241233,0,0,3.1759229534510434,4.080465276244197,INSR
negative regulation of toll-like receptor signaling pathway (GO:0034122),1/36,0.27670248081352977,0.3819463232241233,0,0,3.1759229534510434,4.080465276244197,TNFAIP3
regulation of microtubule-based process (GO:0032886),1/36,0.27670248081352977,0.3819463232241233,0,0,3.1759229534510434,4.080465276244197,MACF1
dendrite morphogenesis (GO:0048813),1/36,0.27670248081352977,0.3819463232241233,0,0,3.1759229534510434,4.080465276244197,CDC42
regulation of receptor internalization (GO:0002090),1/36,0.27670248081352977,0.3819463232241233,0,0,3.1759229534510434,4.080465276244197,INSR
establishment of protein localization to plasma membrane (GO:0061951),1/36,0.27670248081352977,0.3819463232241233,0,0,3.1759229534510434,4.080465276244197,MACF1
positive regulation of innate immune response (GO:0045089),1/36,0.27670248081352977,0.3819463232241233,0,0,3.1759229534510434,4.080465276244197,RPS19
positive regulation of mitotic nuclear division (GO:0045840),1/36,0.27670248081352977,0.3819463232241233,0,0,3.1759229534510434,4.080465276244197,INSR
intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),1/36,0.27670248081352977,0.3819463232241233,0,0,3.1759229534510434,4.080465276244197,DDX5
membrane fusion (GO:0061025),1/36,0.27670248081352977,0.3819463232241233,0,0,3.1759229534510434,4.080465276244197,HUWE1
positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),1/36,0.27670248081352977,0.3819463232241233,0,0,3.1759229534510434,4.080465276244197,CDC42
positive regulation of telomere maintenance via telomere lengthening (GO:1904358),1/36,0.27670248081352977,0.3819463232241233,0,0,3.1759229534510434,4.080465276244197,HNRNPA2B1
"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",1/36,0.27670248081352977,0.3819463232241233,0,0,3.1759229534510434,4.080465276244197,CALM1
regulation of actin cytoskeleton reorganization (GO:2000249),1/37,0.28318765709630056,0.3871322595565033,0,0,3.0875468164794007,3.895389552644805,CDC42
negative regulation of epithelial cell apoptotic process (GO:1904036),1/37,0.28318765709630056,0.3871322595565033,0,0,3.0875468164794007,3.895389552644805,TNFAIP3
negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),1/37,0.28318765709630056,0.3871322595565033,0,0,3.0875468164794007,3.895389552644805,KANK2
regulation of erythrocyte differentiation (GO:0045646),1/37,0.28318765709630056,0.3871322595565033,0,0,3.0875468164794007,3.895389552644805,PRKDC
regulation of glucose import (GO:0046324),1/37,0.28318765709630056,0.3871322595565033,0,0,3.0875468164794007,3.895389552644805,INSR
regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),1/37,0.28318765709630056,0.3871322595565033,0,0,3.0875468164794007,3.895389552644805,DDX5
positive regulation of cytokinesis (GO:0032467),1/37,0.28318765709630056,0.3871322595565033,0,0,3.0875468164794007,3.895389552644805,CDC42
positive regulation of myeloid cell differentiation (GO:0045639),1/37,0.28318765709630056,0.3871322595565033,0,0,3.0875468164794007,3.895389552644805,PRKDC
lysosome localization (GO:0032418),1/37,0.28318765709630056,0.3871322595565033,0,0,3.0875468164794007,3.895389552644805,MYH9
ncRNA metabolic process (GO:0034660),1/37,0.28318765709630056,0.3871322595565033,0,0,3.0875468164794007,3.895389552644805,DDX17
regulation of protein binding (GO:0043393),2/118,0.2850089856148942,0.38924711317375826,0,0,1.9194428209624002,2.4093509854253106,RPL11;RACK1
MAPK cascade (GO:0000165),4/303,0.28772377064419635,0.3910215954620803,0,0,1.4923650262780697,1.8591202811970275,CALM1;RPS27A;UBA52;ZFP36L2
phosphorylation (GO:0016310),5/400,0.288536946145997,0.3910215954620803,0,0,1.4132111159610068,1.7565255142810525,GRK2;PRKDC;INSR;PGK1;YWHAZ
regulation of apoptotic signaling pathway (GO:2001233),1/38,0.28961500833731246,0.3910215954620803,0,0,3.003947767992712,3.722500471465051,RPS3
regulation of axon extension (GO:0030516),1/38,0.28961500833731246,0.3910215954620803,0,0,3.003947767992712,3.722500471465051,MACF1
regulation of cell communication (GO:0010646),1/38,0.28961500833731246,0.3910215954620803,0,0,3.003947767992712,3.722500471465051,GRK2
histone exchange (GO:0043486),1/38,0.28961500833731246,0.3910215954620803,0,0,3.003947767992712,3.722500471465051,NPM1
spliceosomal snRNP assembly (GO:0000387),1/38,0.28961500833731246,0.3910215954620803,0,0,3.003947767992712,3.722500471465051,PRPF8
lymphocyte proliferation (GO:0046651),1/38,0.28961500833731246,0.3910215954620803,0,0,3.003947767992712,3.722500471465051,HSPD1
lysosome organization (GO:0007040),1/38,0.28961500833731246,0.3910215954620803,0,0,3.003947767992712,3.722500471465051,HPS4
ventricular septum development (GO:0003281),1/38,0.28961500833731246,0.3910215954620803,0,0,3.003947767992712,3.722500471465051,MDM4
mRNA destabilization (GO:0061157),1/38,0.28961500833731246,0.3910215954620803,0,0,3.003947767992712,3.722500471465051,ZFP36L2
ncRNA export from nucleus (GO:0097064),1/38,0.28961500833731246,0.3910215954620803,0,0,3.003947767992712,3.722500471465051,NPM1
cellular response to lipopolysaccharide (GO:0071222),2/120,0.2916308202365774,0.39336894858907157,0,0,1.8867183759456094,2.324940021099274,PDE4B;TNFAIP3
phosphate-containing compound metabolic process (GO:0006796),3/212,0.295286035167364,0.39585559105580764,0,0,1.5994997825141366,1.9510870799965108,PFKFB2;PGK1;CALM1
transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),5/404,0.29546898473756966,0.39585559105580764,0,0,1.3987555094633135,1.705350696556533,CDC42;HSP90AA1;HNRNPH1;INSR;WASF2
protein monoubiquitination (GO:0006513),1/39,0.29598504729401826,0.39585559105580764,0,0,2.924748669426375,3.560724568373006,HUWE1
cellular response to ketone (GO:1901655),1/39,0.29598504729401826,0.39585559105580764,0,0,2.924748669426375,3.560724568373006,KLF9
DNA replication-independent nucleosome assembly (GO:0006336),1/39,0.29598504729401826,0.39585559105580764,0,0,2.924748669426375,3.560724568373006,NPM1
regulation of peptidyl-threonine phosphorylation (GO:0010799),1/39,0.29598504729401826,0.39585559105580764,0,0,2.924748669426375,3.560724568373006,CALM1
regulation of protein tyrosine kinase activity (GO:0061097),1/39,0.29598504729401826,0.39585559105580764,0,0,2.924748669426375,3.560724568373006,SH3BP5
regulation of viral entry into host cell (GO:0046596),1/39,0.29598504729401826,0.39585559105580764,0,0,2.924748669426375,3.560724568373006,GSN
membrane protein proteolysis (GO:0033619),1/39,0.29598504729401826,0.39585559105580764,0,0,2.924748669426375,3.560724568373006,MYH9
epithelium development (GO:0060429),2/122,0.2982450476243186,0.39850256363362346,0,0,1.8550847457627118,2.2443554003191,KANK2;PGK1
negative regulation of ERBB signaling pathway (GO:1901185),1/40,0.30229828207251697,0.40202555038509985,0,0,2.8496110630942093,3.409106720007189,CDC42
negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),1/40,0.30229828207251697,0.40202555038509985,0,0,2.8496110630942093,3.409106720007189,TNFAIP3
negative regulation of protein kinase B signaling (GO:0051898),1/40,0.30229828207251697,0.40202555038509985,0,0,2.8496110630942093,3.409106720007189,RACK1
positive regulation of cation channel activity (GO:2001259),1/40,0.30229828207251697,0.40202555038509985,0,0,2.8496110630942093,3.409106720007189,CALM1
positive regulation of double-strand break repair (GO:2000781),1/40,0.30229828207251697,0.40202555038509985,0,0,2.8496110630942093,3.409106720007189,PRKDC
non-canonical Wnt signaling pathway (GO:0035567),2/124,0.30484984451654534,0.4046579040549569,0,0,1.8244882837825322,2.1673751983223983,CDC42;CALM1
cellular response to oxidative stress (GO:0034599),2/125,0.3081481550282896,0.4046579040549569,0,0,1.8095631803775665,2.130171792847895,RPS3;PTPRK
platelet degranulation (GO:0002576),2/125,0.3081481550282896,0.4046579040549569,0,0,1.8095631803775665,2.130171792847895,PECAM1;CALM1
regulation of protein secretion (GO:0050708),2/125,0.3081481550282896,0.4046579040549569,0,0,1.8095631803775665,2.130171792847895,ITPR1;MYO18A
negative regulation of cell-cell adhesion (GO:0022408),1/41,0.3085552164816514,0.4046579040549569,0,0,2.778230337078652,3.266794554762887,AKNA
regulation of cell development (GO:0060284),1/41,0.3085552164816514,0.4046579040549569,0,0,2.778230337078652,3.266794554762887,RPS19
carboxylic acid transmembrane transport (GO:1905039),1/41,0.3085552164816514,0.4046579040549569,0,0,2.778230337078652,3.266794554762887,SLC38A1
regulation of filopodium assembly (GO:0051489),1/41,0.3085552164816514,0.4046579040549569,0,0,2.778230337078652,3.266794554762887,CDC42
regulation of protein dephosphorylation (GO:0035304),1/41,0.3085552164816514,0.4046579040549569,0,0,2.778230337078652,3.266794554762887,CALM1
epithelial cell migration (GO:0010631),1/41,0.3085552164816514,0.4046579040549569,0,0,2.778230337078652,3.266794554762887,KANK2
gluconeogenesis (GO:0006094),1/41,0.3085552164816514,0.4046579040549569,0,0,2.778230337078652,3.266794554762887,PGK1
heart contraction (GO:0060047),1/41,0.3085552164816514,0.4046579040549569,0,0,2.778230337078652,3.266794554762887,GRK2
response to growth factor (GO:0070848),1/41,0.3085552164816514,0.4046579040549569,0,0,2.778230337078652,3.266794554762887,RACK1
import into cell (GO:0098657),1/41,0.3085552164816514,0.4046579040549569,0,0,2.778230337078652,3.266794554762887,SLC38A1
T cell differentiation (GO:0030217),1/41,0.3085552164816514,0.4046579040549569,0,0,2.778230337078652,3.266794554762887,ZFP36L2
circulatory system development (GO:0072359),2/126,0.31144345432149023,0.40806857034367,0,0,1.7948788044468744,2.0937934051457545,PDLIM1;AKAP13
ATP-dependent chromatin remodeling (GO:0043044),1/42,0.3147563498033621,0.4097607893311659,0,0,2.7103315976979996,3.133025243602289,SMARCA2
calcium ion transmembrane import into cytosol (GO:0097553),1/42,0.3147563498033621,0.4097607893311659,0,0,2.7103315976979996,3.133025243602289,ITPR1
regulation of DNA recombination (GO:0000018),1/42,0.3147563498033621,0.4097607893311659,0,0,2.7103315976979996,3.133025243602289,IL7R
negative regulation of protein catabolic process (GO:0042177),1/42,0.3147563498033621,0.4097607893311659,0,0,2.7103315976979996,3.133025243602289,MDM4
nucleic acid-templated transcription (GO:0097659),1/42,0.3147563498033621,0.4097607893311659,0,0,2.7103315976979996,3.133025243602289,BAZ2A
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),1/42,0.3147563498033621,0.4097607893311659,0,0,2.7103315976979996,3.133025243602289,CD164
monocyte chemotaxis (GO:0002548),1/42,0.3147563498033621,0.4097607893311659,0,0,2.7103315976979996,3.133025243602289,RPS19
"transcription, DNA-templated (GO:0006351)",3/221,0.31727622101199854,0.41266265592669654,0,0,1.5327616763969976,1.7595836192773315,BTF3;DDX5;BAZ2A
negative regulation of type I interferon production (GO:0032480),1/43,0.3209021768800045,0.415243869793622,0,0,2.645666131621188,3.0071142532146395,TNFAIP3
positive regulation of axonogenesis (GO:0050772),1/43,0.3209021768800045,0.415243869793622,0,0,2.645666131621188,3.0071142532146395,MACF1
positive regulation of leukocyte mediated cytotoxicity (GO:0001912),1/43,0.3209021768800045,0.415243869793622,0,0,2.645666131621188,3.0071142532146395,HLA-B
signal release from synapse (GO:0099643),1/43,0.3209021768800045,0.415243869793622,0,0,2.645666131621188,3.0071142532146395,HSPA8
positive regulation of neuron differentiation (GO:0045666),1/43,0.3209021768800045,0.415243869793622,0,0,2.645666131621188,3.0071142532146395,TCF4
cellular response to insulin stimulus (GO:0032869),2/129,0.32130921003058277,0.415243869793622,0,0,1.7522131767427376,1.989377592858318,PRKDC;INSR
DNA-dependent DNA replication (GO:0006261),2/129,0.32130921003058277,0.415243869793622,0,0,1.7522131767427376,1.989377592858318,RPS27A;UBA52
organelle organization (GO:0006996),5/420,0.3234571148515775,0.41763935029516697,0,0,1.3437197064118542,1.5166413023101666,CDC42;NUMA1;MYO18A;HUWE1;TNFAIP3
regulation of response to external stimulus (GO:0032101),2/130,0.3245904091460588,0.41764476522657396,0,0,1.7384357344632768,1.9560725398091858,AKNA;CALM1
G2/M transition of mitotic cell cycle (GO:0000086),2/130,0.3245904091460588,0.41764476522657396,0,0,1.7384357344632768,1.9560725398091858,DYNC1H1;HSP90AA1
antibacterial humoral response (GO:0019731),1/44,0.3269931882781703,0.41764476522657396,0,0,2.584008361640972,2.888445733811662,RPL39
negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),1/44,0.3269931882781703,0.41764476522657396,0,0,2.584008361640972,2.888445733811662,CDC42
regulation of endothelial cell apoptotic process (GO:2000351),1/44,0.3269931882781703,0.41764476522657396,0,0,2.584008361640972,2.888445733811662,TNFAIP3
neurotransmitter secretion (GO:0007269),1/44,0.3269931882781703,0.41764476522657396,0,0,2.584008361640972,2.888445733811662,HSPA8
positive regulation of cell division (GO:0051781),1/44,0.3269931882781703,0.41764476522657396,0,0,2.584008361640972,2.888445733811662,CDC42
hexose biosynthetic process (GO:0019319),1/44,0.3269931882781703,0.41764476522657396,0,0,2.584008361640972,2.888445733811662,PGK1
positive regulation of mRNA catabolic process (GO:0061014),1/44,0.3269931882781703,0.41764476522657396,0,0,2.584008361640972,2.888445733811662,ZFP36L2
intracellular protein transmembrane transport (GO:0065002),1/44,0.3269931882781703,0.41764476522657396,0,0,2.584008361640972,2.888445733811662,HSPD1
positive regulation of receptor-mediated endocytosis (GO:0048260),1/44,0.3269931882781703,0.41764476522657396,0,0,2.584008361640972,2.888445733811662,INSR
positive regulation of stress fiber assembly (GO:0051496),1/44,0.3269931882781703,0.41764476522657396,0,0,2.584008361640972,2.888445733811662,CDC42
cell cycle G2/M phase transition (GO:0044839),2/131,0.3278675887480608,0.41817291894576536,0,0,1.7248718959400866,1.923483037871514,DYNC1H1;HSP90AA1
cellular response to oxygen-containing compound (GO:1901701),4/323,0.3279960949870591,0.41817291894576536,0,0,1.3973667711598745,1.5577196054081,PDE4B;RPS3;TNFAIP3;PTPRK
amino acid transmembrane transport (GO:0003333),1/45,0.333029870096283,0.4211848357100049,0,0,2.5251532175689477,2.7764642761703553,SLC38A1
regulation of DNA repair (GO:0006282),1/45,0.333029870096283,0.4211848357100049,0,0,2.5251532175689477,2.7764642761703553,RPS3
negative regulation of T cell activation (GO:0050868),1/45,0.333029870096283,0.4211848357100049,0,0,2.5251532175689477,2.7764642761703553,PAG1
regulation of insulin receptor signaling pathway (GO:0046626),1/45,0.333029870096283,0.4211848357100049,0,0,2.5251532175689477,2.7764642761703553,PTPRE
regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),1/45,0.333029870096283,0.4211848357100049,0,0,2.5251532175689477,2.7764642761703553,DDX5
positive regulation of RNA metabolic process (GO:0051254),1/45,0.333029870096283,0.4211848357100049,0,0,2.5251532175689477,2.7764642761703553,DDX5
microtubule bundle formation (GO:0001578),1/45,0.333029870096283,0.4211848357100049,0,0,2.5251532175689477,2.7764642761703553,NUMA1
zymogen activation (GO:0031638),1/45,0.333029870096283,0.4211848357100049,0,0,2.5251532175689477,2.7764642761703553,PGK1
protein deacetylation (GO:0006476),1/45,0.333029870096283,0.4211848357100049,0,0,2.5251532175689477,2.7764642761703553,BAZ2A
positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),2/134,0.3376731264568525,0.42667690689427756,0,0,1.6854134565998973,1.8298145122512166,PECAM1;CD44
regulation of DNA metabolic process (GO:0051052),1/46,0.33901270430157027,0.4272282659004691,0,0,2.4689138576779026,2.6706678109547566,IL7R
negative regulation of tumor necrosis factor production (GO:0032720),1/46,0.33901270430157027,0.4272282659004691,0,0,2.4689138576779026,2.6706678109547566,TNFAIP3
posttranscriptional regulation of gene expression (GO:0010608),1/46,0.33901270430157027,0.4272282659004691,0,0,2.4689138576779026,2.6706678109547566,RPL10
regulation of nucleic acid-templated transcription (GO:1903506),5/430,0.3411075726302075,0.42948681948736867,0,0,1.3114266396213659,1.4105146126223596,INSR;JMJD1C;BAZ2A;SMARCA2;RPL6
regulation of autophagy (GO:0010506),3/231,0.3417426646059565,0.42990500095376977,0,0,1.4647876794258374,1.5727385293348142,TP53INP1;ITPR1;EIF4G2
negative regulation of inflammatory response to antigenic stimulus (GO:0002862),2/136,0.3441866636903518,0.4312536890823869,0,0,1.660089383590522,1.770603429297561,GPR176;MYH9
organic substance transport (GO:0071702),2/136,0.3441866636903518,0.4312536890823869,0,0,1.660089383590522,1.770603429297561,CENPF;MYH9
polyol metabolic process (GO:0019751),1/47,0.3449421685049395,0.4312536890823869,0,0,2.4151196873473375,2.5706014786495186,CALM1
positive regulation of cell-cell adhesion (GO:0022409),1/47,0.3449421685049395,0.4312536890823869,0,0,2.4151196873473375,2.5706014786495186,CD44
regulation of wound healing (GO:0061041),1/47,0.3449421685049395,0.4312536890823869,0,0,2.4151196873473375,2.5706014786495186,TNFAIP3
histone deacetylation (GO:0016575),1/47,0.3449421685049395,0.4312536890823869,0,0,2.4151196873473375,2.5706014786495186,BAZ2A
telomere organization (GO:0032200),1/47,0.3449421685049395,0.4312536890823869,0,0,2.4151196873473375,2.5706014786495186,PRKDC
regulation of inflammatory response to antigenic stimulus (GO:0002861),2/137,0.34743585856712955,0.43398898178411693,0,0,1.6477087256748273,1.7419168191998626,GPR176;MYH9
base-excision repair (GO:0006284),1/48,0.35081873612179865,0.43439073870578737,0,0,2.3636146306478603,2.4758523136927773,HUWE1
negative regulation of mitotic cell cycle (GO:0045930),1/48,0.35081873612179865,0.43439073870578737,0,0,2.3636146306478603,2.4758523136927773,ZFP36L2
cellular response to alcohol (GO:0097306),1/48,0.35081873612179865,0.43439073870578737,0,0,2.3636146306478603,2.4758523136927773,KLF9
negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),1/48,0.35081873612179865,0.43439073870578737,0,0,2.3636146306478603,2.4758523136927773,TNFAIP3
regulation of protein metabolic process (GO:0051246),1/48,0.35081873612179865,0.43439073870578737,0,0,2.3636146306478603,2.4758523136927773,HSP90AB1
establishment of protein localization to mitochondrion (GO:0072655),1/48,0.35081873612179865,0.43439073870578737,0,0,2.3636146306478603,2.4758523136927773,HSPD1
positive regulation of DNA repair (GO:0045739),1/48,0.35081873612179865,0.43439073870578737,0,0,2.3636146306478603,2.4758523136927773,RPS3
positive regulation of endocytosis (GO:0045807),1/48,0.35081873612179865,0.43439073870578737,0,0,2.3636146306478603,2.4758523136927773,CDC42
Golgi to plasma membrane transport (GO:0006893),1/48,0.35081873612179865,0.43439073870578737,0,0,2.3636146306478603,2.4758523136927773,MACF1
inositol phosphate metabolic process (GO:0043647),1/48,0.35081873612179865,0.43439073870578737,0,0,2.3636146306478603,2.4758523136927773,CALM1
protein dephosphorylation (GO:0006470),2/139,0.35391825642284336,0.4378465613461331,0,0,1.623489628438286,1.6863013163908316,PTPRE;PTPRK
negative regulation of catabolic process (GO:0009895),1/49,0.35664287649387955,0.438921285121262,0,0,2.314255617977528,2.386044622976128,MDM4
receptor internalization (GO:0031623),1/49,0.35664287649387955,0.438921285121262,0,0,2.314255617977528,2.386044622976128,GRK2
regulation of cellular protein metabolic process (GO:0032268),1/49,0.35664287649387955,0.438921285121262,0,0,2.314255617977528,2.386044622976128,RPL10
positive regulation of actin filament polymerization (GO:0030838),1/49,0.35664287649387955,0.438921285121262,0,0,2.314255617977528,2.386044622976128,GSN
RNA catabolic process (GO:0006401),1/49,0.35664287649387955,0.438921285121262,0,0,2.314255617977528,2.386044622976128,ZFP36L2
mitotic cytokinesis (GO:0000281),1/49,0.35664287649387955,0.438921285121262,0,0,2.314255617977528,2.386044622976128,SON
amino acid transport (GO:0006865),1/50,0.3624150547196057,0.44486761474664405,0,0,2.266911258885577,2.300835957547096,SLC38A1
regulation of cellular component movement (GO:0051270),1/50,0.3624150547196057,0.44486761474664405,0,0,2.266911258885577,2.300835957547096,RPS19
neuron migration (GO:0001764),1/50,0.3624150547196057,0.44486761474664405,0,0,2.266911258885577,2.300835957547096,USP9X
protein localization to organelle (GO:0033365),2/142,0.3635994418190839,0.4456910505662,0,0,1.588458434221146,1.607047292533206,DDX3X;RPL11
axonogenesis (GO:0007409),3/240,0.3637140497220998,0.4456910505662,0,0,1.4085155350978136,1.424554720895253,HSP90AA1;HSP90AB1;USP9X
regulation of epithelial cell migration (GO:0010632),1/51,0.36813573176503045,0.44839880117989545,0,0,2.2214606741573033,2.2199135878505025,MACF1
negative regulation of transport (GO:0051051),1/51,0.36813573176503045,0.44839880117989545,0,0,2.2214606741573033,2.2199135878505025,RACK1
positive regulation of actin filament bundle assembly (GO:0032233),1/51,0.36813573176503045,0.44839880117989545,0,0,2.2214606741573033,2.2199135878505025,CDC42
regulation of smoothened signaling pathway (GO:0008589),1/51,0.36813573176503045,0.44839880117989545,0,0,2.2214606741573033,2.2199135878505025,RACK1
regulation of substrate adhesion-dependent cell spreading (GO:1900024),1/51,0.36813573176503045,0.44839880117989545,0,0,2.2214606741573033,2.2199135878505025,CDC42
sensory perception (GO:0007600),1/51,0.36813573176503045,0.44839880117989545,0,0,2.2214606741573033,2.2199135878505025,GNAS
intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),1/51,0.36813573176503045,0.44839880117989545,0,0,2.2214606741573033,2.2199135878505025,PRKDC
ameboidal-type cell migration (GO:0001667),1/52,0.3738053646134639,0.4529716587416783,0,0,2.177792465300727,2.142991412489484,PDLIM1
cartilage development (GO:0051216),1/52,0.3738053646134639,0.4529716587416783,0,0,2.177792465300727,2.142991412489484,CD44
regulation of release of sequestered calcium ion into cytosol (GO:0051279),1/52,0.3738053646134639,0.4529716587416783,0,0,2.177792465300727,2.142991412489484,CALM1
signal transduction in response to DNA damage (GO:0042770),1/52,0.3738053646134639,0.4529716587416783,0,0,2.177792465300727,2.142991412489484,MDM4
positive regulation of protein localization to cell periphery (GO:1904377),1/52,0.3738053646134639,0.4529716587416783,0,0,2.177792465300727,2.142991412489484,NUMA1
positive regulation of protein localization to plasma membrane (GO:1903078),1/52,0.3738053646134639,0.4529716587416783,0,0,2.177792465300727,2.142991412489484,RACK1
bicellular tight junction assembly (GO:0070830),1/53,0.37942440614699086,0.45743690086880207,0,0,2.1358038029386344,2.0698072417592632,PECAM1
cardiac muscle tissue development (GO:0048738),1/53,0.37942440614699086,0.45743690086880207,0,0,2.1358038029386344,2.0698072417592632,AKAP13
regulation of immune effector process (GO:0002697),1/53,0.37942440614699086,0.45743690086880207,0,0,2.1358038029386344,2.0698072417592632,IRF4
positive regulation of chemokine production (GO:0032722),1/53,0.37942440614699086,0.45743690086880207,0,0,2.1358038029386344,2.0698072417592632,DDX3X
positive regulation of macroautophagy (GO:0016239),1/53,0.37942440614699086,0.45743690086880207,0,0,2.1358038029386344,2.0698072417592632,SLC25A5
positive regulation of phagocytosis (GO:0050766),1/53,0.37942440614699086,0.45743690086880207,0,0,2.1358038029386344,2.0698072417592632,MYO18A
regulation of cyclin-dependent protein kinase activity (GO:1904029),1/54,0.3849933053088833,0.46218739444442086,0,0,2.0953996184015264,2.0001204014908907,HSP90AB1
regulation of focal adhesion assembly (GO:0051893),1/54,0.3849933053088833,0.46218739444442086,0,0,2.0953996184015264,2.0001204014908907,MACF1
regulation of megakaryocyte differentiation (GO:0045652),1/54,0.3849933053088833,0.46218739444442086,0,0,2.0953996184015264,2.0001204014908907,KMT2C
regulation of proteasomal protein catabolic process (GO:0061136),1/54,0.3849933053088833,0.46218739444442086,0,0,2.0953996184015264,2.0001204014908907,HSP90AB1
striated muscle contraction (GO:0006941),1/54,0.3849933053088833,0.46218739444442086,0,0,2.0953996184015264,2.0001204014908907,GRK2
regulation of cardiac conduction (GO:1903779),1/55,0.39051250711969415,0.46841694640984444,0,0,2.0564918851435707,1.93370961653662,ITPR1
ubiquitin-dependent protein catabolic process (GO:0006511),4/354,0.3908979679104305,0.46848329093319335,0,0,1.2715755102040815,1.1944019454006185,RNF213;USP9X;HUWE1;TNFAIP3
autophagosome organization (GO:1905037),1/56,0.39598245251515657,0.47178765753065255,0,0,2.0189989785495404,1.8703711370532194,TP53INP1
"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",1/56,0.39598245251515657,0.47178765753065255,0,0,2.0189989785495404,1.8703711370532194,MDM4
peptidyl-tyrosine modification (GO:0018212),1/56,0.39598245251515657,0.47178765753065255,0,0,2.0189989785495404,1.8703711370532194,INSR
glycosaminoglycan catabolic process (GO:0006027),1/56,0.39598245251515657,0.47178765753065255,0,0,2.0189989785495404,1.8703711370532194,CD44
Rho protein signal transduction (GO:0007266),1/56,0.39598245251515657,0.47178765753065255,0,0,2.0189989785495404,1.8703711370532194,CDC42
telomere maintenance (GO:0000723),1/56,0.39598245251515657,0.47178765753065255,0,0,2.0189989785495404,1.8703711370532194,PRKDC
tight junction assembly (GO:0120192),1/56,0.39598245251515657,0.47178765753065255,0,0,2.0189989785495404,1.8703711370532194,PECAM1
dephosphorylation (GO:0016311),2/153,0.398600696677292,0.4745087152559374,0,0,1.471919781494369,1.3538646370462761,PTPRE;PTPRK
carboxylic acid transport (GO:0046942),1/57,0.4014035787249117,0.4758950507063984,0,0,1.9828451043338684,1.8099170724500997,SLC38A1
cellular response to peptide (GO:1901653),1/57,0.4014035787249117,0.4758950507063984,0,0,1.9828451043338684,1.8099170724500997,RPL23
renal system development (GO:0072001),1/57,0.4014035787249117,0.4758950507063984,0,0,1.9828451043338684,1.8099170724500997,CENPF
protein K48-linked ubiquitination (GO:0070936),1/57,0.4014035787249117,0.4758950507063984,0,0,1.9828451043338684,1.8099170724500997,TNFAIP3
negative regulation of nucleic acid-templated transcription (GO:1903507),5/464,0.4014421252259048,0.4758950507063984,0,0,1.2121553602283826,1.1063243816968944,HSPA8;CENPF;ARID5B;PTPRK;SMARCA2
cellular response to interleukin-1 (GO:0071347),2/155,0.40487139618190376,0.4786198976410704,0,0,1.4525312950038773,1.313358174765674,RPS27A;UBA52
receptor metabolic process (GO:0043112),1/58,0.40677631892539173,0.4786198976410704,0,0,1.94795978710822,1.7521739128281448,GRK2
autophagosome assembly (GO:0000045),1/58,0.40677631892539173,0.4786198976410704,0,0,1.94795978710822,1.7521739128281448,TP53INP1
nucleosome assembly (GO:0006334),1/58,0.40677631892539173,0.4786198976410704,0,0,1.94795978710822,1.7521739128281448,NPM1
regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),1/58,0.40677631892539173,0.4786198976410704,0,0,1.94795978710822,1.7521739128281448,LDLRAD4
regulation of phagocytosis (GO:0050764),1/58,0.40677631892539173,0.4786198976410704,0,0,1.94795978710822,1.7521739128281448,RACK1
fat cell differentiation (GO:0045444),1/58,0.40677631892539173,0.4786198976410704,0,0,1.94795978710822,1.7521739128281448,NR4A1
positive regulation of mitotic cell cycle phase transition (GO:1901992),1/58,0.40677631892539173,0.4786198976410704,0,0,1.94795978710822,1.7521739128281448,DDX3X
positive regulation of protein binding (GO:0032092),1/58,0.40677631892539173,0.4786198976410704,0,0,1.94795978710822,1.7521739128281448,RPL11
positive regulation of cell differentiation (GO:0045597),3/258,0.40725615125944736,0.4787874719446195,0,0,1.3078877005347593,1.17489242875857,CDC42;HSP90AB1;TCF4
peptidyl-serine phosphorylation (GO:0018105),2/156,0.40799513726914133,0.47925918856366845,0,0,1.4430259006530193,1.2936727532794137,GRK2;PRKDC
negative regulation of autophagy (GO:0010507),1/59,0.4121011026865712,0.48328220224152435,0,0,1.9142774118558699,1.6969812070380053,EIF4G2
mitotic DNA damage checkpoint signaling (GO:0044773),1/59,0.4121011026865712,0.48328220224152435,0,0,1.9142774118558699,1.6969812070380053,PRKDC
T cell receptor signaling pathway (GO:0050852),2/158,0.4142188432436298,0.48536460657531844,0,0,1.424380704041721,1.255393370876225,PDE4B;PAG1
response to lipopolysaccharide (GO:0032496),2/159,0.4173185922237742,0.487456696794465,0,0,1.4152362445571989,1.2367825097273835,PDE4B;TNFAIP3
apical junction assembly (GO:0043297),1/60,0.4173783556062544,0.487456696794465,0,0,1.8817368120358027,1.6441903856137925,PECAM1
peptidyl-threonine phosphorylation (GO:0018107),1/60,0.4173783556062544,0.487456696794465,0,0,1.8817368120358027,1.6441903856137925,PRKDC
homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),1/60,0.4173783556062544,0.487456696794465,0,0,1.8817368120358027,1.6441903856137925,PECAM1
protein transport (GO:0015031),4/369,0.4211272011295379,0.49143050855494597,0,0,1.2183796477495108,1.0536795139902557,MACF1;NPM1;CENPF;MYH9
B cell differentiation (GO:0030183),1/61,0.4226084996504611,0.4927538709975384,0,0,1.8502808988764046,1.5936637040544372,SLC25A5
double-strand break repair via nonhomologous end joining (GO:0006303),1/62,0.42779195299298617,0.49757113221069454,0,0,1.8198563271320685,1.5452732974879233,PRKDC
positive regulation of cysteine-type endopeptidase activity (GO:2001056),1/62,0.42779195299298617,0.49757113221069454,0,0,1.8198563271320685,1.5452732974879233,DDX3X
glucose metabolic process (GO:0006006),1/62,0.42779195299298617,0.49757113221069454,0,0,1.8198563271320685,1.5452732974879233,PGK1
positive regulation of Ras protein signal transduction (GO:0046579),1/63,0.4329291301101491,0.5027221240804433,0,0,1.7904131931859368,1.4989003303379014,AKAP13
positive regulation of viral process (GO:0048524),1/63,0.4329291301101491,0.5027221240804433,0,0,1.7904131931859368,1.4989003303379014,DDX3X
adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),2/165,0.43574122603724824,0.5055738346253927,0,0,1.3627257287442376,1.1320254341455152,GNAS;WASF2
plasma membrane organization (GO:0007009),1/64,0.43802044180957644,0.5073885770839093,0,0,1.7619047619047619,1.454434231389281,MYH9
lipid homeostasis (GO:0055088),1/64,0.43802044180957644,0.5073885770839093,0,0,1.7619047619047619,1.454434231389281,DDX3X
regulation of MAPK cascade (GO:0043408),2/166,0.43878146277863445,0.5078555429713558,0,0,1.3543475265261127,1.1156489170763422,INSR;YWHAZ
regulation of cell-matrix adhesion (GO:0001952),1/65,0.44306629542028597,0.5111472139848665,0,0,1.7342872191011236,1.411772003621464,MACF1
regulation of cellular catabolic process (GO:0031329),1/65,0.44306629542028597,0.5111472139848665,0,0,1.7342872191011236,1.411772003621464,ITPR1
chemical homeostasis (GO:0048878),1/65,0.44306629542028597,0.5111472139848665,0,0,1.7342872191011236,1.411772003621464,DDX3X
protein autoubiquitination (GO:0051865),1/65,0.44306629542028597,0.5111472139848665,0,0,1.7342872191011236,1.411772003621464,RNF213
peptidyl-serine modification (GO:0018209),2/169,0.44784861412228466,0.5148236493262655,0,0,1.3298149463784297,1.068240371132256,GRK2;PRKDC
cellular response to nutrient levels (GO:0031669),1/66,0.44806709437486814,0.5148236493262655,0,0,1.7075194468452894,1.370817603404935,HSPA8
embryonic organ development (GO:0048568),1/66,0.44806709437486814,0.5148236493262655,0,0,1.7075194468452894,1.370817603404935,RPL10
ERBB signaling pathway (GO:0038127),1/66,0.44806709437486814,0.5148236493262655,0,0,1.7075194468452894,1.370817603404935,HSP90AA1
positive regulation of T cell proliferation (GO:0042102),1/66,0.44806709437486814,0.5148236493262655,0,0,1.7075194468452894,1.370817603404935,RPS3
cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),2/170,0.45085286845550226,0.5176053562608073,0,0,1.3218321226795804,1.0529902742734583,CD164;PECAM1
anion transmembrane transport (GO:0098656),1/67,0.45302323892131435,0.5184193355075363,0,0,1.6815628192032686,1.3314813747820013,SLC25A5
regulation of epidermal growth factor receptor signaling pathway (GO:0042058),1/67,0.45302323892131435,0.5184193355075363,0,0,1.6815628192032686,1.3314813747820013,CDC42
peptidyl-threonine modification (GO:0018210),1/67,0.45302323892131435,0.5184193355075363,0,0,1.6815628192032686,1.3314813747820013,PRKDC
regulation of viral genome replication (GO:0045069),1/67,0.45302323892131435,0.5184193355075363,0,0,1.6815628192032686,1.3314813747820013,DDX3X
regulation of myeloid cell differentiation (GO:0045637),1/68,0.4579351254444111,0.523618004033537,0,0,1.6563810162669796,1.2936795422566587,KMT2C
negative regulation of cellular catabolic process (GO:0031330),1/69,0.46280314699605685,0.5270607267956698,0,0,1.6319398545935229,1.257333746292125,EIF4G2
cell chemotaxis (GO:0060326),1/69,0.46280314699605685,0.5270607267956698,0,0,1.6319398545935229,1.257333746292125,NR4A1
peptidyl-tyrosine phosphorylation (GO:0018108),1/69,0.46280314699605685,0.5270607267956698,0,0,1.6319398545935229,1.257333746292125,INSR
RNA 3'-end processing (GO:0031123),1/69,0.46280314699605685,0.5270607267956698,0,0,1.6319398545935229,1.257333746292125,SRSF3
positive regulation of MAP kinase activity (GO:0043406),1/69,0.46280314699605685,0.5270607267956698,0,0,1.6319398545935229,1.257333746292125,RPS3
neutrophil chemotaxis (GO:0030593),1/70,0.4676276931387506,0.530426615958343,0,0,1.6082071323888618,1.2223706238220045,PDE4B
defense response to Gram-positive bacterium (GO:0050830),1/70,0.4676276931387506,0.530426615958343,0,0,1.6082071323888618,1.2223706238220045,RPL39
regulation of plasma membrane bounded cell projection assembly (GO:0120032),1/70,0.4676276931387506,0.530426615958343,0,0,1.6082071323888618,1.2223706238220045,CDC42
establishment of protein localization to membrane (GO:0090150),1/70,0.4676276931387506,0.530426615958343,0,0,1.6082071323888618,1.2223706238220045,NACA
positive regulation of cell-substrate adhesion (GO:0010811),1/70,0.4676276931387506,0.530426615958343,0,0,1.6082071323888618,1.2223706238220045,CDC42
regulation of hematopoietic stem cell differentiation (GO:1902036),1/71,0.4724091500367019,0.5345682487257416,0,0,1.5851524879614767,1.1887214257809942,PRKDC
gland development (GO:0048732),1/71,0.4724091500367019,0.5345682487257416,0,0,1.5851524879614767,1.1887214257809942,ARID5B
response to metal ion (GO:0010038),1/71,0.4724091500367019,0.5345682487257416,0,0,1.5851524879614767,1.1887214257809942,CALM1
cell junction organization (GO:0034330),1/72,0.47714790026958004,0.5377204922593416,0,0,1.5627472701376801,1.1563216696258989,CDC42
negative regulation of supramolecular fiber organization (GO:1902904),1/72,0.47714790026958004,0.5377204922593416,0,0,1.5627472701376801,1.1563216696258989,HSPA8
cytoskeleton-dependent cytokinesis (GO:0061640),1/72,0.47714790026958004,0.5377204922593416,0,0,1.5627472701376801,1.1563216696258989,SON
extrinsic apoptotic signaling pathway (GO:0097191),1/72,0.47714790026958004,0.5377204922593416,0,0,1.5627472701376801,1.1563216696258989,DDX3X
positive regulation of protein secretion (GO:0050714),1/72,0.47714790026958004,0.5377204922593416,0,0,1.5627472701376801,1.1563216696258989,MYO18A
regulation of immune response (GO:0050776),2/179,0.47746851321125466,0.5377204922593416,0,0,1.2540457722876568,0.9270621934285044,IRF4;HLA-B
negative regulation of cell adhesion (GO:0007162),1/73,0.48184432327148907,0.540076694093399,0,0,1.5409644194756553,1.125110820353292,CD164
"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",1/73,0.48184432327148907,0.540076694093399,0,0,1.5409644194756553,1.125110820353292,HLA-B
chromatin assembly (GO:0031497),1/73,0.48184432327148907,0.540076694093399,0,0,1.5409644194756553,1.125110820353292,NPM1
granulocyte chemotaxis (GO:0071621),1/73,0.48184432327148907,0.540076694093399,0,0,1.5409644194756553,1.125110820353292,PDE4B
response to molecule of bacterial origin (GO:0002237),1/73,0.48184432327148907,0.540076694093399,0,0,1.5409644194756553,1.125110820353292,TNFAIP3
insulin receptor signaling pathway (GO:0008286),1/73,0.48184432327148907,0.540076694093399,0,0,1.5409644194756553,1.125110820353292,INSR
positive regulation of nucleic acid-templated transcription (GO:1903508),5/511,0.4836421813250567,0.541663974191204,0,0,1.0968947344509563,0.7967952387451591,NPM1;IRF4;TP53INP1;TCF4;SMARCA2
negative regulation of protein binding (GO:0032091),1/74,0.48649879492275916,0.5435762125947995,0,0,1.5197783592427274,1.0950320018904065,RACK1
"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",1/74,0.48649879492275916,0.5435762125947995,0,0,1.5197783592427274,1.0950320018904065,MDM4
regulation of peptide hormone secretion (GO:0090276),1/74,0.48649879492275916,0.5435762125947995,0,0,1.5197783592427274,1.0950320018904065,ITPR1
regulation of hematopoietic progenitor cell differentiation (GO:1901532),1/75,0.49111168791416604,0.5474371446584458,0,0,1.499164895232311,1.0660317307484233,PRKDC
fibroblast growth factor receptor signaling pathway (GO:0008543),1/75,0.49111168791416604,0.5474371446584458,0,0,1.499164895232311,1.0660317307484233,HNRNPH1
positive regulation of T cell activation (GO:0050870),1/75,0.49111168791416604,0.5474371446584458,0,0,1.499164895232311,1.0660317307484233,HSPD1
antigen receptor-mediated signaling pathway (GO:0050851),2/185,0.49477378749965495,0.5499411292484512,0,0,1.2125590441789387,0.8532227683879547,PDE4B;PAG1
regulation of BMP signaling pathway (GO:0030510),1/76,0.4956833716058978,0.5499411292484512,0,0,1.4791011235955056,1.038059673729511,NUMA1
regulation of epithelial to mesenchymal transition (GO:0010717),1/76,0.4956833716058978,0.5499411292484512,0,0,1.4791011235955056,1.038059673729511,LDLRAD4
cellular response to hormone stimulus (GO:0032870),1/76,0.4956833716058978,0.5499411292484512,0,0,1.4791011235955056,1.038059673729511,KLF9
positive regulation of interleukin-6 production (GO:0032755),1/76,0.4956833716058978,0.5499411292484512,0,0,1.4791011235955056,1.038059673729511,HSPD1
protein import into nucleus (GO:0006606),1/76,0.4956833716058978,0.5499411292484512,0,0,1.4791011235955056,1.038059673729511,RPL23
negative regulation of developmental process (GO:0051093),1/77,0.5002142120557579,0.5528068278092838,0,0,1.4595653459491424,1.0110684253124462,HUWE1
positive regulation of endothelial cell proliferation (GO:0001938),1/77,0.5002142120557579,0.5528068278092838,0,0,1.4595653459491424,1.0110684253124462,NR4A1
import into nucleus (GO:0051170),1/77,0.5002142120557579,0.5528068278092838,0,0,1.4595653459491424,1.0110684253124462,BACH2
positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),1/77,0.5002142120557579,0.5528068278092838,0,0,1.4595653459491424,1.0110684253124462,INSR
positive regulation of protein modification by small protein conjugation or removal (GO:1903322),1/77,0.5002142120557579,0.5528068278092838,0,0,1.4595653459491424,1.0110684253124462,HUWE1
negative regulation of blood vessel morphogenesis (GO:2000181),1/78,0.5047045721625029,0.556477928598817,0,0,1.4405369910987889,0.9850133030334619,PGK1
antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),1/78,0.5047045721625029,0.556477928598817,0,0,1.4405369910987889,0.9850133030334619,HLA-B
extracellular matrix organization (GO:0030198),3/300,0.5047125398919502,0.556477928598817,0,0,1.1205234159779613,0.7661760826561242,GSN;PECAM1;CD44
negative regulation of NF-kappaB transcription factor activity (GO:0032088),1/79,0.5091548115667478,0.5587728510005919,0,0,1.4219965427830596,0.9598521601922136,TNFAIP3
regulation of neuron differentiation (GO:0045664),1/79,0.5091548115667478,0.5587728510005919,0,0,1.4219965427830596,0.9598521601922136,TCF4
positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),1/79,0.5091548115667478,0.5587728510005919,0,0,1.4219965427830596,0.9598521601922136,RACK1
positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),1/79,0.5091548115667478,0.5587728510005919,0,0,1.4219965427830596,0.9598521601922136,RACK1
mRNA 3'-end processing (GO:0031124),1/79,0.5091548115667478,0.5587728510005919,0,0,1.4219965427830596,0.9598521601922136,SRSF3
innate immune response (GO:0045087),3/302,0.5091566570428226,0.5587728510005919,0,0,1.11291425965339,0.7512166084658652,DDX3X;RPL39;SERINC5
negative regulation of cell differentiation (GO:0045596),2/191,0.5117142089138552,0.5607123262152591,0,0,1.1737063940453771,0.7863703679600301,LDLRAD4;ZFP36L2
negative regulation of Wnt signaling pathway (GO:0030178),2/191,0.5117142089138552,0.5607123262152591,0,0,1.1737063940453771,0.7863703679600301,RNF213;RACK1
regulation of fat cell differentiation (GO:0045598),1/80,0.5135652867259022,0.5614400168444185,0,0,1.4039254729057034,0.9355452131008957,ZFP36L2
glycerophospholipid metabolic process (GO:0006650),1/80,0.5135652867259022,0.5614400168444185,0,0,1.4039254729057034,0.9355452131008957,SERINC5
response to interferon-gamma (GO:0034341),1/80,0.5135652867259022,0.5614400168444185,0,0,1.4039254729057034,0.9355452131008957,RPL13A
negative regulation of protein modification process (GO:0031400),1/81,0.5179363509749813,0.5653979260066969,0,0,1.386306179775281,0.9120548820773493,PRKDC
chemical synaptic transmission (GO:0007268),3/306,0.5179825960596941,0.5653979260066969,0,0,1.097997299729973,0.7222775956444962,HSPA8;GPR176;CALM1
negative regulation of macromolecule metabolic process (GO:0010605),2/194,0.5200445305906166,0.5667766427865477,0,0,1.1551906779661016,0.7553108378375548,HSP90AB1;RACK1
cellular response to tumor necrosis factor (GO:0071356),2/194,0.5200445305906166,0.5667766427865477,0,0,1.1551906779661016,0.7553108378375548,RPS3;ZFP36L2
regulation of G protein-coupled receptor signaling pathway (GO:0008277),1/82,0.5222683545401083,0.5683272968500105,0,0,1.3691219309196838,0.8893456450245969,CALM1
ephrin receptor signaling pathway (GO:0048013),1/82,0.5222683545401083,0.5683272968500105,0,0,1.3691219309196838,0.8893456450245969,CDC42
regulation of defense response (GO:0031347),1/83,0.5265616444809689,0.571683988920042,0,0,1.3523568100849548,0.8673839025270685,AKNA
regulation of interleukin-1 beta production (GO:0032651),1/83,0.5265616444809689,0.571683988920042,0,0,1.3523568100849548,0.8673839025270685,TNFAIP3
regulation of osteoblast differentiation (GO:0045667),1/83,0.5265616444809689,0.571683988920042,0,0,1.3523568100849548,0.8673839025270685,DDX5
nuclear export (GO:0051168),1/84,0.5308165649649703,0.5754229989956401,0,0,1.3359956680655205,0.8461378524243511,SRSF3
lymphocyte differentiation (GO:0030098),1/84,0.5308165649649703,0.5754229989956401,0,0,1.3359956680655205,0.8461378524243511,SLC25A5
negative regulation of defense response (GO:0031348),1/85,0.5350334568389218,0.5790399289971198,0,0,1.320024077046549,0.825577375630834,TNFAIP3
"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",1/85,0.5350334568389218,0.5790399289971198,0,0,1.320024077046549,0.825577375630834,CDC42
cilium assembly (GO:0060271),3/314,0.5353772986921925,0.5790399289971198,0,0,1.069314527915814,0.6680901262237476,DYNC1H1;HSP90AA1;GSN
negative regulation of phosphorylation (GO:0042326),1/86,0.5392126581253696,0.5823004276102736,0,0,1.3044282881692002,0.8056739282064902,PRKDC
positive regulation of proteasomal protein catabolic process (GO:1901800),1/86,0.5392126581253696,0.5823004276102736,0,0,1.3044282881692002,0.8056739282064902,RACK1
"regulation of transcription, DNA-templated (GO:0006355)",20/2244,0.5433441813766254,0.5854366294762807,0,0,0.9952603954572191,0.6071210912172117,DDX17;HSPA8;DDX5;NPM1;INSR;JMJD1C;ARID5B;BAZ2A;PTPRK;SMARCA2;RPL6;BACH2;HSPD1;NR4A1;CENPF;IRF4;TP53INP1;KLF9;TCF4;MDM4
negative regulation of angiogenesis (GO:0016525),1/87,0.5433545038902479,0.5854366294762807,0,0,1.289195192056441,0.7864004429456913,PGK1
protein targeting to membrane (GO:0006612),1/87,0.5433545038902479,0.5854366294762807,0,0,1.289195192056441,0.7864004429456913,NACA
regulation of angiogenesis (GO:0045765),2/203,0.5444642281888293,0.5861872077389597,0,0,1.1029597773842652,0.6705477445739999,PGK1;TNFAIP3
negative regulation of binding (GO:0051100),1/88,0.5474593261516013,0.5885187756129714,0,0,1.2743122820612165,0.7677312380469176,RACK1
regulation of establishment of planar polarity (GO:0090175),1/88,0.5474593261516013,0.5885187756129714,0,0,1.2743122820612165,0.7677312380469176,CDC42
transcription by RNA polymerase II (GO:0006366),3/320,0.548190081294321,0.5888582326696756,0,0,1.0487525093203327,0.6304399398768388,BTF3;NR4A1;DDX5
proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),3/321,0.5503055872858046,0.5902092437473839,0,0,1.0454009433962264,0.6243986872756743,HUWE1;RPS27A;UBA52
regulation of cation channel activity (GO:2001257),1/89,0.5515274539880417,0.5902092437473839,0,0,1.259767620020429,0.7496419319167674,CALM1
positive regulation of inflammatory response (GO:0050729),1/89,0.5515274539880417,0.5902092437473839,0,0,1.259767620020429,0.7496419319167674,RPS19
post-Golgi vesicle-mediated transport (GO:0006892),1/89,0.5515274539880417,0.5902092437473839,0,0,1.259767620020429,0.7496419319167674,HSPA8
protein import (GO:0017038),1/89,0.5515274539880417,0.5902092437473839,0,0,1.259767620020429,0.7496419319167674,HSP90AA1
regulation of inflammatory response (GO:0050727),2/206,0.5524111257029551,0.5907094102279528,0,0,1.0865736124958458,0.6448409282765649,AKNA;TNFAIP3
positive regulation of autophagy (GO:0010508),1/90,0.5555592136888062,0.5927357324995609,0,0,1.2455498043176367,0.7321093639794743,TP53INP1
positive regulation of binding (GO:0051099),1/90,0.5555592136888062,0.5927357324995609,0,0,1.2455498043176367,0.7321093639794743,RPL11
protein complex oligomerization (GO:0051259),1/90,0.5555592136888062,0.5927357324995609,0,0,1.2455498043176367,0.7321093639794743,RNF213
mitotic cell cycle phase transition (GO:0044772),2/209,0.5602605001565434,0.597302516695819,0,0,1.0706624089085401,0.620291933153224,DYNC1H1;HSP90AA1
regulation of endothelial cell proliferation (GO:0001936),1/92,0.5635149187029522,0.6003210733029198,0,0,1.2180516113100384,0.6986274736701248,NR4A1
negative regulation of cell death (GO:0060548),1/94,0.5713289936848839,0.6072777842987642,0,0,1.1917361362812613,0.6671220482050944,KANK2
regulation of kinase activity (GO:0043549),1/94,0.5713289936848839,0.6072777842987642,0,0,1.1917361362812613,0.6671220482050944,INSR
nucleosome organization (GO:0034728),1/94,0.5713289936848839,0.6072777842987642,0,0,1.1917361362812613,0.6671220482050944,NPM1
negative regulation of multicellular organismal process (GO:0051241),2/214,0.5731248562778939,0.6087306669598289,0,0,1.045144440891163,0.5817814159096835,RPS19;LDLRAD4
extracellular structure organization (GO:0043062),2/216,0.5781940207241987,0.6136554341119206,0,0,1.0352711336395797,0.5671689327385655,PECAM1;CD44
external encapsulating structure organization (GO:0045229),2/217,0.580712153728995,0.6158673737977907,0,0,1.0304033635527525,0.5600243078211247,PECAM1;CD44
intracellular protein transport (GO:0006886),3/336,0.5813314719619515,0.6160637481060561,0,0,0.9975429975429976,0.5411014030103806,NPM1;RPL11;HPS4
protein maturation (GO:0051604),1/97,0.5827900226460548,0.6166883237395614,0,0,1.1543188202247192,0.6232494265372677,HSPD1
calcium ion homeostasis (GO:0055074),1/97,0.5827900226460548,0.6166883237395614,0,0,1.1543188202247192,0.6232494265372677,TPT1
cellular response to lipid (GO:0071396),2/219,0.5857154847726892,0.6193221109481714,0,0,1.0208024161003932,0.5460487800634354,PDE4B;TNFAIP3
antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),1/98,0.5865422389024972,0.6197345026080742,0,0,1.14236070890768,0.609461541391426,DYNC1H1
sensory perception of chemical stimulus (GO:0007606),1/99,0.5902608960101774,0.6231995620821739,0,0,1.1306466406787434,0.5960663297257704,GNAS
antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),1/100,0.5939462924164232,0.6261588327926482,0,0,1.1191692202928158,0.5830495378794144,DYNC1H1
organic acid transport (GO:0015849),1/100,0.5939462924164232,0.6261588327926482,0,0,1.1191692202928158,0.5830495378794144,SLC38A1
cellular response to chemical stress (GO:0062197),1/101,0.5975987238944925,0.6285975181847583,0,0,1.1079213483146066,0.5703975521474017,DDX3X
epithelial cell differentiation (GO:0030855),1/101,0.5975987238944925,0.6285975181847583,0,0,1.1079213483146066,0.5703975521474017,PGK1
positive regulation of protein localization to membrane (GO:1905477),1/101,0.5975987238944925,0.6285975181847583,0,0,1.1079213483146066,0.5703975521474017,YWHAZ
regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),2/224,0.5980314655034699,0.6285975181847583,0,0,0.9975568789128111,0.5128558708721266,AKAP13;TNFAIP3
cell junction assembly (GO:0034329),1/102,0.601218483726814,0.6314796657352695,0,0,1.09689620647458,0.558097364087282,CDC42
antigen processing and presentation of exogenous peptide antigen (GO:0002478),1/103,0.6048058624732913,0.6347777506284026,0,0,1.0860872438863185,0.5461365387530054,DYNC1H1
cellular metal ion homeostasis (GO:0006875),1/104,0.6083611483166952,0.637566077888767,0,0,1.0754881640667613,0.5345031838647409,TPT1
regulation of insulin secretion (GO:0050796),1/104,0.6083611483166952,0.637566077888767,0,0,1.0754881640667613,0.5345031838647409,ITPR1
cellular response to DNA damage stimulus (GO:0006974),3/350,0.6090513612358442,0.6378183627997513,0,0,0.9566085931359707,0.4743369325356668,NPM1;PRKDC;RPS3
positive regulation of cellular metabolic process (GO:0031325),1/105,0.6118846266505551,0.6403128947029039,0,0,1.0650929127052722,0.5231859222100053,INSR
regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),1/106,0.615376580458621,0.6430186801699435,0,0,1.0548956661316211,0.5121738643450551,INSR
protein localization to nucleus (GO:0034504),1/106,0.615376580458621,0.6430186801699435,0,0,1.0548956661316211,0.5121738643450551,RPL11
response to calcium ion (GO:0051592),1/107,0.6188372902577597,0.6461590249269764,0,0,1.0448908204367182,0.5014565836993639,CALM1
response to endoplasmic reticulum stress (GO:0034976),1/110,0.6290347232834805,0.6563237296612198,0,0,1.0159777342542007,0.4709755992692885,ITPR1
regulation of ERK1 and ERK2 cascade (GO:0070372),2/238,0.6310545102589603,0.6579473549283354,0,0,0.9377094704586805,0.4316867759624605,YWHAZ;CD44
cellular divalent inorganic cation homeostasis (GO:0072503),1/111,0.6323732125078794,0.6583547971743806,0,0,1.0066905005107252,0.4613416256947912,TPT1
Fc-epsilon receptor signaling pathway (GO:0038095),1/111,0.6323732125078794,0.6583547971743806,0,0,1.0066905005107252,0.4613416256947912,CALM1
protein-containing complex subunit organization (GO:0043933),1/112,0.6356818232848254,0.6608296756345547,0,0,0.9975706043121774,0.45195646366632986,MDM4
Fc receptor signaling pathway (GO:0038093),1/112,0.6356818232848254,0.6608296756345547,0,0,0.9975706043121774,0.45195646366632986,CALM1
activation of protein kinase activity (GO:0032147),1/114,0.6422104709159115,0.6666398377686016,0,0,0.9798150541911107,0.4339005075944154,INSR
positive regulation of kinase activity (GO:0033674),1/114,0.6422104709159115,0.6666398377686016,0,0,0.9798150541911107,0.4339005075944154,INSR
anterograde trans-synaptic signaling (GO:0098916),2/244,0.6445506768962745,0.6685799784472322,0,0,0.9141803240416492,0.40150967118616876,GPR176;CALM1
protein phosphorylation (GO:0006468),4/496,0.6515598863172939,0.6753568142324617,0,0,0.8979790940766551,0.3846816416373176,GRK2;PRKDC;INSR;YWHAZ
adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),1/118,0.6549207688968499,0.6778501612433478,0,0,0.9461250360126765,0.40043891978292484,GNAS
negative regulation of response to external stimulus (GO:0032102),1/118,0.6549207688968499,0.6778501612433478,0,0,0.9461250360126765,0.40043891978292484,TNFAIP3
cytoskeleton organization (GO:0007010),1/120,0.6611065072512863,0.6837537418291365,0,0,0.9301293551128317,0.38492503147229445,TNFAIP3
protein homooligomerization (GO:0051260),1/121,0.6641579003214862,0.6864093667561463,0,0,0.9223314606741573,0.3774506437392849,RNF213
regulation of anatomical structure morphogenesis (GO:0022603),1/123,0.6701789614701605,0.691122054016103,0,0,0.9071191748019893,0.3630386145084013,TNFAIP3
cellular response to organic substance (GO:0071310),1/123,0.6701789614701605,0.691122054016103,0,0,0.9071191748019893,0.3630386145084013,RACK1
positive regulation of epithelial cell proliferation (GO:0050679),1/123,0.6701789614701605,0.691122054016103,0,0,0.9071191748019893,0.3630386145084013,NR4A1
defense response to symbiont (GO:0140546),1/124,0.6731491140394888,0.6931774984194737,0,0,0.8996985475472732,0.3560902555428851,SERINC5
regulation of tumor necrosis factor production (GO:0032680),1/124,0.6731491140394888,0.6931774984194737,0,0,0.8996985475472732,0.3560902555428851,TNFAIP3
synapse organization (GO:0050808),1/126,0.6790098581022191,0.6987055755236032,0,0,0.8852134831460674,0.3426835186945961,CDC42
muscle contraction (GO:0006936),1/129,0.6876055935093058,0.7070379254997862,0,0,0.8643346207865169,0.3237277770903813,CALM1
positive regulation of canonical Wnt signaling pathway (GO:0090263),1/130,0.6904196617618304,0.7094174511513668,0,0,0.8575908021949308,0.3176993673410311,DDX3X
regulation of cell adhesion (GO:0030155),1/133,0.6987115082481125,0.7163812356965835,0,0,0.8379724208375894,0.30042764550421863,CD164
regulation of cell motility (GO:2000145),1/133,0.6987115082481125,0.7163812356965835,0,0,0.8379724208375894,0.30042764550421863,MACF1
defense response to virus (GO:0051607),1/133,0.6987115082481125,0.7163812356965835,0,0,0.8379724208375894,0.30042764550421863,SERINC5
positive regulation of MAPK cascade (GO:0043410),2/274,0.7062563683045094,0.7235940697646923,0,0,0.8121053506148223,0.28243154586758273,INSR;CD44
cellular calcium ion homeostasis (GO:0006874),1/136,0.7067824709974472,0.7236106250688149,0,0,0.8192259675405743,0.2842979039776754,TPT1
neuron projection morphogenesis (GO:0048812),1/140,0.7172102496791465,0.7327007518320438,0,0,0.7954894511357207,0.26440975248369714,CDC42
enzyme linked receptor protein signaling pathway (GO:0007167),1/140,0.7172102496791465,0.7327007518320438,0,0,0.7954894511357207,0.26440975248369714,INSR
transcription initiation from RNA polymerase II promoter (GO:0006367),1/140,0.7172102496791465,0.7327007518320438,0,0,0.7954894511357207,0.26440975248369714,NR4A1
negative regulation of DNA-binding transcription factor activity (GO:0043433),1/143,0.7247883082014563,0.7399097908905514,0,0,0.778564646304795,0.25060100584119255,TNFAIP3
brain development (GO:0007420),1/150,0.7416942376260062,0.756080548269614,0,0,0.7417238518965388,0.22164058588588423,CENPF
regulation of cytokine production (GO:0001817),1/150,0.7416942376260062,0.756080548269614,0,0,0.7417238518965388,0.22164058588588423,HLA-B
cellular response to starvation (GO:0009267),1/158,0.7597540224207232,0.773934643083278,0,0,0.7036427395691691,0.1933332680969042,HSPA8
protein autophosphorylation (GO:0046777),1/159,0.7619213321632278,0.775585631520531,0,0,0.6991537476888067,0.19010827094839838,INSR
double-strand break repair (GO:0006302),1/164,0.772469672140411,0.7857594729514287,0,0,0.6775349831116013,0.1749141456380724,PRKDC
"DNA-templated transcription, initiation (GO:0006352)",1/168,0.780572650646778,0.7934330883007006,0,0,0.66117203794657875,0.1637904703582599,NR4A1
neuron projection development (GO:0031175),1/171,0.7864609706166704,0.7982747620207835,0,0,0.6494051553205552,0.15599502926521966,CDC42
positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),1/171,0.7864609706166704,0.7982747620207835,0,0,0.6494051553205552,0.15599502926521966,AKAP13
positive regulation of ERK1 and ERK2 cascade (GO:0070374),1/172,0.7883886122631473,0.7996593572561872,0,0,0.6455746106840135,0.15349449722714037,CD44
mitochondrion organization (GO:0007005),1/175,0.7940683245723251,0.8048449661200924,0,0,0.6343471522665634,0.14627142676744367,HSPD1
cellular protein localization (GO:0034613),2/329,0.7962515369927714,0.806481749459488,0,0,0.6736121909500855,0.15347589710995613,NPM1;PTPRK
regulation of mitotic cell cycle (GO:0007346),1/178,0.7995964191823784,0.8092919535091262,0,0,0.6235002856598744,0.13944468829728626,MKI67
negative regulation of cytokine production (GO:0001818),1/182,0.8067383039916954,0.8159384557121994,0,0,0.6095971196225712,0.13091460600668475,TNFAIP3
endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),1/185,0.8119280942159534,0.8206025396669785,0,0,0.599566438690767,0.12491576831851395,DYNC1H1
cellular protein modification process (GO:0006464),7/1025,0.8169348087003954,0.8250750843742782,0,0,0.7517076346689816,0.1519922624804042,PTPRE;GRK2;PRKDC;INSR;PTPRK;UBA52;YWHAZ
regulation of GTPase activity (GO:0043087),1/189,0.818632840099593,0.8262019915372137,0,0,0.5866901745158977,0.11740820207030862,RACK1
regulation of signal transduction (GO:0009966),1/198,0.8328620318363504,0.8399653327475347,0,0,0.559630411224548,0.1023492829198739,GRK2
regulation of macromolecule metabolic process (GO:0060255),1/200,0.8358701042759268,0.8424003394655825,0,0,0.5539495228953758,0.0993132091800345,AFF1
generation of neurons (GO:0048699),1/202,0.838824335324858,0.8447776663065817,0,0,0.5483816870702667,0.09638025764815318,USP9X
proteasomal protein catabolic process (GO:0010498),1/205,0.8431568206015445,0.8485386726479373,0,0,0.5402346331791144,0.09216527715665335,HUWE1
positive regulation of GTPase activity (GO:0043547),1/214,0.8554715469345555,0.8603218462793298,0,0,0.5171704383605,0.08073157000929751,RACK1
cilium organization (GO:0044782),1/228,0.8727435370147318,0.8770701692803856,0,0,0.48492798099292184,0.06600526333084518,GSN
inflammatory response (GO:0006954),1/230,0.8750372905547505,0.8787529478394841,0,0,0.48064373681369904,0.06416054400194234,CD44
apoptotic process (GO:0006915),1/231,0.8761687019488552,0.8792668939642331,0,0,0.4785295554469956,0.06325999193152194,HSPD1
regulation of canonical Wnt signaling pathway (GO:0060828),1/253,0.8986369619392574,0.9011772784394391,0,0,0.43626270733012307,0.046626078716525306,DDX3X
protein-containing complex assembly (GO:0065003),1/267,0.9107728941671623,0.9127024977564997,0,0,0.4130058291796908,0.038600229259940166,MDM4
central nervous system development (GO:0007417),1/268,0.9115822645159952,0.9128689014454461,0,0,0.411437949753819,0.03808822517671233,GSN
plasma membrane bounded cell projection assembly (GO:0120031),1/278,0.9192850150369914,0.919933311944634,0,0,0.3963817790938223,0.033359121358775966,GSN
nervous system development (GO:0007399),1/447,0.9828238038599055,0.9828238038599055,0,0,0.24405451705547437,0.0042283465659106335,GSN
